Document And Entity Information
Document And Entity Information | 6 Months Ended |
Nov. 30, 2020 | |
Document Information Line Items | |
Entity Registrant Name | CLS HOLDINGS USA, INC. |
Document Type | S-1 |
Amendment Flag | false |
Entity Central Index Key | 0001522222 |
Entity Filer Category | Non-accelerated Filer |
Document Fiscal Year Focus | 2020 |
Document Fiscal Period Focus | Q2 |
Entity Small Business | true |
Entity Emerging Growth Company | false |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Current assets | |||
Cash and cash equivalents | $ 2,805,516 | $ 2,925,568 | $ 10,525,791 |
Accounts Receivable | 281,827 | 161,409 | 163,571 |
Inventory | 1,388,400 | 575,242 | 746,833 |
Prepaid expenses and other current assets | 297,320 | 234,092 | 390,413 |
Interest receivable - current portion | 0 | 3,322 | 0 |
Notes receivable - current portion | 2,656,224 | 4,042,175 | 850,958 |
Total current assets | 7,429,287 | 7,941,808 | 12,677,566 |
Investment | 0 | 0 | 2,709 |
Note receivable | 0 | 0 | 4,299,042 |
Interest receivable | 0 | 0 | 178,258 |
Property, plant and equipment, net of accumulated depreciation of $868,200 and $546,408, and $1,151,948 | 3,654,780 | 3,775,509 | 1,910,301 |
Right of use assets, operating leases | 1,227,702 | 1,403,429 | 0 |
Intangible assets, net of accumulated amortization of $242,389 and $116,476 and $301,491 | 1,362,621 | 1,421,204 | 1,525,087 |
Goodwill | 557,896 | 557,896 | 25,742,899 |
Other assets | 167,455 | 167,455 | 167,455 |
Total assets | 14,399,741 | 15,267,301 | 46,503,317 |
Current liabilities | |||
Accounts payable and accrued liabilities | 1,430,765 | 1,172,883 | 1,517,127 |
Accrued interest | 267,945 | 222,433 | 474,800 |
Lease liability - operating leases, current | 176,275 | 336,900 | 0 |
Notes payable, net of discount | 5,147,073 | 0 | 3,932,616 |
Contingent liability | 150,000 | 150,000 | 1,000,000 |
Total current liabilities | 7,172,058 | 1,882,216 | 6,924,543 |
Noncurrent liabilities | |||
Lease liability - operating leases, non-current | 1,089,367 | 1,136,151 | 0 |
Convertible notes payable - Long Term, net of discount of $2,238,730 and $3,819,010 | 13,500,150 | 17,644,482 | 14,541,220 |
Total Liabilities | 21,761,575 | 20,662,849 | 21,465,763 |
Commitments and contingencies | 0 | 0 | 0 |
Stockholder's deficit | |||
Preferred stock, $0.001 par value; 20,000,000 shares authorized; no shares issued | 0 | 0 | 0 |
Common stock, $0.0001 par value; 750,000,000 shares authorized at May 31, 2020 and 2019; 126,521,416 and 125,839,095 and 126,571,416 shares issued and outstanding at May 31, 2020 and 2019, respectively | 12,658 | 12,653 | 12,585 |
Additional paid-in capital | 71,211,779 | 71,196,814 | 70,758,025 |
Common stock subscribed | 254,265 | 241,109 | 455,095 |
Accumulated deficit | (78,840,536) | (76,846,124) | (46,188,151) |
Total stockholder's deficit | (7,361,834) | (5,395,548) | 25,037,554 |
Total liabilities and stockholders' deficit | $ 14,399,741 | $ 15,267,301 | $ 46,503,317 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Statement of Financial Position [Abstract] | |||
Property, plant and equipment, accumulated depreciation (in Dollars) | $ 1,151,948 | $ 868,200 | $ 546,408 |
Intangible assets, accumulated amortization (in Dollars) | 301,491 | 242,389 | 116,476 |
Convertible notes payable - Long Term, discount (in Dollars) | $ 0 | $ 2,238,730 | $ 3,819,010 |
Preferred stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 20,000,000 | 20,000,000 | 20,000,000 |
Preferred stock, shares issued | 0 | 0 | 0 |
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 750,000,000 | 750,000,000 | 750,000,000 |
Common stock, shares issued | 126,571,416 | 126,521,416 | 125,839,095 |
Common stock, outstanding | 126,571,416 | 126,521,416 | 125,839,095 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | |
Income Statement [Abstract] | ||||||
Revenue | $ 4,907,889 | $ 3,056,431 | $ 8,688,758 | $ 5,915,446 | $ 11,917,629 | $ 8,459,048 |
Cost of goods sold | 2,209,323 | 1,587,632 | 3,998,183 | 2,999,204 | 5,959,286 | 4,836,166 |
Gross margin | 2,698,566 | 1,468,799 | 4,690,575 | 2,916,242 | 5,958,343 | 3,622,882 |
Selling, general and administrative expenses | 2,801,118 | 2,021,653 | 5,205,561 | 4,319,967 | 8,776,876 | 26,472,057 |
Impairment of goodwill | 0 | 0 | 0 | 0 | 25,185,003 | 0 |
Total operating expenses | 2,801,118 | 2,021,653 | 5,205,561 | 4,319,967 | 33,961,879 | 26,472,057 |
Operating loss | (102,552) | (552,854) | (514,986) | (1,403,725) | (28,003,536) | (22,849,175) |
Other (income) expense: | ||||||
Interest expense, net | 746,824 | 729,120 | 1,479,426 | 1,529,749 | 2,941,131 | 4,447,993 |
Gain on settlement of liabilities | 0 | 0 | 0 | (275,000) | (275,000) | 0 |
Gain on modification of operating leases | 0 | 0 | 0 | 0 | (28,511) | 0 |
Loss on disposal of assets | 0 | 0 | 0 | 0 | 16,817 | 0 |
Loss on revaluation of contingent liability | 0 | 0 | 0 | 0 | 0 | 321,889 |
Total other expense | 746,824 | 729,120 | 1,479,426 | 1,254,749 | 2,654,437 | 4,769,882 |
Loss before income taxes | (849,376) | (1,281,974) | (1,994,412) | (2,658,474) | (30,657,973) | (27,619,057) |
Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
Net loss | $ (849,376) | $ (1,281,974) | $ (1,994,412) | $ (2,658,474) | $ (30,657,973) | $ (27,619,057) |
Net loss per share - basic (in Dollars per share) | $ (0.01) | $ (0.01) | $ (0.02) | $ (0.02) | $ (0.24) | $ (0.27) |
Net loss per share - diluted (in Dollars per share) | $ (0.01) | $ (0.01) | $ (0.02) | $ (0.02) | $ (0.24) | $ (0.27) |
Weighted average shares outstanding - basic (in Shares) | 126,548,887 | 126,421,414 | 126,535,075 | 126,260,495 | 126,390,105 | 102,869,612 |
Weighted average shares outstanding - diluted (in Shares) | 126,548,887 | 126,421,414 | 126,535,075 | 126,260,495 | 126,390,105 | 102,869,612 |
CONSOLIDATED STATEMENT OF CHANG
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) | Common Stock [Member]Issued to Officers [Member] | Common Stock [Member]Common stock issued for exercise of special warrants [Member] | Common Stock [Member]Oasis Acquisition [Member] | Common Stock [Member]Cashless Exercise Of Warrants [Member] | Common Stock [Member]Warrant issued to Consultants [Member] | Common Stock [Member] | Additional Paid-in Capital [Member]Issued to Officers [Member] | Additional Paid-in Capital [Member]Common stock issued for exercise of special warrants [Member] | Additional Paid-in Capital [Member]Oasis Acquisition [Member] | Additional Paid-in Capital [Member]Special Warrants Issued for Cash [Member] | Additional Paid-in Capital [Member]Cashless Exercise Of Warrants [Member] | Additional Paid-in Capital [Member]Warrant Issued Due to Penalty [Member] | Additional Paid-in Capital [Member]Warrants Issued as Compensation for Offering [Member] | Additional Paid-in Capital [Member]Warrants issued to Placement Agent [Member] | Additional Paid-in Capital [Member]Special Warrant Issued Due to Penalty [Member] | Additional Paid-in Capital [Member]Warrant issued to Consultants [Member] | Additional Paid-in Capital [Member] | Stock Payable [Member]Issued to Officers [Member] | Stock Payable [Member]To Be Issued to Officers [Member] | Stock Payable [Member]Warrant issued to Consultants [Member] | Stock Payable [Member] | Retained Earnings [Member] | Issued to Officers [Member] | To Be Issued to Officers [Member] | Oasis Acquisition [Member] | Special Warrants Issued for Cash [Member] | Warrant Issued Due to Penalty [Member] | Warrants Issued as Compensation for Offering [Member] | Warrants issued to Placement Agent [Member] | Special Warrant Issued Due to Penalty [Member] | Total |
Balance at May. 31, 2018 | $ 5,013 | $ 17,628,717 | $ 307,584 | $ (18,569,094) | $ (627,780) | ||||||||||||||||||||||||||
Balance (in Shares) at May. 31, 2018 | 50,128,972 | ||||||||||||||||||||||||||||||
Common stock issued for conversion of debt | $ 370 | 1,295,320 | 1,295,690 | ||||||||||||||||||||||||||||
Common stock issued for conversion of debt, Shares (in Shares) | 3,697,511 | ||||||||||||||||||||||||||||||
Common stock issued in connection with Oasis acquisition | $ 2,206 | $ 15,438,970 | $ 15,441,176 | 25,313 | |||||||||||||||||||||||||||
Common stock issued in connection with Oasis acquisition (in Shares) | 22,058,823 | ||||||||||||||||||||||||||||||
Stock issued for services | $ 73 | 515,240 | (25,313) | 490,000 | |||||||||||||||||||||||||||
Stock issued for services, Shares (in Shares) | 731,250 | ||||||||||||||||||||||||||||||
Common stock issued | $ 62 | $ 5 | $ 281,438 | 47,495 | $ (230,820) | $ 50,680 | 47,500 | ||||||||||||||||||||||||
Common stock issued (in Shares) | 625,000 | 50,000 | |||||||||||||||||||||||||||||
Foreign currency transaction loss on equity offering | 403,588 | 403,588 | |||||||||||||||||||||||||||||
Discount on notes payable and accrued interest | 5,888,707 | 5,888,707 | |||||||||||||||||||||||||||||
Reclasification of deritivate upon adoption of ASU 2017-11 | Accounting Standards Update 2017-11 [Member] | 1,265,751 | 1,265,751 | |||||||||||||||||||||||||||||
Reclasification of deritivate upon adoption of ASU 2017-11 | 1,265,751 | ||||||||||||||||||||||||||||||
Derivative valuation of reset event | 35,883 | 35,883 | |||||||||||||||||||||||||||||
Imputed interest | 807 | 807 | |||||||||||||||||||||||||||||
Net loss | (27,619,057) | (27,619,057) | |||||||||||||||||||||||||||||
Common stock issued | $ 403,644 | $ 403,644 | |||||||||||||||||||||||||||||
Common stock to be issued to consultant | $ (73) | (515,240) | 25,313 | (490,000) | |||||||||||||||||||||||||||
Common stock issued for cash | $ 1,438 | 5,748,562 | 5,750,000 | ||||||||||||||||||||||||||||
Common stock issued for cash (in Shares) | 14,375,000 | ||||||||||||||||||||||||||||||
Warrants issued | $ 9,785,978 | $ 941,972 | $ 2,369,830 | $ 1,413,300 | $ 7,142,550 | $ 9,785,978 | $ 941,972 | $ 2,369,830 | $ 1,413,300 | $ 7,142,550 | |||||||||||||||||||||
Common stock issued for exercise of special warrants | $ 3,347 | $ (3,347) | |||||||||||||||||||||||||||||
Common stock issued for exercise of special warrants (in Shares) | 33,463,838 | ||||||||||||||||||||||||||||||
Units issued as compensation for offering | $ 56 | 557,279 | 557,335 | ||||||||||||||||||||||||||||
Units issued as compensation for offering (in Shares) | 559,750 | ||||||||||||||||||||||||||||||
Cashless exercise of warrant | $ 15 | $ (15) | |||||||||||||||||||||||||||||
Cashless exercise of warrant (in Shares) | 148,951 | ||||||||||||||||||||||||||||||
Balance at May. 31, 2019 | $ 12,585 | 70,758,025 | 455,095 | (46,188,151) | 25,037,554 | ||||||||||||||||||||||||||
Balance (in Shares) at May. 31, 2019 | 125,839,095 | ||||||||||||||||||||||||||||||
Common stock issued for conversion of debt | $ 3 | 25,854 | 25,857 | ||||||||||||||||||||||||||||
Common stock issued for conversion of debt, Shares (in Shares) | 32,319 | ||||||||||||||||||||||||||||||
Stock issued for services | 30,000 | 30,000 | |||||||||||||||||||||||||||||
Common stock issued | $ 55 | 390,445 | (390,500) | ||||||||||||||||||||||||||||
Common stock issued (in Shares) | 550,000 | ||||||||||||||||||||||||||||||
Net loss | (2,658,474) | (2,658,474) | |||||||||||||||||||||||||||||
Common stock issued | 93,902 | 93,902 | |||||||||||||||||||||||||||||
Common stock to be issued to consultant | (30,000) | (30,000) | |||||||||||||||||||||||||||||
Balance at Nov. 30, 2019 | $ 12,643 | 71,174,324 | 188,497 | (48,846,625) | 22,528,839 | ||||||||||||||||||||||||||
Balance (in Shares) at Nov. 30, 2019 | 126,421,414 | ||||||||||||||||||||||||||||||
Balance at May. 31, 2019 | $ 12,585 | 70,758,025 | 455,095 | (46,188,151) | 25,037,554 | ||||||||||||||||||||||||||
Balance (in Shares) at May. 31, 2019 | 125,839,095 | ||||||||||||||||||||||||||||||
Common stock issued for conversion of debt | $ 3 | 25,854 | 25,857 | ||||||||||||||||||||||||||||
Common stock issued for conversion of debt, Shares (in Shares) | 32,321 | ||||||||||||||||||||||||||||||
Common stock issued in connection with Oasis acquisition | 0 | ||||||||||||||||||||||||||||||
Stock issued for services | $ 10 | $ 10 | $ 22,490 | 22,490 | $ (22,500) | 45,000 | 45,000 | ||||||||||||||||||||||||
Stock issued for services, Shares (in Shares) | 100,000 | ||||||||||||||||||||||||||||||
Common stock issued | $ 55 | $ 390,445 | $ (390,500) | ||||||||||||||||||||||||||||
Common stock issued (in Shares) | 550,000 | ||||||||||||||||||||||||||||||
Reclasification of deritivate upon adoption of ASU 2017-11 | 0 | ||||||||||||||||||||||||||||||
Net loss | (30,657,973) | (30,657,973) | |||||||||||||||||||||||||||||
Common stock issued | 154,014 | 154,014 | |||||||||||||||||||||||||||||
Common stock to be issued to consultant | $ (10) | (10) | $ (22,490) | (22,490) | $ 22,500 | (45,000) | (45,000) | ||||||||||||||||||||||||
Balance at May. 31, 2020 | $ 12,653 | 71,196,814 | 241,109 | (76,846,124) | (5,395,548) | ||||||||||||||||||||||||||
Balance (in Shares) at May. 31, 2020 | 126,521,416 | ||||||||||||||||||||||||||||||
Common stock issued in connection with Oasis acquisition | 14,970 | ||||||||||||||||||||||||||||||
Stock issued for services | 25,750 | 25,750 | |||||||||||||||||||||||||||||
Common stock issued | 53,876 | 53,876 | |||||||||||||||||||||||||||||
Net loss | (1,994,412) | (1,994,412) | |||||||||||||||||||||||||||||
Common stock issued | $ 5 | 14,965 | (14,970) | ||||||||||||||||||||||||||||
Common stock issued (in Shares) | 50,000 | ||||||||||||||||||||||||||||||
Common stock to be issued to consultant | (25,750) | (25,750) | |||||||||||||||||||||||||||||
Balance at Nov. 30, 2020 | $ 12,658 | $ 71,211,779 | $ 254,265 | $ (78,840,536) | $ (7,361,834) | ||||||||||||||||||||||||||
Balance (in Shares) at Nov. 30, 2020 | 126,571,416 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 6 Months Ended | 12 Months Ended | ||
Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||||
Net income (loss) | $ (1,994,412) | $ (2,658,474) | $ (30,657,973) | $ (27,619,057) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||
Gain on contingent liabilities | (275,000) | (275,000) | 0 | |
Gain on modification of leases | (28,511) | 0 | ||
Loss on disposal of assets | 0 | 0 | 16,817 | 0 |
Impairment of goodwill | 0 | 0 | 25,185,003 | 0 |
Imputed interest | 0 | 807 | ||
Bad debt expense | 5,992 | 0 | 108,392 | 0 |
Fair value of shares issued to consultants | (25,750) | 45,000 | 490,000 | |
Warrants issued to placement agent | 0 | 3,783,130 | ||
Revaluation of contingent liability | 0 | 0 | 0 | 321,889 |
Amortization of debt discounts | 790,140 | 853,983 | 1,647,664 | 3,576,161 |
Warrants and Special Warrants issued to penalty | 0 | 8,084,522 | ||
Units issued to placement agent | 0 | 557,335 | ||
Non-cash offering costs of equity financing | 0 | 403,588 | ||
Fair value of shares vested by officers | 53,876 | 93,902 | 154,014 | 454,324 |
Depreciation and amortization expense | 342,331 | 171,497 | 449,192 | 288,351 |
Expense from derivative triggering event | 0 | 12,659 | ||
Fair value of shares issued in settlement | 30,000 | 0 | 47,500 | |
Changes in assets and liabilities: | ||||
Accounts receivable | (126,410) | (110,217) | (106,230) | (128,134) |
Prepaid expenses and other current assets | (63,228) | (41,394) | (122,936) | (292,769) |
Inventory | (813,158) | 145,877 | 171,591 | (340,880) |
Interest receivable | 3,322 | (163,446) | (224,517) | (178,258) |
Right of use asset | 175,727 | 1,124,112 | 1,300,392 | 0 |
Accounts payable and accrued expenses | 257,882 | (225,318) | (74,319) | (484,609) |
Accrued compensation | 0 | (120,417) | ||
Accrued interest, related party | 0 | (362) | ||
Deferred rent | 0 | 1,667 | ||
Accrued interest | 258,113 | 838,662 | 1,300,715 | 995,941 |
Due to related parties | 0 | (17,930) | ||
Contingent liability | (850,000) | 0 | ||
Operating lease liability | (207,409) | (992,296) | (1,202,259) | 0 |
Net cash used in operating activities | (1,342,984) | (1,208,112) | (3,162,965) | (10,164,542) |
CASH FLOWS FROM INVESTING ACTIVITIES | ||||
Payments to purchase property, plant and equipment | (163,019) | (1,566,882) | (1,923,338) | (1,037,262) |
Payments to purchase intangible assets | (22,030) | 0 | ||
Loan made to borrower under note receivable | (175,000) | (175,000) | (5,150,000) | |
Proceeds from collection of note receivable | 1,385,951 | 1,682,278 | 0 | |
Payment for investment in Alternative Solutions | 0 | (5,982,710) | ||
Net cash used in investing activities | 1,222,932 | (1,741,882) | (438,090) | (12,169,972) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||||
Proceeds from convertible note payable | 0 | 18,369,000 | ||
Principal payments on notes payable | (2,638,784) | (3,999,168) | (1,060,000) | |
Principal payments on related party notes payable | 0 | (137) | ||
Principal payments on convertible notes payable | 0 | (37,500) | ||
Principal payments on notes payable | (2,638,784) | (3,999,168) | (1,060,000) | |
Proceeds from sale of equity | 0 | 15,535,978 | ||
Net cash provided by financing activities | (2,638,784) | (3,999,168) | 32,807,341 | |
Net increase in cash and cash equivalents | (120,052) | (5,588,778) | (7,600,223) | 10,472,827 |
Cash and cash equivalents at beginning of period | 2,925,568 | 10,525,791 | 10,525,791 | 52,964 |
Cash and cash equivalents at end of period | 2,805,516 | 4,937,013 | 2,925,568 | 10,525,791 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||
Interest paid | 541,412 | 242 | 307,612 | 8,964 |
Income taxes paid | 0 | 0 | ||
NONCASH INVESTING AND FINANCING ACTIVITIES: | ||||
Common stock issued for services, previously accrued | 0 | 17,500 | ||
Capitalized interest on convertible debentures | 212,601 | 753,977 | 1,553,082 | 491,230 |
Convertible note issued for unpaid accrued salary | 0 | 75,000 | ||
Beneficial conversion feature on convertible notes | 0 | 5,888,707 | ||
Note payable exchanged for common stock | 0 | 1,295,690 | ||
Charge to paid-in capital for par value of shares issued in cashless exercise of warrants | 0 | 3,362 | ||
Reclassify derivative liability to paid-in capital upon adoption of ASU 2017-11 | 0 | 1,265,751 | ||
Adoption of lease standard ASU 2016-02 | 1,781,446 | 2,675,310 | 0 | |
Reclassification of deposit to fixed assets | 136,190 | 281,966 | 0 | |
Common stock issued for conversion of convertible notes payable | $ 25,857 | 25,857 | 1,295,690 | |
Shares issued for services from stock payable | $ 14,970 | 0 | 25,313 | |
Capitalized interest on note receivable | 399,453 | 0 | ||
Non-Related Party Debt [Member] | ||||
NONCASH INVESTING AND FINANCING ACTIVITIES: | ||||
Common stock issued for conversion of convertible notes payable | $ 25,857 | $ 0 |
BUSINESS ORGANIZATION AND NATUR
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS | 12 Months Ended |
May 31, 2020 | |
Accounting Policies [Abstract] | |
Nature of Operations [Text Block] | NOTE 1 – BUSINESS ORGANIZATION AND NATURE OF OPERATIONS CLS Holdings USA, Inc. (the “Company”) was originally incorporated as Adelt Design, Inc. (“Adelt”) on March 31, 2011 to manufacture and market carpet binding art. Production and marketing of carpet binding art never commenced. On November 12, 2014, CLS Labs, Inc. (“CLS Labs”) acquired 10,000,000 shares, or 55.6%, of the outstanding shares of common stock of Adelt from its founder, Larry Adelt. On that date, Jeffrey Binder, the Chairman, President and Chief Executive Officer of CLS Labs, was appointed Chairman, President and Chief Executive Officer of the Company. On November 20, 2014, Adelt adopted amended and restated articles of incorporation, thereby changing its name to CLS Holdings USA, Inc. Effective December 10, 2014, the Company effected a reverse stock split of its issued and outstanding common stock at a ratio of 1-for-0.625 (the “Reverse Split”), wherein 0.625 shares of the Company’s common stock were issued in exchange for each share of common stock issued and outstanding. As a result, 6,250,000 shares of the Company’s common stock were issued to CLS Labs in exchange for the 10,000,000 shares that it owned by virtue of the above-referenced purchase from Larry Adelt. On April 29, 2015, the Company, CLS Labs and CLS Merger Inc., a Nevada corporation and wholly owned subsidiary of CLS Holdings (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) and completed a merger, whereby CLS Merger Inc. merged with and into CLS Labs, with CLS Labs remaining as the surviving entity (the “Merger”). Upon the consummation of the Merger, the shares of the common stock of CLS Holdings owned by CLS Labs were extinguished and the former stockholders of CLS Labs were issued an aggregate of 15,000,000 (post Reverse Split) shares of common stock in CLS Holdings in exchange for their shares of common stock in CLS Labs. As a result of the Merger, the Company acquired the business of CLS Labs and abandoned its previous business. The Company has been issued a U.S. patent with respect to its proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter. These concentrates may be ingested in a number of ways, including through vaporization via electronic cigarettes (“e-cigarettes”), and used for a variety of pharmaceutical and other purposes. Internal testing of this extraction method and conversion process has revealed that it produces a cleaner, higher quality product and a significantly higher yield than the cannabinoid extraction processes currently existing in the marketplace. The Company has not commercialized its patented proprietary process or otherwise earned any revenues from it. The Company plans to generate revenues through licensing, fee-for-service and joint venture arrangements related to its patented proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into saleable concentrates. On December 4, 2017, the Company and Alternative Solutions, entered into a Membership Interest Purchase Agreement (the “Acquisition Agreement”), as amended, for the Company to acquire the Oasis LLCs from Alternative Solutions. Pursuant to the Acquisition Agreement, the Company initially contemplated acquiring all of the membership interests in the Oasis LLCs from Alternative Solutions. Just prior to closing, the parties agreed that the Company would instead acquire all of the membership interests in Alternative Solutions, the parent of the Oasis LLCs, from its members, and the membership interests in the Oasis LLCs owned by members other than Alternative Solutions. Pursuant to the Acquisition Agreement, the Company paid a non-refundable deposit of $250,000 upon signing, which was followed by an additional payment of $1,800,000 paid in February 2018, for an initial 10% of each of the Oasis LLCs. At that time, the Company applied for regulatory approval to own an interest in the Oasis LLCs, which approval was received. On June 27, 2018, the Company made the payments to indirectly acquire the remaining 90% of the Oasis LLCs, which were equal to cash in the amount of $5,995,543, a $4.0 million promissory note due in December 2019 (the “Oasis Note”), and 22,058,823 shares of its common stock (the “Purchase Price Shares”) (collectively, the “Closing Consideration”). The cash payment of $5,995,543 was less than the $6,200,000 payment originally contemplated because the Company assumed an additional $204,457 of liabilities. The Company used the proceeds of a Canadian private securities offering to fund the cash portion of the Closing Consideration. The Company then applied for regulatory approval to own the additional 90% in membership interests in the Oasis LLCs, which it received on December 12, 2018. On October 31, 2018, the Company, CLS Massachusetts, Inc., a Massachusetts corporation and a wholly-owned subsidiary of the Company (“CLS Massachusetts”), and In Good Health, Inc., a Massachusetts corporation (“IGH”), entered into an Option Agreement (the “IGH Option Agreement”). Under the terms of the IGH Option Agreement, CLS Massachusetts has an exclusive option to acquire all of the outstanding capital stock of IGH (the “IGH Option”) during the period beginning on the earlier of the date that is one year after the effective date of the conversion and December 1, 2019 and ending on the date that is 60 days after such date. If CLS Massachusetts exercises the IGH Option, the Company, a wholly-owned subsidiary of the Company and IGH will enter into a merger agreement (the form of which has been agreed to by the parties) (the “IGH Merger Agreement”). At the effective time of the merger contemplated by the IGH Merger Agreement, CLS Massachusetts will pay a purchase price of $47,500,000, subject to reduction as provided in the IGH Merger Agreement, payable as follows: $35 million in cash, $7.5 million in the form of a five-year promissory note, and $5 million in the form of restricted common stock of the Company, plus $2.5 million as consideration for a non-competition agreement with IGH’s President, payable in the form of a five-year promissory note. IGH and certain IGH stockholders holding sufficient aggregate voting power to approve the transactions contemplated by the IGH Merger Agreement have entered into agreements pursuant to which such stockholders have, among other things, agreed to vote in favor of such transactions. On October 31, 2018, as consideration for the IGH Option, the Company made a loan to IGH, in the principal amount of $5,000,000, subject to the terms and conditions set forth in that certain loan agreement, dated as of October 31, 2018 between IGH as the borrower and the Company as the lender. The loan is evidenced by a secured promissory note of IGH, which bears interest at the rate of 6% per annum and matures on October 31, 2021. To secure the obligations of IGH to the Company under the loan agreement and the promissory note, the Company and IGH entered into a security agreement dated as of October 31, 2018, pursuant to which IGH granted to the Company a first priority lien on and security interest in all personal property of IGH. If the Company does not exercise the Option on or prior to the date that is 30 days following the end of the option period, the loan amount will be reduced to $2,500,000 as a break-up fee, subject to certain exceptions set forth in the IGH Option Agreement. On August 26, 2019, the parties amended the IGH Option Agreement to, among other things, delay closing until January 2020. By letter agreement dated January 31, 2020, the Company, CLS Massachusetts and IGH extended the IGH Option Agreement to February 4, 2020. On February 4, 2020, CLS Massachusetts exercised the IGH Option. By letter dated February 26, 2020, the Company informed IGH that as a result of its breaches of the IGH Option, which remained uncured, an event of default had occurred under the IGH Note. The Company advised IGH that it was electing to cause the IGH Note to bear interest at the default rate of 15% per annum effective February 26, 2020 and to accelerate all amounts due under the Note. This dispute, including whether IGH breached the IGH Option and whether CLS is entitled to collect default interest, is now in litigation. On January 29, 2019, the Company made a line of credit loan to CannAssist, LLC (“CannAssist”), in the principal amount of up to $500,000, subject to the terms and conditions set forth in that certain Loan Agreement, dated as of January 29, 2019 between CannAssist as the Borrower and the Company as the Lender (the “CannAssist Loan Agreement”). Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company. The loan is evidenced by a secured promissory note of CannAssist (the “CannAssist Note”), which bears interest at the rate of 8% per annum and is personally guaranteed by the two equity owners of CannAssist. To secure the obligations of CannAssist to the Company under the CannAssist Loan Agreement and the CannAssist Note, the Company and CannAssist entered into a security agreement dated as of January 29, 2019, pursuant to which CannAssist granted to the Company a first priority lien on and security interest in all personal property of CannAssist. On March 11, 2019, the Company, through its wholly-owned subsidiary, CLS Massachusetts, entered into a membership interest purchase agreement (the “CannAssist Purchase Agreement”) with CannAssist, each of the members of CannAssist, and David Noble, as the members’ representative, to acquire an 80% ownership interest in CannAssist. After conducting diligence, the parties decided to terminate the CannAssist Purchase Agreement effective August 26, 2019. On August 26, 2019, the Company and CannAssist entered into an agreement to amend the CannAssist Note. Pursuant to the amendment, there will be no additional advances under the CannAssist Note beyond the $150,000 advanced on February 4, 2019, and the $175,000 advanced on June 24, 2019. In addition, the CannAssist Note shall become due and payable in full on or before February 28, 2020. See note 16. On December 23, 2019, the Company received payment in full on the CannAssist loan in the amount of $342,567, which is made up of $325,000 of principal and $17,567 of interest. At May 31, 2020, the Company was owed $0 pursuant to the CannAssist Note. On January 4, 2018, the Attorney General of the United States issued new written guidance concerning the enforcement of federal laws relating to marijuana. The Attorney General’s memorandum stated that previous DOJ guidance specific to marijuana enforcement, including the memorandum issued by former Deputy Attorney General James Cole on August 29, 2013 (as amended on February 14, 2014, the “Cole Memo”) is unnecessary and is rescinded, effective immediately. The Cole Memo told federal prosecutors that in states that had legalized marijuana, they should use their prosecutorial discretion to focus not on businesses that comply with state regulations, but on illicit enterprises that create harms like selling drugs to children, operating with criminal gangs, and selling across state lines. While the rescission did not change federal law, as the Cole Memo and other DOJ guidance documents were not themselves laws, the rescission removed the DOJ’s formal policy that state-regulated cannabis businesses in compliance with the Cole Memo guidelines should not be a prosecutorial priority. Notably, former Attorney General Sessions’ rescission of the Cole Memo has not affected the status of the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (“FinCEN”) memorandum issued by the Department of Treasury, which remains in effect. This memorandum outlines Bank Secrecy Act-compliant pathways for financial institutions to service state-sanctioned cannabis businesses, which echoed the enforcement priorities outlined in the Cole Memo. In addition to his rescission of the Cole Memo, Attorney General Sessions issued a one-page memorandum known as the “Sessions Memorandum”. The Sessions Memorandum explains the DOJ’s rationale for rescinding all past DOJ cannabis enforcement guidance, claiming that Obama-era enforcement policies are “unnecessary” due to existing general enforcement guidance adopted in the 1980s, in chapter 9.27.230 of the U.A. Attorneys’ Manual (“USAM”). The USAM enforcement priorities, like those of the Cole Memo, are based on the use of the federal government’s limited resources and include “law enforcement priorities set by the Attorney General,” the “seriousness” of the alleged crimes, the “deterrent effect of criminal prosecution,” and “the cumulative impact of particular crimes on the community.” Although the Sessions Memorandum emphasizes that cannabis is a federally illegal Schedule I controlled substance, it does not otherwise instruct U.S. Attorneys to consider the prosecution of cannabis-related offenses a DOJ priority, and in practice, most U.S. Attorneys have not changed their prosecutorial approach to date. However, due to the lack of specific direction in the Sessions Memorandum as to the priority federal prosecutors should ascribe to such cannabis activities, there can be no assurance that the federal government will not seek to prosecute cases involving cannabis businesses that are otherwise compliant with state law. |
GOING CONCERN
GOING CONCERN | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Substantial Doubt about Going Concern [Text Block] | Note 2 – Going Concern As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $78,840,536 as of November 30, 2020. The Company’s auditors stated in their opinion on the Company’s financial statements for the year ended May 31, 2020 that there was substantial doubt about the Company’s ability to continue as a going concern, and that further losses were anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. | NOTE 2 – GOING CONCERN As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $76,846,124 as of May 31, 2020. Further losses are anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with the proceeds from the sale of securities, and/or revenues from operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
May 31, 2020 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in US dollars. The Company has adopted a fiscal year end of May 31st. Principals of Consolidation The accompanying consolidated financial statements include the accounts of CLS Holdings USA, Inc., and its direct and indirect wholly owned operating subsidiaries, CLS Nevada, Inc., (“CLS Nevada”), CLS Labs, Inc. (“CLS Labs”), CLS Labs Colorado, Inc. (“CLS Colorado”), CLS Massachusetts, Inc. (“CLS Massachusetts”), and Alternative Solutions, LLC (“Alternative Solutions”). Alternative Solutions is the sole owner of the following three entities (collectively, the “Oasis LLCs”): Serenity Wellness Center, LLC (“Serenity Wellness Center”); Serenity Wellness Products, LLC (“Serenity Wellness Products”); and Serenity Wellness Growers, LLC (“Serenity Wellness Growers”). All material intercompany transactions have been eliminated upon consolidation of these entities. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Reclassification Certain amounts in the prior period have been reclassified to conform to the current period presentation. Cash and Cash Equivalents The Company considers all highly liquid investments with maturities of three months or less to be cash equivalents. The Company had cash and cash equivalents of $2,925,568 and $10,525,791 as of May 31, 2020 and 2019. Allowance for Doubtful Accounts The Company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products. The Company evaluates the collectability of its accounts receivable considering a combination of factors. In circumstances where it is aware of a specific customer’s inability to meet its financial obligations to it, the Company records a specific reserve for bad debts against amounts due in order to reduce the net recognized receivable to the amount it reasonably believe will be collected. For all other customers, the Company recognizes reserves for bad debts based on past write-off experience and the length of time the receivables are past due. The Company had $108,392 and $0 bad debts expense during the years ended May 31, 2020 and 2019, respectively. Inventory Inventories are stated at the lower of cost or market. Cost is determined using a perpetual inventory system whereby costs are determined by acquisition costs of individual items included in inventory. Market is determined based on net realizable value. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable values. Our cannabis products consist of prepackaged purchased goods ready for resale, along with produced edibles and extracts developed under our production license. Property, Plant, and Equipment Property and equipment is recorded at the lower of cost or estimated net recoverable amount, and is depreciated using the straight-line method over its estimated useful life. Property acquired in a business combination is recorded at estimated initial fair value. Property, plant, and equipment are depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based upon the following life expectancy: Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which extend the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation are eliminated and any resulting gain or loss is reflected in operations. Long-Lived Assets The Company reviews its property and equipment and any identifiable intangibles including goodwill for impairment on an annual basis utilizing the guidance set forth in the Statement of Financial Accounting Standards Board ASC 350 “Intangibles – Goodwill and Other” and ASC 360 “Property, Plant, and Equipment”. As a result of the impairment test, it was calculated that the net carrying value of goodwill exceeded the fair value by $25,185,003, and the Company recorded an impairment charge to operations during the year ended May 31, 2020. At May 31, 2020, the net carrying value of goodwill on the Company’s balance sheet was $557,896. Comprehensive Income ASC 220-10-15 “Reporting Comprehensive Income,” establishes standards for reporting and displaying of comprehensive income, its components and accumulated balances. Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, ASC 220-10-15 requires that all items that are required to be recognized under current accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The Company does not have any items of comprehensive income in any of the periods presented. Concentrations of Credit Risk The Company maintains its cash in bank deposit accounts and other accounts, the balances of which at times may be uninsured or exceed federally insured limits. From time to time, some of the Company’s funds are also held by escrow agents; these funds may not be federally insured. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. Advertising and Marketing Costs All costs associated with advertising and promoting products are expensed as incurred. Total recognized advertising and marketing expenses were $836,000 and $1,655,374 for the years ended May 31, 2020 and 2019, respectively. Research and Development Research and development expenses are charged to operations as incurred. The Company incurred research and development costs of $0 for the years ended May 31, 2020 and 2019. Fair Value of Financial Instruments Pursuant to Accounting Standards Codification (“ASC”) No. 825 - Financial Instruments A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows: Level 1 - Quoted prices in active markets for identical assets or liabilities. Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly. Level 3 - Significant unobservable inputs that cannot be corroborated by market data. Derivative Financial Instruments Derivatives are recorded on the condensed consolidated balance sheets at fair value. The conversion features of the convertible notes are embedded derivatives and are separately valued and accounted for on the consolidated balance sheets with changes in fair value recognized during each period of change as a separate component of other income/expense. Fair values for exchange-traded securities and derivatives are based on quoted market prices. The pricing model the Company uses for determining the fair value of its derivatives is the Lattice Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income (see note 20). On June 1, 2018, the Company adopted ASU 2017-11 and accordingly reclassified the fair value of the reset provisions embedded in convertible notes payable and certain warrants with embedded anti-dilutive provisions from liability to equity in the aggregate amount of $1,265,751. The following assumptions were used for the valuation of the derivative liability related to the convertible notes that contain a derivative component: There were no derivative liabilities on the Company’s balance sheet during the year ended May 31, 2020 which required valuation. For the year ended May 31, 2019 - That the quoted market price of the common stock, which decreased from $0.6865 as of June 1, 2018 to $0.2999 as of May 31, 2019, would fluctuate with the Company’s projected volatility; - That the conversion price of the YAN II PN Convertible Notes would be equal to $0.40 with a full reset feature, and upon default, 75% of the lowest Volume Weighted Average Price (the “VWAP”) in the 15 consecutive trading days ending on the trading day that is immediately prior to the applicable conversion date; - That the new convertible notes issued during this period with full resets would be initially issued with conversion prices of $0.40, which were not reset as a result of subsequent transactions; - That an event of default at 24% or 15% interest rate would occur 0% of the time, increasing 1.00% per month to a maximum of 25%, and that instead of a penalty, there would be an alternative conversion price; - That the projected volatility curve from an annualized analysis for each valuation period would be based on the historical volatility of the Company and the remaining term for each convertible note. The projected volatility was in the range of 97.4% to 242.8% during the year ended May 31, 2019; - That the Company would redeem the convertible notes, projected initially at 0% of the time and increasing monthly by 1.00% to a maximum of 10.0%; - That the holder would automatically convert the notes at the maximum of 2 times the conversion price or the stock price if the common stock underlying the 2017 Convertible Notes was eligible for sale in compliance with securities laws and the Company was not in default; - That unless an Event of Default occurred, the holder would sell, per trading day, an amount of Common Stock up to the greater of (i) $5,000 or (ii) 25% multiplied by the “Aggregate Amount,” as defined in the YAN II PN Convertible Notes. Revenue Recognition Revenue from the sale of cannabis products is recognized by Oasis at the point of sale, at which time payment is received. Management estimates an allowance for sales returns. The Company also recognizes revenue from Serenity Wellness Products LLC and Serenity Wellness Growers LLC, d/b/a City Trees (“City Trees”). City Trees recognizes revenue from the sale of the following cannabis products and services to licensed dispensaries within the State of Nevada: ● Premium organic medical cannabis sold wholesale to licensed retailers ● Recreational marijuana cannabis products sold wholesale to licensed distributors and retailers ● Extraction products such as oils and waxes derived from in-house cannabis production ● Processing and extraction services for licensed medical cannabis cultivators in Nevada ● High quality cannabis strains in the form of vegetative cuttings for sale to licensed medical cannabis cultivators in Nevada Effective June 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from commercial sales of products and licensing agreements by applying the following steps: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to each performance obligation in the contract; and (5) recognizing revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of the service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. There was no impact on the Company’s financial statements as a result of adopting Topic 606 for the years ended May 31, 2020 and 2019. Disaggregation of Revenue The following table represents a disaggregation of revenue for the years ended May 31, 2020 and 2019: 2020 2019 Cannabis Dispensary $ 9,365,105 $ 5,492,312 Cannabis Production 2,552,524 2,966,736 $ 11,917,629 $ 8,459,048 Basic and Diluted Earnings or Loss Per Share Basic net earnings per share is based on the weighted average number of shares outstanding during the period, while fully diluted net earnings per share is based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of options and warrants to purchase common stock, and convertible debt. Basic and diluted net loss per share are computed based on the weighted average number of shares of common stock outstanding during the period. At May 31, 2020 and 2019, the Company excluded from the calculation of fully diluted shares outstanding the following shares because the result would have been anti-dilutive: At May 31, 2020 a total of 88,130,526 shares (54,835,145 issuable upon the exercise of warrants; 7,676,974 issuable upon the exercise of unit warrants; 25,131,739 issuable upon the conversion of convertible notes payable and accrued interest; and 486,668 in stock to be issued). At May 31, 2019, the Company excluded from the calculation of fully diluted shares outstanding a total of 86,439,117 shares (54,818,985 issuable upon the exercise of warrants; 7,676,974 issuable upon the exercise of unit warrants; 23,261,393 issuable upon the conversion of convertible notes payable and accrued interest; and 681,764 in stock to be issued). The Company uses the treasury stock method to calculate the impact of outstanding stock options and warrants. Stock options and warrants for which the exercise price exceeds the average market price over the period have an anti-dilutive effect on earnings per common share and, accordingly, are excluded from the calculation. A net loss causes all outstanding stock options and warrants to be antidilutive. As a result, the basic and dilutive losses per common share are the same for the years ended May 31, 2020 and 2019. Income Taxes The Company accounts for income taxes under the asset and liability method in accordance with ASC 740. The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The components of the deferred tax assets and liabilities are classified as current and non-current based on their characteristics. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. Section 280E of the Internal Revenue Code, as amended, prohibits businesses from deducting certain expenses associated with trafficking controlled substances (within the meaning of Schedule I and II of the Controlled Substances Act). The IRS has invoked Section 280E in tax audits against various cannabis businesses in the U.S. that are permitted under applicable state laws. Although the IRS has issued a clarification allowing the deduction of certain expenses, the bulk of operating costs and general administrative costs are generally not permitted to be deducted. The operations of certain of the Company’s subsidiaries are subject to Section 280E. This results in permanent differences between ordinary and necessary business expenses deemed non-deductible under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income or loss. Commitments and Contingencies Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims brought to such legal counsel’s attention as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the nature of the guarantee would be disclosed. Recent Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Codification (“ASC”) No. 2016-02, Leases (Topic 842): Accounting for Leases. This update requires that lessees recognize right-of-use assets and lease liabilities that are measured at the present value of the future lease payments at the lease commencement date. The recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee will largely remain unchanged and shall continue to depend on its classification as a finance or operating lease. The Company has performed a comprehensive review in order to determine what changes were required to support the adoption of this new standard. The Company adopted the ASU and related amendments on June 1, 2019 and has elected certain practical expedients permitted under the transition guidance. The Company has elected the optional transition method that allows for a cumulative-effect adjustment in the period of adoption and will not restate prior periods. Under the new guidance, the majority of the Company’s leases continue to be classified as operating. During the first quarter of fiscal 2020, the Company completed its implementation of its processes and policies to support the new lease accounting and reporting requirements. This resulted in an initial increase in both its total assets of $2,703,821 and total liabilities in the amount of $2,675,310. In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment, which simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, current U.S. GAAP requires the performance of procedures to determine the fair value at the impairment testing date of assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, the amendments under this ASU require the goodwill impairment test to be performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The ASU became effective for the Company on January 1, 2020. The adoption of this ASU did not have a material impact on our consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230). The update addresses eight specific cash flow issues and is intended to reduce diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This update is effective for reporting periods beginning after December 15, 2017, including interim periods within the reporting period. Adoption of ASU 2016-15 did not have a material effect on our financial statements. In May 2017, the FASB issued ASU No. 2017-09, Stock Compensation - Scope of Modification Accounting, which provides guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The ASU requires that an entity account for the effects of a modification unless the fair value (or calculated value or intrinsic value, if used), vesting conditions and classification (as equity or liability) of the modified award are all the same as for the original award immediately before the modification. The ASU became effective for the Company on January 1, 2018, and is applied to an award modified on or after the adoption date. Adoption of ASU 2017-09 did not have a material effect on the Company’s financial statements. Effective June 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products and licensing agreements by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of a service has been rendered to a customer or delivery has occurred; (3) the amount of the fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. There was no impact on the Company’s financial statements as a result of adopting ASC 606. In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the codification, to a scope exception. Those amendments do not have an accounting effect. The amendments in Part I of this update became effective the Company on June 1, 2019. The adoption of ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815) did not have a material effect on the Company’s financial statements. On June 1, 2018, the Company adopted ASU 2017-11 and accordingly reclassified the fair value of the reset provisions embedded in convertible notes payable and certain warrants with embedded anti-dilutive provisions from liability to equity in the aggregate amount of $1,265,751. There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s consolidated financial position, results of operations or cash flows. |
ACQUISITION OF ALTERNATIVE SOLU
ACQUISITION OF ALTERNATIVE SOLUTIONS | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Business Combinations [Abstract] | ||
Business Combination Disclosure [Text Block] | Note 3 – Acquisition of Alternative Solutions On June 27, 2018, the Company closed on the purchase of all of the membership interests in Alternative Solutions and its three operating subsidiaries (collectively, the “Oasis LLCs”) from the members of such entities (other than Alternative Solutions). The Oasis LLCs operate a fully integrated cannabis business in Las Vegas, Nevada, including a grow; extraction, conversion and processing facility; and a retail dispensary. The closing occurred pursuant to a Membership Interest Purchase Agreement (the “Acquisition Agreement”) entered into between the Company and Alternative Solutions on December 4, 2017, as amended. Pursuant to the Acquisition Agreement, the Company initially contemplated acquiring all of the membership interests in the Oasis LLCs from Alternative Solutions. Just prior to closing, the parties agreed that the Company would instead acquire all of the membership interests in Alternative Solutions, the parent of the Oasis LLCs, from its members, and the membership interests in the Oasis LLCs owned by members other than Alternative Solutions. The revised structure of the transaction is referenced in the Oasis Note, which modified the Acquisition Agreement. Pursuant to the Acquisition Agreement, the Company paid a non-refundable deposit of $250,000 upon signing, which was followed by an additional payment of $1,800,000 paid in February 2018, for an initial 10% of each of the Oasis LLCs. At that time, the Company applied for regulatory approval to own an interest in the Oasis LLCs, which approval was received. On June 27, 2018, the Company made the payments to indirectly acquire the remaining 90% of the Oasis LLCs, which were equal to cash in the amount of $5,995,543, a $4.0 million promissory note due in December 2019 (see note 15), (the “Oasis Note”), and 22,058,823 shares of its common stock (see note 17), (the “Purchase Price Shares”) (collectively, the “Closing Consideration”). The cash payment of $5,995,543 was less than the $6,200,000 payment originally contemplated because the Company assumed an additional $204,457 of liabilities. The Company used the proceeds of a Canadian private securities offering to fund the cash portion of the Closing Consideration (see note 17). The Company then applied for regulatory approval to own the additional 90% in membership interests in the Oasis LLCs, which it received on December 12, 2018. On August 14, 2019, the Company made a prepayment in the amount of $2,500,000, which, along with certain legal fees and other costs in the aggregate amount of $138,784, was applied to the amount due under the $4.0 million promissory note. The Company repaid the balance due under the Oasis Note on December 31, 2019. The number of Purchase Price Shares was equal to 80% of the offering price of the Company’s common stock in its last equity offering, which price was $0.34 per share. The sellers were also entitled to a $1,000,000 payment from the Company on May 30, 2020 if the Oasis LLCs maintained an average revenue of $20,000 per day during the 2019 calendar year. The fair value of this contingent consideration was $678,111 at the acquisition date as determined by the Company’s outside valuation consultants. At May 31, 2019, the Company increased the value of this contingent consideration to $1,000,000 and charged the amount of $321,889 to operations during the year ended May 31, 2019. This amount was recorded as a contingent liability on the Company’s balance sheet at May 31, 2019. The full amount of the bonus payment was earned, and on May 27, 2020, the Company made a payment in the amount of $850,000 to the sellers. The Company deposited the balance due to sellers of $150,000 with an escrow agent to hold pending the outcome of a tax audit. During the year ended May 31, 2020, the State of Nevada notified the Oasis LLCs that it would be conducting a tax audit for periods both before and after the closing of the sale to CLS. The Oasis LLCs have not yet received the demand from the State of Nevada with the precise amount due and the amount escrowed is the Company’s best estimate of the pre-closing tax liability. If the ultimate tax liability is less than $150,000, the balance of the escrowed amount will be paid to sellers. As of November 30, 2020, the $150,000 remains a liability on the Company’s balance sheet and $150,0000 in recorded in an escrow account in the asset section of the Company’s balance sheet. The acquisition date estimated fair value of the consideration transferred totaled $27,975,650, which consisted of the following: Initial purchase price $ 2,050,000 Cash paid in connection with transaction 5,995,543 Note payable 3,810,820 Contingent consideration 678,111 Common stock 15,441,176 Total purchase price $ 27,975,650 Net tangible assets $ 595,151 Intangible assets 1,637,600 Goodwill 25,742,899 Total purchase price $ 27,975,650 The above estimated fair value of the intangible assets is based on a preliminary purchase price allocation prepared by a third party valuation expert. During the preliminary purchase price allocation period, which may be up to one year from the business combination date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. After the preliminary purchase price allocation period, the Company may record adjustments to assets acquired or liabilities assumed subsequent to the purchase price allocation period in its operating results in the period in which the adjustments were determined. The Company assessed these intangible assets as of May 31, 2020 for purposes of determining if an impairment existed as set forth in ASC 350 – Intangibles – Goodwill and Other and ASC 360 – Property Plant and Equipment. Pursuant to ASC 360, the Company recorded an impairment of goodwill in the amount of $25,185,003 based upon the difference between the carrying value of $25,742,899 and the fair value $557,896. Fair value was based upon the price of the Company’s common stock at May 31, 2020 of $0.06 per share. (see note 12). At November 30, and May 31, 2020, the net amount of goodwill on the Company’s balance sheet was $557,896. The Company recognized revenue from the Oasis LLCs in the amounts of $4,907,889 and $3,056,431 for the three months ended November 30, 2020 and 2019, respectively. The Company recognized revenue from the Oasis LLCs in the amounts of $8,688,758 and $5,915,446 for the six months ended November 30, 2020 and 2019, respectively. | NOTE 4 – ACQUISITION OF ALTERNATIVE SOLUTIONS On June 27, 2018, the Company closed on the purchase of all of the membership interests in Alternative Solutions and its three operating subsidiaries (collectively, the “Oasis LLCs”) from the members of such entities (other than Alternative Solutions). The Oasis LLCs operate a fully integrated cannabis business in Las Vegas, Nevada, including a grow; extraction, conversion and processing facility; and a retail dispensary. The closing occurred pursuant to a Membership Interest Purchase Agreement (the “Acquisition Agreement”) entered into between the Company and Alternative Solutions on December 4, 2017, as amended. Pursuant to the Acquisition Agreement, the Company initially contemplated acquiring all of the membership interests in the Oasis LLCs from Alternative Solutions. Just prior to closing, the parties agreed that the Company would instead acquire all of the membership interests in Alternative Solutions, the parent of the Oasis LLCs, from its members, and the membership interests in the Oasis LLCs owned by members other than Alternative Solutions. The revised structure of the transaction is referenced in the Oasis Note, which modified the Acquisition Agreement. Pursuant to the Acquisition Agreement, the Company paid a non-refundable deposit of $250,000 upon signing, which was followed by an additional payment of $1,800,000 paid in February 2018, for an initial 10% of each of the Oasis LLCs. At that time, the Company applied for regulatory approval to own an interest in the Oasis LLCs, which approval was received. On June 27, 2018, the Company made the payments to indirectly acquire the remaining 90% of the Oasis LLCs, which were equal to cash in the amount of $5,995,543, a $4.0 million promissory note due in December 2019 (see note 16), (the “Oasis Note”), and 22,058,823 shares of its common stock (see note 18), (the “Purchase Price Shares”) (collectively, the “Closing Consideration”). The cash payment of $5,995,543 was less than the $6,200,000 payment originally contemplated because the Company assumed an additional $204,457 of liabilities. The Company used the proceeds of a Canadian private securities offering to fund the cash portion of the Closing Consideration (see note 18). The Company then applied for regulatory approval to own the additional 90% in membership interests in the Oasis LLCs, which it received on December 12, 2018. On August 14, 2019, the Company made a prepayment in the amount of $2,500,000, which, along with certain legal fees and other costs in the aggregate amount of $138,784, was applied to the amount due under the $4.0 million promissory note. The Company repaid the balance due under the Oasis Note on December 31, 2019. The number of Purchase Price Shares was equal to 80% of the offering price of the Company’s common stock in its last equity offering, which price was $0.34 per share. The Oasis Note is secured by a first priority security interest over the membership interests in Alternative Solutions and the Oasis LLCs, as well as by the assets of the Oasis LLCs. The Company also delivered a confession of judgment to a representative of the sellers that will become effective, in general, if the Company defaults under the Oasis Note. A claim was made that Oasis owed certain amounts to a consultant at the acquisition date; Oasis disputed this claim. This claim was accrued on the Company’s balance sheet as of May 31, 2019, and was resolved during the year ended May 31, 2020. The sellers were also entitled to a $1,000,000 payment from the Company on May 30, 2020 if the Oasis LLCs maintained an average revenue of $20,000 per day during the 2019 calendar year. The fair value of this contingent consideration was $678,111 at the acquisition date as determined by the Company’s outside valuation consultants. At May 31, 2019, the Company increased the value of this contingent consideration to $1,000,000 and charged the amount of $321,889 to operations during the year ended May 31, 2019. This amount was recorded as a contingent liability on the Company’s balance sheet at May 31, 2019. The full amount of the bonus payment was earned, and on May 27, 2020, the Company made a payment in the amount of $850,000 to the sellers. The Company deposited the balance due to sellers of $150,000 with an escrow agent to hold pending the outcome of a tax audit. During the year ended May 31, 2020, the State of Nevada notified the Oasis LLCs that it would be conducting a tax audit for periods both before and after the closing of the sale to CLS. The Oasis LLCs have not yet received the demand from the State of Nevada with the precise amount due and the amount escrowed is the Company’s best estimate of the pre-closing tax liability. If the ultimate tax liability is less than $150,000, the balance of the escrowed amount will be paid to sellers. As of May 31, 2020, the $150,000 remains a liability on the Company’s balance sheet and $150,0000 in recorded in an escrow account in the asset section of the Company’s balance sheet. The acquisition date estimated fair value of the consideration transferred totaled $27,975,650, which consisted of the following: Initial purchase price $ 2,050,000 Cash paid in connection with transaction 5,995,543 Note payable 3,810,820 Contingent consideration 678,111 Common stock 15,441,176 Total purchase price $ 27,975,650 Net tangible assets $ 595,151 Intellectual property 319,600 License & customer relationships 990,000 Tradenames 301,000 Non-compete agreements 27,000 Goodwill 25,742,899 Total purchase price $ 27,975,650 The above estimated fair value of the intangible assets is based on a preliminary purchase price allocation prepared by a third party valuation expert. During the preliminary purchase price allocation period, which may be up to one year from the business combination date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. After the preliminary purchase price allocation period, the Company may record adjustments to assets acquired or liabilities assumed subsequent to the purchase price allocation period in its operating results in the period in which the adjustments were determined. The Company assessed these intangible assets as of May 31, 2020 for purposes of determining if an impairment exists as set forth in ASC 350 – Intangibles – Goodwill and Other and ASC 360 – Property Plant and Equipment. Pursuant to ASC 360, the Company recorded an impairment of goodwill in the amount of $25,185,003 based upon the difference between the carrying value of $25,742,899 and the fair value $557,896. Fair value was based upon the price of the Company’s common stock at May 31, 2020 of $0.06 per share. (see note 12). At May 31, 2020, the net amount of goodwill on the Company’s balance sheet was $557,896. The Company recognized revenue from the Oasis LLCs in the amount of $11,917,629 and $8,459,048 for the years ended May 31, 2020 and 2019, respectively. Pro forma results The following table sets forth the unaudited pro forma results of the Company as if the acquisition of the Oasis LLCs was effective on June 1, 2018. These combined results are not necessarily indicative of the results that may have been achieved had the companies always been combined. Twelve months ended May 31, 2019 (unaudited) Revenues $ 9,759,956 Net loss $ (26,671,841 ) Basic net loss per share $ (0.26 ) Diluted net loss per share $ (0.26 ) Weighted average shares - basic 102,869,612 Weighted average shares - diluted 102,869,612 |
JOINT VENTURE AND OPTIONS TRANS
JOINT VENTURE AND OPTIONS TRANSACTION | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Equity Method Investments and Joint Ventures [Abstract] | ||
Equity Method Investments and Joint Ventures Disclosure [Text Block] | Note 4 – Joint Venture and Options Transaction In Good Health On October 31, 2018, the Company, CLS Massachusetts, and IGH, which converted to a for-profit corporation on November 6, 2018 (the “Conversion”), entered into the IGH Option Agreement. Under the terms of the IGH Option Agreement, CLS Massachusetts had an exclusive option to acquire all of the outstanding capital stock of IGH (the “IGH Option”) during the period beginning on the earlier of the date that is one year after the effective date of the Conversion and December 1, 2019, and ending on the date that is 60 days after such date (the “Option Period”). If CLS Massachusetts exercised the IGH Option, the Company, a wholly-owned subsidiary of the Company and IGH would enter into the IGH Merger Agreement (the form of which had been agreed to by the parties). At the effective time of the merger contemplated by the IGH Merger Agreement, CLS Massachusetts would pay a purchase price of $47,500,000, subject to reduction as provided in the IGH Merger Agreement, payable as follows: $35 million in cash, $7.5 million in the form of a five-year promissory note, and $5 million in the form of restricted common stock of the Company, plus $2.5 million as consideration for a non-competition agreement with IGH’s President, payable in the form of a five-year promissory note. IGH and certain IGH stockholders holding sufficient aggregate voting power to approve the transactions contemplated by the IGH Merger Agreement entered into agreements pursuant to which such stockholders, among other things, agreed to vote in favor of such transactions. On October 31, 2018, as consideration for the IGH Option, the Company made a loan to IGH (the “IGH Loan”), in the principal amount of $5,000,000 (the “IGH Loan Amount”), subject to the terms and conditions set forth in that certain Loan Agreement, dated as of October 31, 2018 between IGH as the borrower and the Company as the lender (the “IGH Loan Agreement”) (see note 9). The IGH Loan is evidenced by a secured promissory note of IGH (the “IGH Note”), which bears interest at the rate of 6% per annum and matures on October 31, 2021. The Company recorded interest income in the amounts of $50,162 and $75,616 on the IGH Loan during the three months ended November 30, 2020 and 2019, respectively. The Company recorded interest income in the amounts of $110,727 and $150,411 on the IGH Loan during the six months ended November 30, 2020 and 2019, respectively. On March 1, 2020, the Company capitalized interest in the amount of $399,453 into the principal amount due. During the three and six months ended November 30, 2020, the Company received payments on the IGH Note in the amounts of $750,000 and $1,500,000, which comprise $688,869 and $697,082 of principal and $61,131 and $52,918 of interest, respectively. As of November 30, 2020, the principal balance of the IGH Note was $2,656,224 and the interest receivable was $0. To secure the obligations of IGH to the Company under the IGH Loan Agreement and the IGH Note, the Company and IGH entered into a Security Agreement dated as of October 31, 2018 (the “IGH Security Agreement”), pursuant to which IGH granted to the Company a first priority lien on and security interest in all personal property of IGH. If the Company did exercise the IGH Option on or prior to the date that is 30 days following the end of the Option Period, the IGH Loan Amount would be reduced to $2,500,000 as a break-up fee (the “Break-Up Fee”), except in the event of a Purchase Exception (as defined in the IGH Option Agreement), in which case the Break-Up Fee would not apply and there would be no reduction to the Loan Amount. On August 26, 2019, the parties amended the IGH Option to, among other things, extend the Option Period and delay closing until January 2020. By letter agreement dated January 31, 2020, the Company, CLS Massachusetts and IGH extended the IGH Option Agreement to February 4, 2020. On February 4, 2020, CLS Massachusetts exercised the IGH Option. By letter dated February 26, 2020, the Company informed IGH that as a result of its breaches of the IGH Option, which remained uncured, an event of default had occurred under the IGH Note. The Company advised IGH that it was electing to cause the IGH Note to bear interest at the default rate of 15% per annum effective February 26, 2020 and to accelerate all amounts due under the Note. This dispute, including whether IGH breached the IGH Option and whether CLS is entitled to collect default interest, is now in litigation. On March 3, 2020, the Company filed a claim for declaratory relief, among other things, requesting the court declare that CLS Massachusetts had validly exercised the IGH Option and instruct IGH to comply with its diligence requests and ultimately execute a merger agreement with CLS and CLS Massachusetts. The dispute regarding whether CLS Massachusetts properly exercised the IGH Option arose after CLS Massachusetts delivered a notice of exercise to IGH and IGH subsequently asserted that CLS Massachusetts’ exercise was invalid. CLS and CLS Massachusetts intend to pursue this suit vigorously and believe that their claims are meritorious, however, there can be no assurance as to the ultimate outcome of this matter. CannAssist On January 29, 2019, the Company made a line of credit loan to CannAssist in the principal amount of up to $500,000, subject to the terms and conditions set forth in the CannAssist Loan Agreement. Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company. The loan is evidenced by the CannAssist Note, which bears interest at the rate of 8% per annum and is personally guaranteed by the two equity owners of CannAssist. On June 24, 2019, the Company advanced the sum of $175,000 to CannAssist, increasing the balance due to the Company under the CannAssist Note to $325,000. The Company recorded interest income in the amounts of $0 and $6,482 on the CannAssist loan during the three months ended November 30, 2020 and 2019, respectively. The Company recorded interest income in the amounts of $0 and $13,035 on the CannAssist loan during the six months ended November 30, 2020 and 2019, respectively. To secure the obligations of CannAssist to the Company under the CannAssist Loan Agreement and the CannAssist Note, the Company and CannAssist entered into a security agreement dated as of January 29, 2019, pursuant to which CannAssist granted to the Company a first priority lien on and security interest in all personal property of CannAssist. On March 11, 2019, the Company, through its wholly-owned subsidiary, CLS Massachusetts, entered into the CannAssist Purchase Agreement with CannAssist, each of the members of CannAssist, and David Noble, as the members’ representative. On August 26, 2019, the Company and CannAssist amended the CannAssist Note. Pursuant to the amendment, there will be no additional advances under the CannAssist Note beyond the $150,000 advanced on February 4, 2019, and the $175,000 advanced on June 24, 2019. In addition, the CannAssist Note was to become due and payable in full on or before February 28, 2020. Finally, the Company and CannAssist terminated the CannAssist Purchase Agreement. On December 23, 2019, the Company received payment in full on the CannAssist loan in the amount of $342,567, which comprises $325,000 of principal and $17,567 of interest. | NOTE 5 – JOINT VENTURE AND OPTIONS TRANSACTION In Good Health On October 31, 2018, the Company, CLS Massachusetts, and IGH, which converted to a for-profit corporation on November 6, 2018 (the “Conversion”), entered into the IGH Option Agreement. Under the terms of the IGH Option Agreement, CLS Massachusetts has an exclusive option to acquire all of the outstanding capital stock of IGH (the “IGH Option”) during the period beginning on the earlier of the date that is one year after the effective date of the Conversion and December 1, 2019, and ending on the date that is 60 days after such date (the “Option Period”). If CLS Massachusetts exercises the IGH Option, the Company, a wholly-owned subsidiary of the Company and IGH will enter into the IGH Merger Agreement (the form of which has been agreed to by the parties). At the effective time of the merger contemplated by the IGH Merger Agreement, CLS Massachusetts will pay a purchase price of $47,500,000, subject to reduction as provided in the IGH Merger Agreement, payable as follows: $35 million in cash, $7.5 million in the form of a five-year promissory note, and $5 million in the form of restricted common stock of the Company, plus $2.5 million as consideration for a non-competition agreement with IGH’s President, payable in the form of a five-year promissory note. IGH and certain IGH stockholders holding sufficient aggregate voting power to approve the transactions contemplated by the IGH Merger Agreement have entered into agreements pursuant to which such stockholders have, among other things, agreed to vote in favor of such transactions. On October 31, 2018, as consideration for the IGH Option, the Company made a loan to IGH (the “IGH Loan”), in the principal amount of $5,000,000 (the “IGH Loan Amount”), subject to the terms and conditions set forth in that certain Loan Agreement, dated as of October 31, 2018 between IGH as the borrower and the Company as the lender (the “IGH Loan Agreement”) (see note 9). The IGH Loan is evidenced by a secured promissory note of IGH (the “IGH Note”), which bears interest at the rate of 6% per annum and matures on October 31, 2021. The Company recorded interest income in the amount of $296,250 and $174,247 on the IGH Loan during the years ended May 31, 2020 and 2019, respectively. On March 1, 2020, the Company capitalized interest in the amount of $399,453 into the principal amount due. During the year ended May 31, 2020, the Company also received payments on this note in the amount of $1,425,000, which is made up of $1,357,278 of principal and $67,722 of interest. As of May 31, 2020, the principal balance of the IGH Note was $4,042,175 and the balance of interest receivable was $3,322. To secure the obligations of IGH to the Company under the IGH Loan Agreement and the IGH Note, the Company and IGH entered into a Security Agreement dated as of October 31, 2018 (the “IGH Security Agreement”), pursuant to which IGH granted to the Company a first priority lien on and security interest in all personal property of IGH. If the Company does not exercise the IGH Option on or prior to the date that is 30 days following the end of the Option Period, the IGH Loan Amount will be reduced to $2,500,000 as a break-up fee (the “Break-Up Fee”), except in the event of a Purchase Exception (as defined in the IGH Option Agreement), in which case the Break-Up Fee will not apply and there will be no reduction to the Loan Amount. On August 26, 2019, the parties amended the IGH Option to, among other things, extend the Option Period and delay closing until January 2020. By letter agreement dated January 31, 2020, the Company, CLS Massachusetts and IGH extended the IGH Option Agreement to February 4, 2020. On February 4, 2020, CLS Massachusetts exercised the IGH Option. By letter dated February 26, 2020, the Company informed IGH that as a result of its breaches of the IGH Option, which remained uncured, an event of default had occurred under the IGH Note. The Company advised IGH that it was electing to cause the IGH Note to bear interest at the default rate of 15% per annum effective February 26, 2020 and to accelerate all amounts due under the Note. This dispute, including whether IGH breached the IGH Option and whether CLS is entitled to collect default interest, is now in litigation. On March 3, 2020, the Company filed a claim for declaratory relief, among other things, requesting the court declare that CLS Massachusetts had validly exercised the IGH Option and instruct IGH to comply with its diligence requests and ultimately execute a merger agreement with CLS and CLS Massachusetts. The dispute regarding whether CLS Massachusetts properly exercised the IGH Option arose after CLS Massachusetts delivered a notice of exercise to IGH and IGH subsequently asserted that CLS Massachusetts’ exercise was invalid. CLS and CLS Massachusetts intend to pursue this suit vigorously and believe that their claims are meritorious, however, there can be no assurance as to the ultimate outcome of this matter. CannAssist On January 29, 2019, the Company made a line of credit loan to CannAssist in the principal amount of up to $500,000, subject to the terms and conditions set forth in the CannAssist Loan Agreement. Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company. The loan is evidenced by the CannAssist Note, which bears interest at the rate of 8% per annum and is personally guaranteed by the two equity owners of CannAssist. On June 24, 2019, the Company advanced the sum of $175,000 to CannAssist, increasing the balance due to the Company under the CannAssist Note to $325,000. The Company recorded interest income in the amount of $14,673 and $4,011 on the loan during the years ended May 31, 2020 and 2019, respectively. To secure the obligations of CannAssist to the Company under the CannAssist Loan Agreement and the CannAssist Note, the Company and CannAssist entered into a security agreement dated as of January 29, 2019, pursuant to which CannAssist granted to the Company a first priority lien on and security interest in all personal property of CannAssist. On March 11, 2019, the Company, through its wholly-owned subsidiary, CLS Massachusetts, entered into the CannAssist Purchase Agreement with CannAssist, each of the members of CannAssist, and David Noble, as the members’ representative. On August 26, 2019, the Company and CannAssist amended the CannAssist Note. Pursuant to the amendment, there will be no additional advances under the CannAssist Note beyond the $150,000 advanced on February 4, 2019, and the $175,000 advanced on June 24, 2019. In addition, the CannAssist Note shall become due and payable in full on or before February 28, 2020. Finally, the Company and CannAssist terminated the CannAssist Purchase Agreement. On December 23, 2019, the Company received payment in full on the CannAssist loan in the amount of $342,567, which comprises $325,000 of principal and $17,567 of interest. |
ACCOUNTS RECEIVABLE
ACCOUNTS RECEIVABLE | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Receivables [Abstract] | ||
Loans, Notes, Trade and Other Receivables Disclosure [Text Block] | Note 5 – Accounts Receivable Accounts receivable was $281,827 and $161,409 at November 30, 2020 and May 31, 2020, respectively. During the six months ended November 30, 2020, the Company had bad debt expense in the net amount of $5,992, consisting of the write-off of a receivable from a credit card processor in the amount of $7,668, partially offset by the collection from a customer in the amount of $1,746 which had been previously written-off. No allowance for doubtful accounts was necessary during the three and six months ended November 30, 2020 and 2019. | NOTE 6 – ACCOUNTS RECEIVABLE Accounts receivable was $161,409 and $163,571 at May 31, 2020 and 2019, respectively. The Company had bad debt expense of $108,392 during the year ended May 31, 2020, including $101,512 in connection with a receivable from a credit card company. The Company had bad debt expense of $0 during the prior period. |
PREPAID EXPENSES AND OTHER CURR
PREPAID EXPENSES AND OTHER CURRENT ASSETS | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Disclosure Text Block Supplement [Abstract] | ||
Other Assets Disclosure [Text Block] | Note 6 – Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following: November 30, 2020 May 31, 2020 Deposits $ 2,262 $ 2,315 Prepaid expenses 295,058 231,777 Total $ 297,320 $ 234,092 | NOTE 7 – PREPAID EXPENSES AND OTHER CURRENT ASSETS Prepaid expenses and other current assets consisted of the following at May 31, 2020 and 2019: May 31, May 31, 2020 2019 Deposits $ 2,315 211,493 Prepaid expenses 231,777 178,920 Total $ 234,092 $ 390,413 Deposits consist of amounts paid in advance for the acquisition of property and equipment. Prepaid expenses consist primarily of annual license fees charged by the State of Nevada; these fees are paid in advance, and amortized over the one year term of the licenses. During the year ended May 31, 2020, the Company applied deposits in the amount of $281,966 to the acquisition of fixed assets. |
INVENTORY
INVENTORY | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Inventory Disclosure [Abstract] | ||
Inventory Disclosure [Text Block] | Note 7 – Inventory Inventory, consisting of material, overhead, labor, and manufacturing overhead, is stated at the lower of cost (first-in, first-out) or market, and consists of the following: November 30, May 31, 2020 2020 Raw materials $ 527,984 $ 134,697 Finished goods 860,416 440,545 Total $ 1,388,400 $ 575,242 Raw materials consist of cannabis plants and the materials that are used in our production process prior to being tested and packaged for consumption. Finished goods consist of pre-packaged materials previously purchased from other licensed cultivators and the Company’s manufactured edibles and extracts. | NOTE 8 – INVENTORY Inventory, consisting of material, overhead, labor, and manufacturing overhead, is stated at the lower of cost (first-in, first-out) or market, and consists of the following: May 31, May 31, 2020 2019 Raw materials $ 134,697 $ 323,635 Finished goods 440,545 423,198 Total $ 575,242 $ 746,833 Raw materials consist of cannabis plants and the materials that are used in our production process prior to being tested and packaged for consumption. Finished goods consist of pre-packaged materials previously purchased from other licensed cultivators and our manufactured edibles and extracts. |
NOTES RECEIVABLE
NOTES RECEIVABLE | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Disclosure Text Block Supplement [Abstract] | ||
Other Current Assets [Text Block] | Note 8 – Notes Receivable PRH Note Receivable During the year ended May 31, 2015, the Company loaned $500,000 pursuant to a promissory note (the “PRH Note”) to Picture Rock Holdings, LLC, a Colorado limited liability company (“PRH”). Pursuant to the PRH Note, as amended by the parties effective June 30, 2015, October 31, 2015, April 11, 2016, and May 31, 2016, PRH was expected to repay the principal due under the PRH Note in twenty (20) equal quarterly installments of Twenty Five Thousand Dollars ($25,000) commencing in the month following the month in which PRH commenced generating revenue at the grow facility, which commencement was originally anticipated to occur in the first quarter of 2017, and continuing until paid in full. The Company suspended its plans to operate in Colorado due to regulatory delays and has not yet determined when it will pursue them again. Interest will accrue on the unpaid principal balance of the PRH Note at the rate of twelve percent (12%) per annum and will be paid quarterly in arrears commencing after such initial payment and continuing until paid in full. All outstanding principal and any accumulated unpaid interest due under the PRH Note is due and payable on the five-year anniversary of the initial payment thereunder. In the event of default as defined in the agreements underlying the PRH Note, all amounts under the PRH Note shall be due and payable at once. During the year ended May 31, 2015, the Company recorded an impairment related to the note receivable in the amount of $500,000. During the year ended May 31, 2018, the Company received a payment of $50,000 on the PRH Note. As a result, the Company has reduced the impairment of the PRH Note by $50,000 to reflect this payment. The receivable is recorded on the balance sheet as of November 30, 2020 in the amount of $0, net of allowance in the amount of $450,000. IGH Note Receivable On October 31, 2018, in connection with an option to purchase transaction (see note 4), the Company loaned $5,000,000 pursuant to the IGH Note to IGH; on November 6, 2018, IGH converted to a for-profit corporation. The IGH Note bears interest at the rate of 6% per annum. On March 1, 2020 (the “Initial Payment Date”), all accrued interest was added to the outstanding principal due hereunder and such amount is payable in eight equal quarterly installments, commencing on the Initial Payment Date, together with interest accruing after the Initial Payment Date. The IGH Note matures and all outstanding principal, accrued interest and any other amounts due hereunder, is due and payable in full on the third anniversary of the IGH Note. The IGH Note was issued in connection with a loan agreement and security agreement between the Company and IGH, and the IGH Option Agreement between the Company and IGH, among others, in both cases dated as of October 31, 2018 and the other IGH Loan Documents, and is secured by the collateral described in the IGH Loan Documents and by such other collateral as may in the future be granted to the Company to secure the IGH Note. During the three and six months ended November 30, 2020, the Company recorded interest income in the amounts of $50,162 and $110,727, respectively, in connection with the IGH Note. By letter dated February 26, 2020, the Company informed IGH that as a result of its breaches of the IGH Option, which remained uncured, an event of default had occurred under the IGH Note. The Company advised IGH that it was electing to cause the IGH Note to bear interest at the default rate of 15% per annum effective February 26, 2020 and to accelerate all amounts due under the Note. This dispute, including whether IGH breached the IGH Option and whether CLS is entitled to collect default interest, is now in litigation. During the three and six months ended November 30, 2020, the Company received payments on the IGH Note in the amounts of $750,000 and $1,500,000, respectively. The Company applied these payments as follows; $1,385,951 as a repayment of principal and $114,049 as a repayment of accrued interest. As a result, at November 30, 2020, principal in the amount of $2,656,224 and interest receivable in the amount of $0 due under the IGH Note were classified as current assets on the Company’s balance sheet. CannAssist Note Receivable On January 29, 2019, the Company made a line of credit loan to CannAssist pursuant to the CannAssist Note, in the principal amount of up to $500,000. The loan bears interest at the rate of 8% per annum and is personally guaranteed by the two equity owners of CannAssist. Payments on the loan were to commence on July 1, 2019 and the CannAssist Note was to mature on December 1, 2019. On August 26, 2019, the Company and CannAssist amended the CannAssist Note. Pursuant to the amendment, among other things, the CannAssist Note was to become due and payable in full on or before February 28, 2020. On December 23, 2019, the Company received payment in full on the CannAssist loan in the amount of $342,567, which comprised $325,000 of principal and $17,567 of interest. During the three months ended November 30, 2020 and 2019, the Company recorded interest income in the amount of $0 and $6,553 on the CannAssist Note, respectively. During the six months ended November 30, 2020 and 2019, the Company recorded interest income in the amount of $0 and $13,035 on the CannAssist Note, respectively. | NOTE 9 – NOTES RECEIVABLE PRH Note Receivable During the year ended May 31, 2015, the Company loaned $500,000 pursuant to a promissory note (the “PRH Note”) to Picture Rock Holdings, LLC, a Colorado limited liability company (“PRH”). Pursuant to the PRH Note, as amended by the parties effective June 30, 2015, October 31, 2015, April 11, 2016, and May 31, 2016, PRH was expected to repay the principal due under the PRH Note in twenty (20) equal quarterly installments of Twenty Five Thousand Dollars ($25,000) commencing in the month following the month in which PRH commenced generating revenue at the grow facility, which commencement was originally anticipated to occur in the first quarter of 2017, and continuing until paid in full. The Company suspended its plans to operate in Colorado due to regulatory delays and has not yet determined when it will pursue them again. Interest will accrue on the unpaid principal balance of the PRH Note at the rate of twelve percent (12%) per annum and will be paid quarterly in arrears commencing after such initial payment and continuing until paid in full. All outstanding principal and any accumulated unpaid interest due under the PRH Note is due and payable on the five-year anniversary of the initial payment thereunder. In the event of default as defined in the agreements underlying the PRH Note, all amounts under the PRH Note shall be due and payable at once. During the year ended May 31, 2015, the Company recorded an impairment related to the note receivable in the amount of $500,000. During the year ended May 31, 2018, the Company received a payment of $50,000 on the PRH Note. As a result, the Company has reduced the impairment of the PRH Note by $50,000 to reflect this payment. The receivable is recorded on the balance sheet as of May 31, 2020 in the amount of $0, net of allowance in the amount of $450,000. IGH Note Receivable On October 31, 2018, in connection with an option to purchase transaction (see note 5), the Company loaned $5,000,000 pursuant to the IGH Note to IGH; on November 6, 2018, IGH converted to a for-profit corporation. The IGH Note bears interest at the rate of 6% per annum. On March 1, 2020 (the “Initial Payment Date”), all accrued interest shall be added to the outstanding principal due hereunder and such amount shall be payable in eight equal quarterly installments, commencing on the Initial Payment Date, together with interest accruing after the Initial Payment Date. The IGH Note shall mature and all outstanding principal, accrued interest and any other amounts due hereunder, shall become due and payable in full on the third anniversary of the IGH Note. The IGH Note was issued in connection with a loan agreement and security agreement between the Company and IGH, and the IGH Option Agreement between the Company and IGH, among others, in both cases dated as of October 31, 2018 and the other IGH Loan Documents, and is secured by the collateral described in the IGH Loan Documents and by such other collateral as may in the future be granted to the Company to secure the IGH Note. During the years ended May 31, 2020 and 2019, the Company recorded interest income in the amounts of $296,250 and $174,247, respectively, in connection with the IGH Note. During the years ended May 31, 2020 and 2019, the Company capitalized interest in the amount of $399,453 and $0, respectively, on the IGH Note. By letter dated February 26, 2020, the Company informed IGH that as a result of its breaches of the IGH Option, which remained uncured, an event of default had occurred under the IGH Note. The Company advised IGH that it was electing to cause the IGH Note to bear interest at the default rate of 15% per annum effective February 26, 2020 and to accelerate all amounts due under the Note. This dispute, including whether IGH breached the IGH Option and whether CLS is entitled to collect default interest, is now in litigation. During the year ended May 31, 2020, the Company received payments on the IGH Note in the amount of $1,425,000. The Company applied these payments as follows; $1,357,278 as a repayment of principal and $67,722 as a repayment of accrued interest. As a result, at May 31, 2020, principal in the amount of $4,042,175 and interest receivable in the amount of $3,322 due under the IGH Note were classified as current assets on the Company’s balance sheet. CannAssist Note Receivable On January 29, 2019, the Company made a line of credit loan to CannAssist pursuant to the CannAssist Note, in the principal amount of up to $500,000. The loan bears interest at the rate of 8% per annum and is personally guaranteed by the two equity owners of CannAssist. Payments on the loan were to commence on July 1, 2019 and the CannAssist Note was to mature on December 1, 2019. On August 26, 2019, the Company and CannAssist amended the CannAssist Note. Pursuant to the amendment, among other things, the CannAssist Note shall become due and payable in full on or before February 28, 2020. During the years ended May 31, 2020 and 2019, the Company recorded interest income in the amount of $14,673 and $4,011 on the CannAssist Note. On December 23, 2019, the Company received payment in full on the CannAssist loan in the amount of $342,567, which comprises $325,000 of principal and $17,567 of interest. At May 31, 2020, the principal amount of $0 and interest receivable in the amount of $0 due under the CannAssist Note were classified as current assets on the Company’s balance sheet. |
PROPERTY, PLANT AND EQUIPMENT
PROPERTY, PLANT AND EQUIPMENT | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Property, Plant and Equipment [Abstract] | ||
Property, Plant and Equipment Disclosure [Text Block] | Note 9 – Property, Plant and Equipment Property, plant and equipment consisted of the following at November 30, 2020 and May 31, 2020. November 30, 2020 May 31, 2020 Office equipment $ 116,090 $ 94,887 Furniture and fixtures 145,103 144,025 Machinery & Equipment 1,776,316 1,741,830 Leasehold improvements 2,769,219 2,662,967 Less: accumulated depreciation (1,151,948 ) (868,200 ) Property, plant, and equipment, net $ 3,654,780 $ 3,775,509 During the six months ended November 30, 2020 and 2019, the Company made payments in the amounts of $163,019 and $1,566,882, respectively, for property, plant, and equipment. Also, during the six months ended November 30, 2020 and 2019, the Company applied $0 and $136,190 of deposits to the acquisition of fixed assets. See note 6. Depreciation of property, plant, and equipment was $142,856 and $57,644 for the three months ended November 30, 2020 and 2019 respectively. Depreciation of property, plant, and equipment was $283,748 and $113,180 for the six months ended November 30, 2020 and 2019 respectively. | NOTE 10 – PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment consisted of the following at May 31, 2020 and 2019: May 31, May 31, 2020 2019 Office equipment $ 94,887 $ 53,152 Furniture & fixtures 144,025 140,701 Machinery & equipment 1,741,830 969,196 Leasehold improvements 2,662,967 1,293,660 Less: accumulated depreciation (868,200 ) (546,408 ) Property and equipment, net $ 3,775,509 $ 1,910,301 The Company also made payments in the amount of $1,923,338 and $1,037,262 for property and equipment during the years ended May 31, 2020 and 2019, respectively; the Company also reclassified from deposits to property, plant and equipment the amounts of $281,966 and $0 during the years ended May 31, 2020 and 2019, respectively. During the year ended May 31, 2020, the Company disposed of fixed assets a net book value of $16,817 and recorded a loss on disposal of fixed assets in that amount; there was no such comparable transaction during the prior period. During the year ended May 31, 2019, the Company also acquired property, plant, and equipment with an aggregate fair value of $933,142 with the acquisition of Alternative Solutions. See note 4. Depreciation expense totaled $323,279 and $173,277 for the years ended May 31, 2020 and 2019, respectively. |
RIGHT TO USE ASSETS AND LIABILI
RIGHT TO USE ASSETS AND LIABILITIES - OPERATING LEASES | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Disclosure Text Block [Abstract] | ||
Lessee, Operating Leases [Text Block] | Note 10 – Right to Use Assets and Liabilities – Operating Leases The Company has operating leases for offices and warehouses. The Company’s leases have remaining lease terms of 1 year to 4 years, some of which include options to extend. The Company’s lease expense for the three and six months ended November 30, 2020 was entirely comprised of operating leases and amounted to $104,793 and $270,410, respectively. The Company’s right of use (“ROU”) asset amortization for the three and six months ended November 30, 2020 was $88,897 and $175,727, respectively. The difference between the lease expense and the associated ROU asset amortization consists of interest. Right to use assets – operating leases are summarized below: November 30, 2020 Amount at inception of leases $ 2,703,821 Amount amortized (1,476,119 ) Balance – November 30, 2020 $ 1,227,702 Operating lease liabilities are summarized below: Amount at inception of leases $ 2,675,310 Amount amortized (1,409,668 ) Balance – November 30, 2020 $ 1,265,642 November 30, 2020 Warehouses and offices $ 1,265,642 Lease liability $ 1,265,642 Less: current portion (176,275 ) Lease liability, non-current $ 1,089,367 Maturity analysis under these lease agreements is as follows: Twelve months ended November 30, 2021 $ 268,577 Twelve months ended November 30, 2022 178,570 Twelve months ended November 30, 2023 167,234 Twelve months ended November 30, 2024 172,035 Twelve months ended November 30, 2025 176,980 Thereafter 810,327 Total $ 1,773,723 Less: Present value discount (508,081 ) Lease liability $ 1,265,642 | NOTE 11 – RIGHT TO USE ASSETS AND LIABILITIES – OPERATING LEASES The Company has operating leases for offices and warehouses. The Company’s leases have remaining lease terms of 1 year to 4 years, some of which include options to extend. The Company’s lease expense for the year ended May 31, 2020 was entirely comprised of operating leases and amounted to $420,953. The Company’s right of use (“ROU”) asset amortization for the year ended May 31, 2020 was $361,404. The difference between the lease expense and the associated ROU asset amortization consists of interest. The Company has recorded total right to use assets of $2,703,821 and liabilities in the amount of $2,675,310 through May 31, 2020, resulting in a gain in the amount of $28,511. During the year ended May 31, 2020, the Company entered into agreements to amend certain of its operating leases; the lease of the dispensary and administrative offices at 1800 Industrial Road were extended from June 30, 2023 to February 28, 2030, and the lease of the offices at 1718 Industrial Road was extended from August 31, 2020 to August 31, 2022. Right to use assets – operating leases are summarized below: May 31, 2020 Amount at inception of leases $ 2,703,821 Amount amortized (1,300,392 ) Balance – May 31, 2020 $ 1,403,429 Operating lease liabilities are summarized below: Amount at inception of leases $ 2,675,310 Amount amortized (1,202,259 ) Balance – May 31, 2020 $ 1,473,051 May 31, 2020 Warehouses and offices $ 1,473,051 Lease liability $ 1,473,051 Less: current portion (336,900 ) Lease liability, non-current $ 1,136,151 Maturity analysis under these lease agreements is as follows: Twelve months ended May 31, 2021 $ 440,022 Twelve months ended May 31, 2022 184,172 Twelve months ended May 31, 2023 168,886 Twelve months ended May 31, 2024 169,617 Twelve months ended May 31, 2025 174,489 Thereafter 899,441 Total $ 2,036,627 Less: Present value discount (563,576 ) Lease liability $ 1,473,051 |
INTANGIBLE ASSETS
INTANGIBLE ASSETS | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Goodwill and Intangible Assets Disclosure [Text Block] | Note 11 – Intangible Assets Intangible assets consisted of the following at November 30, 2020 and May 31, 2020: Accumulated November 30, 2020 Gross Amortization Net Intellectual Property $ 319,600 $ (77,237 ) $ 242.363 License & Customer Relations 990,000 (119,625 ) 870,375 Tradenames - Trademarks 301,000 (72,742 ) 228,258 Non-Compete Agreements 27,000 (27,000 ) - Domain Names 26,512 (4,887 ) 21,625 Total $ 1,664,112 $ (301,491 ) $ 1,362,621 Accumulated May 31, 2020 Gross Amortization Net Intellectual Property $ 319,600 $ (61,257 ) $ 258,343 License & Customer Relations 990,000 (94,875 ) 895,125 Tradenames - Trademarks 301,000 (57,692 ) 243,308 Non-Compete Agreements 27,000 (25,882 ) 1,118 Domain names 26,512 (3,302 ) 23,310 Total $ 1,664,112 $ (242,908 ) $ 1,421,204 Total amortization expense charged to operations for the three months ended November 30, 2020 and 2019 was $28,715 and $28,030, respectively. Total amortization expense charged to operations for the six months ended November 30, 2020 and 2019 was $58,583 and $58,304, respectively. Amount to be amortized during the twelve months ended November 30, 2021 $ 111,989 2022 111,989 2023 111,989 2024 111,989 2025 111,989 Thereafter 802,676 $ 1,362,621 | NOTE 12 – INTANGIBLE ASSETS Intangible assets consisted of the following at May 31, 2020 and 2019: May 31, 2020 Accumulated Gross Amortization Net Intellectual Property $ 319,600 $ (61,257 ) $ 258,343 License & Customer Relations 990,000 (94,875 ) 895,125 Tradenames - Trademarks 301,000 (57,692 ) 243,308 Non-compete Agreements 27,000 (25,882 ) 1,118 Domain Names 25,993 (2,683 ) 23,310 Total $ 1,663,593 $ (242,389 ) $ 1,421,204 May 31, 2019 Accumulated Gross Amortization Net Intellectual Property $ 319,600 $ (29,297 ) $ 290,303 License & Customer Relations 990,000 (45,375 ) 944,625 Tradenames - Trademarks 301,000 (27,592 ) 273,408 Non-compete Agreements 27,000 (12,378 ) 14,622 Domain Names 3,963 (1,834 ) 2,129 Total $ 1,641,563 $ (116,476 ) $ 1,525,087 Total amortization expense charged to operations for the years ended May 31, 2020 and 2019 was $125,913 and $115,074, respectively. Amount to be amortized during the twelve months ended May 31, 2021 $ 113,080 2022 111,962 2023 111,962 2024 111,962 2025 111,962 Thereafter 860,276 $ 1,421,204 |
GOODWILL
GOODWILL | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Disclosure Text Block Supplement [Abstract] | ||
Goodwill Disclosure [Text Block] | Note 12 – Goodwill The Company recorded goodwill in the amount of $25,742,899 in connection with the acquisition of Alternative Solutions on June 27, 2018 (see note 3). The Company assessed its intangible assets as of May 31, 2020 for purposes of determining if an impairment existed as set forth in ASC 350 – Intangibles – Goodwill and Other and ASC 360 – Property Plant and Equipment. Pursuant to ASC 360, the Company recorded an impairment of goodwill in the amount of $25,185,003 based upon the difference between the carrying value of $25,742,899 and fair value of $557,896. Fair value was based upon the price of the Company’s common stock at May 31, 2020 of $0.06 per share. At November 30, 2020, the net amount of goodwill on the Company’s balance sheet was $557,896. | NOTE 13 – GOODWILL The Company recorded goodwill in the amount of $25,742,899 in connection with the acquisition of Alternative Solutions on June 27, 2018 (see note 4). Goodwill Impairment Test The Company assessed its intangible assets as of May 31, 2020 for purposes of determining if an impairment exists as set forth in ASC 350 – Intangibles – Goodwill and Other and ASC 360 – Property Plant and Equipment. Pursuant to ASC 360, the Company recorded an impairment of goodwill in the amount of $25,185,003 based upon the difference between the carrying value of $25,742,899 and fair value $557,896. Fair value was based upon the price of the Company’s common stock at May 31, 2020 of $0.06 per share. (see note 12). At May 31, 2020, the net amount of goodwill on the Company’s balance sheet was $557,896 |
OTHER ASSETS
OTHER ASSETS | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Other Non-current Assets Disclosure [Abstract] | ||
Other Non-current Assets Disclosure [Text Block] | Note 13 – Other Assets Other assets consisted of the following at November 30, 2020 and May 31, 2020: November 30, May 31, 2020 2020 Security deposits $ 167,455 $ 167,455 $ 167,455 $ 167,455 | NOTE 14 – OTHER ASSETS Other assets included the following as of May 31, 2020 and May 31, 2019: May 31 May 31, 2020 2019 Security deposits 167,455 167,455 $ 167,455 $ 167,455 |
ACCOUNTS PAYABLE AND ACCRUED LI
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Payables and Accruals [Abstract] | ||
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | Note 14 – Accounts Payable and Accrued Liabilities Accrued accounts payable and accrued liabilities consisted of the following at November 30, 2020 and May 31, 2020: November 30, 2020 May 31, 2020 Trade accounts payable $ 723,573 $ 591,060 Accrued payroll and payroll taxes 226,272 212,361 Accrued liabilities 480,920 369,462 Total $ 1,430,765 $ 1,172,883 | NOTE 15 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payable and accrued liabilities consisted of the following at May 31, 2020 and 2019: May 31, May 31, 2020 2019 Trade accounts payable $ 591,060 $ 510,210 Accrued payroll and payroll taxes 212,361 230,119 Accrued liabilities 369,462 625,399 Deferred rent liability - 151,399 Total $ 1,172,883 $ 1,517,127 |
NOTES PAYABLE AND CONVERTIBLE N
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Debt Disclosure [Abstract] | ||
Debt Disclosure [Text Block] | 15 – Convertible Notes Payable November 30, 2020 May 31, 2020 Convertible debenture in the principal amount of $4,000,000 (the “U.S. Convertible Debenture 1”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 1. The U.S. Convertible Debenture 1 matures on a date that is three years following issuance. The U.S. Convertible Debenture 1 is convertible into units (the “Convertible Debenture Units”) at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 1 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 1, the conversion price of U.S. Convertible Debenture 1 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with U.S. Convertible Debenture 1 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 1 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 1 is an unsecured obligation of the Company and ranks pari passu $ 4,504,457 $ 4,504,457 Convertible debenture in the principal amount of $1,000,000 (the “U.S. Convertible Debenture 2”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 2. The U.S. Convertible Debenture 2 matures on a date that is three years following issuance. The U.S. Convertible Debenture 2 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 2 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 2, the conversion price of U.S. Convertible Debenture 2 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with U.S. Convertible Debenture 2 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 2 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 2 is an unsecured obligation of the Company and ranks pari passu 1,126,114 1,126,114 November 30, 2020 May 31, 2020 Convertible debenture in the principal amount of $100,000 (the “U.S. Convertible Debenture 3”) dated October 24, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 3. The U.S. Convertible Debenture 3 matures on a date that is three years following issuance. The U.S. Convertible Debenture 3 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 3 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 3, the conversion price of U.S. Convertible Debenture 3 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with U.S. Convertible Debenture 3 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 3 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 3 is an unsecured obligation of the Company and ranks pari passu 112,613 112,613 Convertible debenture in the principal amount of $532,000 (the “U.S. Convertible Debenture 4”) dated October 25, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 4. The U.S. Convertible Debenture 4 matures on a date that is three years following issuance. The U.S. Convertible Debenture 4 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 4 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 4, the conversion price of U.S. Convertible Debenture 4 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with U.S. Convertible Debenture 4 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 4 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 4 is an unsecured obligation of the Company and ranks pari passu 599,101 599,101 November 30, 2020 May 31, 2020 Convertible debenture in the principal amount of $150,000 (the “U.S. Convertible Debenture 5”) dated October 26, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 5. The U.S. Convertible Debenture 5 matures on a date that is three years following issuance. The U.S. Convertible Debenture 5 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The U.S. Convertible Debenture 5 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 5 is an unsecured obligation of the Company and ranks pari passu 168,919 168,919 Convertible debenture payable in the principal amount of $75,000 (the “U.S. Convertible Debenture 6”) dated October 26, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 6. The U.S. Convertible Debenture 6 matures on a date that is three years following issuance. The U.S. Convertible Debenture 6 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The U.S. Convertible Debenture 6 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 6 is an unsecured obligation of the Company and ranks pari passu 84,459 84,459 November 30, 2020 May 31, 2020 Convertible debentures payable in the aggregate principal amount of $12,012,000 (the “Canaccord Debentures”) dated December 12, 2018, which bear interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the Canaccord Debentures. The Canaccord Debentures mature on a date that is three years following issuance. The Canaccord Debentures are convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The Canaccord Debentures have other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The Canaccord Debentures are unsecured obligations of the Company and rank pari passu 13,500,150 13,287,549 November 30, 2020 May 31, 2020 Total - Convertible Notes Payable $ 20,095,813 $ 19,883,212 Less: Discount (1,448,590 ) (2,238,730 ) Convertible Notes Payable, Net of Discounts $ 18,647,223 $ 17,644,482 Total - Convertible Notes Payable, Net of Discounts, Current Portion, net of discount of $1,448,590 and $0 $ 5,147,073 $ - Total - Convertible Notes Payable, Net of Discounts, Long-term Portion, net of discount of $0 and $2,238,730 $ 13,500,150 $ 17,644,482 November 30, 2020 November 30, 2019 Discounts on notes payable amortized to interest expense – 3 months ended November 30, 2020 and 2019, respectively $ 395,070 $ 259,070 Discounts on notes payable amortized to interest expense – 6 months ended November 30, 2020 and 2019, respectively $ 790,140 $ 853,983 Aggregate maturities of notes payable and convertible notes payable as of November 30, 2020 are as follows: For the twelve months ended November 30, 2021 $ 6,595,663 2022 13,500,150 2023 - 2024 - 2025 - Thereafter - Total $ 20,095,813 | NOTE 16 – NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE Notes Payable May 31, May 31, 2020 2019 The Company issued a secured note payable to Serenity Wellness Enterprises, LLC, as nominee (“Oasis Note”) dated June 27, 2018 in the principal amount of $4,000,000 and bearing interest at a rate of 6% per annum pursuant to the Membership Interest Purchase Agreement with Alternative Solutions. The note is due on December 4, 2019, but may be prepaid at any time without penalty. The Oasis Note is secured by all of the membership interests in Alternative Solutions and the Oasis LLCs and by the assets of the Oasis LLCs. The Company recognized an original issue discount of $189,180 on the Oasis Note. During the year ended May 31, 2020 and 2019, $67,384 and $121,796, respectively, of this discount was charged to operations. On August 14, 2019, the Company made a prepayment in the amount of $2,500,000, which was applied to the amount due under the Oasis Note; in addition, principal due under the Oasis note was further reduced by $133,389 for legal fees and $5,395 for other costs incurred by the Company in connection with a settlement agreement (see note 19). During the years ended May 31, 2020 and 2019, the Company accrued interest in the amounts of $82,037 and $225,333, respectively, on the Oasis Note. On December 31, 2019, the Company repaid the remaining amount of the note, $1,671,296, which comprised $1,363,925 of principal and $370,370 of interest. - 4,000,000 Total – Notes Payable $ - $ 4,000,000 Less: Discount - (67,384 ) Notes Payable, Net of Discounts $ - $ 3,932,616 Current portion $ - $ 3,932,616 Long term portion $ - $ - Convertible Notes Payable May 31, 2020 May 31, 2019 Convertible debenture in the principal amount of $4,000,000 (the “U.S. Convertible Debenture 1”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 1. The U.S. Convertible Debenture 1 matures on a date that is three years following issuance. The U.S. Convertible Debenture 1 is convertible into units (the “Convertible Debenture Units”) at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 1 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 1, the conversion price of Convertible Debenture 1 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with Convertible Debenture 1 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 1 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 1 is an unsecured obligation of the Company and ranks pari passu 4,504,457 4,134,400 Convertible debenture in the principal amount of $1,000,000 (the “U.S. Convertible Debenture 2”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 2. The U.S. Convertible Debenture 2 matures on a date that is three years following issuance. The U.S. Convertible Debenture 2 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 1 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 2, the conversion price of Convertible Debenture 2 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with Convertible Debenture 2 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 2 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 2 is an unsecured obligation of the Company and ranks pari passu 1,126,114 1,033,600 May 31, 2020 May 31, 2019 Convertible debenture in the principal amount of $100,000 (the “U.S. Convertible Debenture 3”) dated October 24, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 3. The U.S. Convertible Debenture 3 matures on a date that is three years following issuance. The U.S. Convertible Debenture 3 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 3 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 3, the conversion price of Convertible Debenture 3 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with Convertible Debenture 3 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 3 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 3 is an unsecured obligation of the Company and ranks pari passu 112,613 103,496 Convertible debenture in the principal amount of $532,000 (the “U.S. Convertible Debenture 4”) dated October 25, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 4. The U.S. Convertible Debenture 4 matures on a date that is three years following issuance. The U.S. Convertible Debenture 4 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 4 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 4, the conversion price of Convertible Debenture 4 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with Convertible Debenture 4 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 4 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 4 is an unsecured obligation of the Company and ranks pari passu 599,101 550,478 May 31, 2020 May 31, 2019 Convertible debenture in the principal amount of $150,000 (the “U.S. Convertible Debenture 5”) dated October 26, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 5. The U.S. Convertible Debenture 5 matures on a date that is three years following issuance. The U.S. Convertible Debenture 5 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The U.S. Convertible Debenture 5 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 5 is an unsecured obligation of the Company and ranks pari passu 168,919 155,176 Convertible debenture payable in the principal amount of $75,000 (the “U.S. Convertible Debenture 6”) dated October 26, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 6. The U.S. Convertible Debenture 6 matures on a date that is three years following issuance. The U.S. Convertible Debenture 6 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The U.S. Convertible Debenture 6 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 6 is an unsecured obligation of the Company and ranks pari passu 84,459 77,588 May 31, 2020 May 31, 2019 Convertible debentures payable in the aggregate principal amount of $12,012,000 (the “Canaccord Debentures”) dated December 12, 2018, which bear interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the Canaccord Debentures. The Canaccord Debentures mature on a date that is three years following issuance. The Canaccord Debentures are convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The Canaccord Debentures have other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The Canaccord Debentures are unsecured obligations of the Company and rank pari passu 13,287,549 12,305,492 Total - Convertible Notes Payable $ 19,883,212 $ 18,360,230 Less: Discount (2,238,730 ) (3,819,010 ) Convertible Notes Payable, Net of Discounts $ 17,644,482 $ 14,541,220 Total - Convertible Notes Payable, Net of Discounts, Current Portion $ - $ - Total - Convertible Notes Payable, Net of Discounts, Long-term Portion $ 17,644,482 $ 14,541,220 Discounts on notes payable amortized to interest expense – years ended May 31, 2020 and 2019, respectively $ 1,580,280 $ 921,827 Aggregate maturities of notes payable and convertible notes payable as of May 31, 2020 are as follows: For the twelve months ended May 31, 2021 $ - 2022 19,883,212 2023 - 2024 - 2025 - Thereafter - Total $ 19,883,212 Beneficial Conversion Features Certain of the Company’s convertible notes contained conversion features that create derivative liabilities. The pricing model the Company uses for determining fair value of its derivatives is the Lattice Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income. The derivative components of the notes were valued at issuance, at conversion, at restructure, and at each period end. On June 1, 2018, the Company adopted ASU 2017-11 and accordingly reclassified the fair value of the reset provisions embedded in convertible notes payable and certain warrants with embedded anti-dilutive provisions from liability to equity in the aggregate amount of $1,265,751. See note 1. Certain of the Company’s other convertible notes payable contain beneficial conversion features that are not derivatives, but which require valuation in order to determine the discount to the related convertible note payable. The value of these conversion features is calculated using the intrinsic value method, whereby the amount of the discount is calculated as the difference between the conversion price and the market price of the underlying common stock at the date of issuance multiplied by the number of shares issuable. |
CONTINGENT LIABILITY
CONTINGENT LIABILITY | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Loss Contingency [Abstract] | ||
Contingencies Disclosure [Text Block] | Note 16 – Contingent Liability The terms of the Company’s acquisition of Alternative Solutions, included a payment of $1,000,000 contingent upon the Oasis LLCs achieving certain revenue targets. (see note 3). The fair value of this contingent consideration at the time of the Acquisition Agreement was $678,111 as determined by the Company’s outside valuation consultants. Management reviewed the value of the contingent consideration, and concluded that, due to the increased revenue of Alternative Solutions, the fair value of this contingent liability was $1,000,000 at May 31, 2019. The Company recorded a charge to operations in the amount of $321,889 during the year ended May 31, 2019. The full amount of the bonus payment was earned, and on May 27, 2020, the Company made a payment in the amount of $850,000 to the sellers. The Company deposited the balance due to sellers of $150,000 with an escrow agent to hold pending the outcome of a tax audit. During the year ended May 31, 2020, the State of Nevada notified the Oasis LLCs that it would be conducting a tax audit for periods both before and after the closing of the sale to CLS. The Oasis LLCs have not yet received the demand from the State of Nevada with the precise amount due and the amount escrowed is the Company’s best estimate of the pre-closing tax liability If the ultimate tax liability is less than $150,000, the balance of the escrowed amount will be paid to sellers. As of November 30, 2020, the $150,000 remains a liability on the Company’s balance sheet and $150,000 is recorded in an escrow account in the asset section of the Company’s balance sheet. | NOTE 17 – CONTINGENT LIABILITY The terms of the Company’s acquisition of Alternative Solutions, include a payment of $1,000,000 contingent upon the Oasis LLCs achieving certain revenue targets. (see note 4). The fair value of this contingent consideration at the time of the Acquisition Agreement was $678,111 as determined by the Company’s outside valuation consultants. Management reviewed the value of the contingent consideration, and concluded that, due to the increased revenue of Alternative Solutions, the fair value of this contingent liability was $1,000,000 at May 31, 2019. The Company recorded a charge to operations in the amount of $321,889 during the year ended May 31, 2019. The full amount of the bonus payment was earned, and on May 27, 2020, the Company made a payment in the amount of $850,000 to the sellers. The Company deposited the balance due to sellers of $150,000 with an escrow agent to hold pending the outcome of a tax audit. During the year ended May 31, 2020, the State of Nevada notified the Oasis LLCs that it would be conducting a tax audit for periods both before and after the closing of the sale to CLS. The Oasis LLCs have not yet received the demand from the State of Nevada with the precise amount due and the amount escrowed is the Company’s best estimate of the pre-closing tax liability If the ultimate tax liability is less than $150,000, the balance of the escrowed amount will be paid to sellers. As of May 31, 2020, the $150,000 remains a liability on the Company’s balance sheet and $150,000 is recorded in an escrow account in the asset section of the Company’s balance sheet. |
STOCKHOLDERS_ EQUITY
STOCKHOLDERS’ EQUITY | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Stockholders' Equity Note [Abstract] | ||
Stockholders' Equity Note Disclosure [Text Block] | Note 17 – Stockholders’ Equity The Company’s authorized capital stock consists of 750,000,000 shares of common stock, par value $0.0001, at November 30, 2020 and May 31, 2020, and 20,000,000 shares of preferred stock, par value $0.001 per share. The Company had 126,571,416 shares of common stock issued and outstanding as of November 30, 2020 and May 31, 2020, respectively. Six months ended November 30, 2020 Common Stock Issued and To Be Issued to Officers and Service Providers: During the six months ended November 30, 2020, the Company charged an aggregate of $53,876 to common stock subscribed representing the accrual over the vesting period of 125,000 shares of restricted common stock issuable to officers. During the six months ended November 30, 2020, the Company recognized the cancellation of a consulting contract, which resulted in a credit to operations in the amount of $22,500 and the reversal of 100,000 shares of common stock to be issued. During the six months ended November 30, 2020, the Company recognized the cancellation of a consulting contract, which resulted in a credit to operations in the amount of $3,250 and the reversal of 25,000 shares of common stock to be issued. During the six months ended November 30, 2020, the Company recognized the issuance of 50,000 to a former officer, which shares were previously recorded in common stock to be issued. Six months ended November 30, 2019 Common Stock and Warrants Issued upon Conversion of Notes Payable: On July 8, 2019, the Company issued 16,644 shares of common stock and three-year warrants to acquire 8,322 shares of common stock at a price of $1.10 per share to Canaccord Genuity Corp., as nominee, in connection with the conversion of a portion of the Canaccord Debentures in the principal amount of $13,315. No gain or loss was recorded on this transaction because the conversion was made pursuant to the terms of the original agreement. On July 19, 2019, the Company issued 15,677 shares of common stock and three-year warrants to acquire 7,838 shares of common stock at a price of $1.10 per share to Canaccord Genuity Corp., as nominee, in connection with the conversion of a portion of the Canaccord Debentures in the principal in the amount of $12,542. No gain or loss was recorded on this transaction because the conversion was made pursuant to the terms of the original agreement. Common Stock Issued and To Be Issued to Officers and Service Providers: On July 22, 2019, the Company issued 500,000 shares of common stock to Ben Sillitoe, the former Chief Executive Officer of CLS Nevada, in connection with his employment agreement. The fair value of these shares in the amount of $355,000 had been charged to operations as the shares vested. At issuance, this amount was transferred from common stock subscribed; $50 was charged to common stock, and $354,950 was charged to additional paid-in capital. On July 22, 2019, the Company issued 50,000 shares of common stock to Don Decatur, the former Chief Operating Officer of CLS Nevada, in connection with his employment agreement. The fair value of these shares in the amount of $35,500 had been charged to operations as the shares vested. At issuance, this amount was transferred from common stock subscribed; $5 was charged to common stock, and $35,495 was charged to additional paid-in capital. During the six months ended November 30, 2019, the Company charged an aggregate of $93,901 to common stock subscribed representing the accrual over the vesting period of 791,668 shares of restricted common stock issuable to officers. The Company also charged $30,000 to common stock subscribed representing the fair value of 133,332 shares of common stock to be issued to a service provider. Warrants The following table summarizes the significant terms of warrants outstanding at November 30, 2020. This table does not include the unit warrants. See Unit Warrants section below. Range of exercise prices Number of warrants outstanding Weighted average remaining contractual life (years) Weighted average exercise price of outstanding warrants Number of warrants exercisable Weighted average exercise price of exercisable warrants $ 0.49 33,465,110 1.00 $ 0.49 33,465,110 $ 0.49 0.50 2,736,500 1.23 0.50 2,736,500 0.50 0.60 17,500,000 1.00 0.60 17,500,000 0.60 0.75 837,500 0.22 0.75 837,500 0.75 1.10 296,035 1.06 1.10 296,035 1.10 54,835,145 1.00 $ 0.53 54,835,145 $ 0.53 Transactions involving warrants are summarized below. This table does not include the unit warrants. See Unit Warrants sections below. Number of Shares Weighted Average Exercise Price Warrants outstanding at May 31, 2019 54,818,985 $ 0.53 Granted 16,160 $ 1.10 Exercised - Cancelled / Expired - $ - Warrants outstanding at May 31, 2020 54,838,145 $ 0.53 Granted - $ - Exercised - $ - Cancelled / Expired - $ - Warrants outstanding at November 30, 2020 54,835,145 $ 0.53 Unit Warrants On June 20, 2018, in connection with the special warrant offering, the Company issued Canaccord Genuity Corp. 2,317,842 three-year broker warrants at an exercise price of C$0.45 per unit as compensation. Each warrant entitles the holder to purchase one unit, which consists of one share of common stock and a warrant to purchase one share of common stock, for C$0.65 per share. These warrants were valued at $1,495,373, and this amount was charged to operations during the six months ended November 30, 2018. On December 12, 2018, in connection with the issuance of the Canaccord Debentures, the Company issued Canaccord Genuity Corp., as compensation, 1,074,720 three-year agent and advisory warrants. Each warrant entitles the holder to purchase a unit for $0.80, which unit consists of one share of common stock and a warrant to purchase one-half share of common stock at an exercise price of $1.10 per share. The Company, in connection with the issuance of the Canaccord Debentures, also issued to National Bank Financial Inc., as compensation, 268,680 three-year agent and advisory warrants. Each warrant entitles the holder to purchase a unit for $0.80, which unit consists of one share of common stock and a warrant to purchase one-half share of common stock at an exercise price of $1.10 per share. The aggregate value of these warrants was $874,457, which was charged to operations during the year ended May 31, 2019. Because the unit warrants are exercisable for Common Stock and warrants, they are not included in the warrant tables above. | NOTE 18 – STOCKHOLDERS’ EQUITY The Company’s authorized capital stock consists of 750,000,000 shares of common stock, par value $0.0001, at May 31, 2020 and 2019, and 20,000,000 shares of preferred stock, par value $0.001 per share. The Company had 126,521,416 and 125,839,095 shares of common stock issued and outstanding as of May 31, 2020 and 2019, respectively. The Company recorded imputed interest of $0 and $807 during the years ended May 31, 2020 and 2019 on related party payables due to a director and officer of the Company, and charged this amount to additional paid-in capital . Year ended May 31, 2020: Common Stock and Warrants Issued upon Conversion of Notes Payable: On July 8, 2019, the Company issued 16,644 shares of common stock and three-year warrants to acquire 8,322 shares of common stock at a price of $1.10 per share to Canaccord Genuity Corp., as nominee, in connection with the conversion of a portion of the Canaccord Debentures in the principal amount of $13,315. No gain or loss was recorded on this transaction because the conversion was made pursuant to the terms of the original agreement. On July 19, 2019, the Company issued 15,677 shares of common stock and three-year warrants to acquire 7,838 shares of common stock at a price of $1.10 per share to Canaccord Genuity Corp., as nominee, in connection with the conversion of a portion of the Canaccord Debentures in the principal in the amount of $12,542. No gain or loss was recorded on this transaction because the conversion was made pursuant to the terms of the original agreement. Common Stock Issued and To Be Issued to Officers and Service Providers: On July 22, 2019, the Company issued 500,000 shares of common stock with a fair value of $355,000 to Ben Sillitoe, Chief Executive Officer of CLS Nevada, in connection with his employment agreement. $325,417 was recorded during fiscal 2019, and issued from stock payable during the year ended May 31, 2020; $29,583 was charged to operations during the year ended May 31, 2020. At issuance, $50 was charged to common stock, and $354,950 was charged to additional paid-in capital. On July 22, 2019, the Company issued 50,000 shares of common stock with a fair value of $35,495 to Don Decatur, Chief Operating Officer of CLS Nevada, in connection with his employment agreement. $32,542 of this amount was recorded during fiscal 2019, and issued from stock payable during the year ended May 31, 2020; $2,958 was charged to operations during the year ended May 31, 2020. At issuance, $5 was charged to common stock, and $35,495 was charged to additional paid-in capital. During the year ended May 31, 2020, the Company charged an aggregate of $154,014 to common stock subscribed representing the accrual over the vesting period of 791,668 shares of restricted common stock issuable to officers. The Company also charged $45,000 to common stock subscribed representing the fair value of 200,000 shares of common stock to be issued to a service provider. During the year ended May 31, 2020, the Company issued 100,000 of these shares of common stock. At issuance, $22,500 was transferred from common stock subscribed; $10 was charged to common stock, and $22,490 was charged to additional paid-in capital. Year ended May 31, 2019: Stock Issued upon Conversion of Notes Payable On June 12, 2018, Darling Capital, holder of a convertible promissory note, converted a total of $565,000, which consisted of $550,000 of principal and $15,000 of accrued interest, into 1,808,000 shares of common stock. On August 9, 2018, Efrat Investments, holder of a convertible promissory note, converted a total of $57,200, which consisted of $55,000 of principal and $2,200 of accrued interest, into 183,040 shares of common stock. On August 21, 2018, David Lamadrid, a former executive officer of the Company and holder of a convertible promissory note, converted a total of $32,497, which consisted of $31,250 of principal and $1,247 of accrued interest, into 103,989 shares of common stock. On August 23, 2018, Jay Lasky, holder of a convertible promissory note, converted a total of $26,185, which consisted of $25,000 of principal and $1,185 of accrued interest, into 65,462 shares of common stock. On October 23, 2018, Newcan, which is owned by a director of the Company and was the holder of a convertible promissory note, converted a total of $78,534, which consisted of $75,000 of principal and $3,534 of accrued interest, into 196,336 shares of common stock. On November 14, 2018, YA II PN, holder of a convertible promissory note, converted a total of $280,247, which consisted of $250,000 of principal and $30,247 of accrued interest, into 700,616 shares of common stock. On January 8, 2019, YA II PN, holder of a convertible promissory note, converted a total of $256,027 which consisted of $250,000 of principal and $6,027 of accrued interest, into 640,068 shares of common stock. There were no gains or losses on the conversion of notes payable during the year ended May 31, 2019, as all conversions were made pursuant to the terms of the convertible note agreements. Stock Issued for Services On June 24, 2018, pursuant to the terms of a severance agreement between the Company and David Lamadrid, the Company issued 600,000 shares of restricted common stock to Mr. Lamadrid. These shares were valued at $264,000 based upon the Company’s stock price of $0.44 on Mr. Lamadrid’s date of employment. Of this amount, $213,320 had been previously expensed and the remaining $50,680 was charged to operations during the year ended May 31, 2019. On July 24, 2018, the Company awarded Star Associates, LLC, a limited liability company owned by Andrew Glashow, a director and executive officer of the Company, a cash payment in the amount of $250,000 and 700,000 shares of the Company’s restricted common stock in recognition of Mr. Glashow’s efforts, through Star Associates, in successfully assisting the Company in negotiating and obtaining the financing necessary to acquire Alternative Solutions. The shares were valued at $490,000 based upon the Company’s stock price of $0.70 at the date of the grant, and were charged to operations during the year ended May 31, 2019. On September 11, 2018, the Company issued 31,250 shares of common stock valued at $25,310 based upon the Company’s stock price of $0.81 at the date of the grant, in exchange for legal services previously rendered to the Company. These shares were accrued on February 8, 2018, and were issued from stock payable. Stock Issued for Acquisition On June 27, 2018, the Company issued 22,058,823 shares of its common stock pursuant to the terms of the Alternative Solutions Acquisition Agreement. These shares were valued at $15,441,176. (See note 4). Special Warrants Issued in Offering On June 20, 2018, the Company executed an Agency Agreement with Canaccord Genuity Corp. and closed on a private offering of its special warrants for aggregate gross proceeds of C$13,037,859 (USD$9,785,978). Pursuant to the offering, the Company issued 28,973,020 special warrants at a price of C$0.45 (USD$0.34) per special warrant. Each special warrant was automatically exercisable, for no additional consideration, into units of the Company on the earlier of: (i) the date that was five business days following the date on which the Company obtained a receipt from the applicable securities regulatory authorities in each of the jurisdictions in Canada in which the special warrants were sold for a final prospectus qualifying the distribution of the units, which was intended to be no later than November 30, 2018, and (ii) the date that was four months and one day after the completion of the Company's acquisition of all of the membership interests in Alternative Solutions, known as Oasis Cannabis. The Company allocated $4,226,394 of the proceeds from the sale of the special warrants to the underlying stock, and $5,559,584 of the value to the underlying warrants. The value of the warrants underlying the special warrants was determined utilizing the Black-Scholes valuation model. The Company recorded a loss on currency conversion in the amount of $403,588 in connection with the special warrants during the year ended May 31, 2019. In connection with the offering, the Company paid Canaccord Genuity Corp. a cash commission equal to C$1,043,028 (USD$799,053), a corporate finance fee equal to 1,448,651 special warrants, and 2,317,842 compensation broker warrants valued at $1,495,373. Each compensation broker warrant entitles the holder thereof to acquire one unit at a price of C$0.45 per unit for a period of 36 months from the date that the Company's common stock is listed on a recognized Canadian stock exchange, subject to adjustment in certain events. The 1,448,651 special warrants that were issued were valued at $1,413,300 and were charged to operations during the year ended May 31, 2019. Upon exercise of the special warrants, each unit was to consist of one share of the Company's common stock and one warrant to purchase one share of common stock. Each warrant was to be exercisable at a price of C$0.65 for three years after the Company's common stock was listed on a recognized Canadian stock exchange, subject to adjustment in certain events. Because the Company did not receive a receipt from the applicable Canadian securities authorities for the qualifying prospectus by August 20, 2018, the unexercised special warrants were adjusted to entitle the holders to receive 1.1 units instead of one unit of the Company. This resulted in the issuance of an additional 3,042,167 units. This penalty was valued at $7,142,550 and was charged to operations during the year ended May 31, 2019. On November 30, 2018, all of the special warrants were automatically converted into 33,463,838 shares of common stock and warrants to purchase 33,463,838 shares of common stock for CD$0.65 per share. Stock Issued in Navy Capital Offering On July 31, 2018, the Company entered into a Subscription Agreement with Navy Capital Green International, Ltd, (the “Navy Capital Offering”) for 7,500,000 units at a price of $0.40 per unit, or an aggregate amount of $3,000,000. The units collectively represent (i) 7,500,000 shares of common stock, and (ii) three-year warrants to purchase an aggregate of 7,500,000 shares of common stock at an exercise price of $0.60 per share of common stock. In connection with the Navy Capital Offering, between August 8, 2018 and August 10, 2018, the Company entered into five subscription agreements for a total of 6,875,000 units at a price of $0.40 per unit, or an aggregate purchase price of $2,750,000. The units collectively represent (i) 6,875,000 shares of common stock, and (ii) three-year warrants to purchase an aggregate of 6,875,000 shares of common stock at an exercise price of $0.60 per share of common stock. Stock Issued to Officers Effective July 1, 2018, the Company granted the Chief Executive Officer of CLS Nevada, Inc. a one-time signing bonus of 500,000 shares of restricted common stock, which shall become fully vested one year from the effective date of his employment agreement. These shares were valued at $350,000 and will be amortized over the vesting period. As of May 31, 2019, $325,417 had been charged to operations, and is carried as Common Stock Subscribed on the Company’s balance sheet at May 31, 2019. Effective July 1, 2018, the Company granted the Chief Operating Officer of CLS Nevada, Inc. a one-time signing bonus of 50,000 shares of restricted common stock, which shall become fully vested one year from the effective date of his employment agreement. These shares were valued at $35,000 and will be amortized over the vesting period. As of May 31, 2019, $32,542 had been charged to operations, and is carried as Common Stock Subscribed on the Company’s balance sheet at May 31, 2019. Effective August 1, 2018, the Company granted 25,000 shares of restricted common stock to its then Chief Financial Officer. These shares vested four months after issuance. The shares were valued at $17,500, and were amortized over the vesting period. On April 11, 2019, these shares were issued. Effective March 1, 2019, the Company granted its President and Chief Operating Officer Chief Operating Officer 500,000 shares of restricted common stock, which shall become fully vested two years from the effective date of his employment agreement. These shares were valued at $215,500 and will be amortized over the vesting period. As of May 31, 2019, $26,938 had been charged to operations, and is carried as Common Stock Subscribed on the Company’s balance sheet at May 31, 2019. Effective May 2, 2019, the Company granted its Chief Financial Officer 50,000 shares of restricted common stock, which shall become fully vested one year from the effective date of his employment agreement. These shares were valued at $17,995 and will be amortized over the vesting period. As of May 31, 2019, $1,428 had been charged to operations, and is carried as Common Stock Subscribed on the Company’s balance sheet at May 31, 2019. Stock Issued upon Cashless Exercise of Warrants On August 14, 2018, the Company issued 129,412 shares of common stock upon the cashless exercise of warrants to purchase 350,000 shares of common stock at an exercise price of $0.75 per share. On September 6, 2018, the Company issued 13,684 shares of common stock upon the cashless exercise of warrants to purchase 40,000 shares of common stock at an exercise price of $0.75 per share. On November 14, 2018, the Company issued 5,867 shares of common stock upon the cashless exercise of warrants to purchase 25,000 shares of common stock at an exercise price of $0.75 per share. Stock Issued for Settlement On November 1, 2018, the Company issued 50,000 shares of common stock with a fair value of $47,500 pursuant to a legal settlement. There was no gain or loss associated with this transaction. Stock Issued for Compensation for Debenture Offering On December 12, 2018, in connection with the issuance of the Canaccord Debentures, the Company issued 559,750 units as , compensation for advisory and agent fees. Each unit is comprised of one share of common stock and one-half of one common stock purchase warrant at an exercise price of $1.10 per whole share of common stock. As a result, the Company issued 559,750 shares of common stock as compensation for agent and advisory services. These shares were valued at $557,335, and this amount was charged to operations during the year May 31, 2019. Additional Paid-in Capital During the year ended May 31, 2019, the Company recorded discounts on two convertible notes payable related to the beneficial conversion features in the amounts of $362,500 on the YA II PN Note 2, and $58,594 on the Newcan Convertible Note 8. Also, during the year ended May 31, 2019, a reset event occurred with regard to the YA II PN 2 Note. During the year ended May 31, 2019, the Company recorded an original issue discount on the Oasis Note in the amount of $189,180. On June 1, 2018, the Company adopted ASU 2017-11 and accordingly reclassified the fair value of the reset provisions embedded in the previously issued convertible notes payable and certain warrants with embedded anti-dilutive provisions from liability to additional paid-in capital in the aggregate amount of $1,265,751. On June 20, 2018, a reset event occurred in connection with the YA II PN 2 Note, and the Company charged the change in fair value of the conversion feature in the amount of $35,833 to additional paid-in capital. This was considered a material modification of the note, and the Company created a new discount to this note in the amount of $750,000, which was charged to additional paid-in capital. During the year ended May 31, 2019, the Company recorded discounts on six convertible debentures related to the beneficial conversion features as follows: a discount of $3,254,896 was recorded on U.S. Convertible Debenture 1; a discount of $813,724 was recorded on U.S. Convertible Debenture 2; a discount of $75,415 was recorded on U.S. Convertible Debenture 3; a discount of $416,653 was recorded on U.S. Convertible Debenture 4; a discount of $120,100 was recorded on U.S. Convertible Debenture 5; and a discount of $60,049 was recorded on U.S. Convertible Debenture 6. Warrants On June 27, 2018, the Company incurred a penalty in connection with the WestPark Offering due to the late filing of the registration statement that included the resale of the securities that were sold in such offering. As a result of the penalty, the Company issued three-year common stock warrants to purchase an aggregate of 1,368,250 shares of the Company’s common stock at an exercise price of $0.50 per share. In addition, the Company reduced the exercise price of the common stock purchase warrants previously issued to the investors in the WestPark Offering from $0.75 per share to $0.50 per share. The fair value of the penalty was $941,972; this amount was charged to operations during the year ended May 31, 2019. On July 20, 2018, in connection with the Company’s sale of a convertible debenture, the Company issued to YA II PN, Ltd. a five-year common stock purchase warrant to purchase 1,250,000 shares of the Company’s common stock at an initial exercise price of $0.60 per share. On August 6, 2018, the Company issued three-year common stock purchase warrants to purchase an aggregate of 7,500,000 shares of the Company’s common stock at an exercise price of $0.60 per share, to investors in the Navy Capital Offering. On August 8, 2018, the Company issued three-year common stock purchase warrants to purchase an aggregate of 6,875,000 shares of the Company’s common stock at an exercise price of $0.60 per share, to investors in the Navy Capital Offering. The Company valued warrants using the Black-Scholes valuation model utilizing the following variables: May 31, May 31, 2020 2019 Volatility - % 79.02 to 400.3 % Dividends $ - $ 0 Risk-free interest rates - % 2.68% to 2.77 % Term (years) - 3 The following table summarizes the significant terms of warrants outstanding at May 31, 2020. This table does not include the unit warrants. See Unit Warrants section below. Range of exercise Prices Number of warrants Outstanding Weighted average remaining contractual life (years) Weighted average exercise price of outstanding Warrants Number of warrants Exercisable Weighted average exercise price of exercisable Warrants $ 0.49 33,465,110 1.50 $ 0.49 33,465,110 $ 0.49 0.50 2,736,500 1.73 0.50 2,736,500 0.50 0.60 17,500,000 1.50 0.60 17,500,000 0.60 0.75 837,500 0.72 0.75 837,500 0.75 1.10 296,035 1.56 1.10 296,035 1.10 54,835,145 1.50 $ 0.53 54,835,145 $ 0.53 Transactions involving warrants are summarized as follows. This table does not include the special warrants or unit warrants. See Special Warrants and Unit Warrants sections below. Number of Shares Weighted Average Exercise Price Warrants outstanding at May 31, 2018 4,495,750 $ 0.61 Granted 50,738,235 $ 0.653 Exercised (415,000 ) $ 0.75 Cancelled / Expired - $ - Warrants outstanding at May 31, 2019 54,818,985 $ 0.53 Granted 16,160 $ 1.10 Exercised - $ - Cancelled / Expired - $ - Warrants outstanding at May 31, 2020 54,835,145 $ 0.53 Special Warrants On June 20, 2018, the Company sold 28,973,019 special warrants for net proceeds of US$9,785,978. Each special warrant was automatically exercisable, for no additional consideration, for units of the Company on the earlier of: (i) the date that was five business days following the date on which the Company obtained a receipt from the applicable securities regulatory authorities in each of the jurisdictions in Canada in which the special warrants were sold for a final prospectus qualifying the distribution of the units, which was intended to be no later than November 30, 2018, and (ii) the date that was four months and one day after the completion of the Company's acquisition of all of the membership interests in Alternative Solutions, known as Oasis Cannabis, which was June 28, 2018. The Company allocated $4,226,394 of the proceeds from the sale of the special warrants to the underlying stock, and $5,559,584 of the value to the underlying warrants. The value of the warrants underlying the special warrants was determined utilizing the Black-Scholes valuation model. The Company recorded a loss on currency conversion in the amount of $403,588 in connection with the special warrants during the year ended May 31, 2019. Upon exercise of the special warrants, each unit was to consist of one share of the Company's common stock and one warrant to purchase one share of common stock. Each warrant was to be exercisable at a price of C$0.65 for three years after the Company's common stock was listed on a recognized Canadian stock exchange, subject to adjustment in certain events. Because the Company did not receive a receipt from the applicable Canadian securities authorities for the qualifying prospectus by August 20, 2018, the unexercised special warrants were adjusted to entitle the holders to receive 1.1 units instead of one unit of the Company. This resulted in the issuance of an additional 3,042,167 units. This penalty was valued at $7,142,550 and was charged to operations during the year ended May 31, 2019. On November 30, 2018, all of the special warrants were automatically exercised for an aggregate of 33,463,838 shares of common stock and three-year warrants to purchase 33,463,838 shares of common stock for CD$0.65 per share. Because the special warrants were exercisable for Common Stock and warrants, they were not included in the warrant tables above. There were no special warrants outstanding at May 31, 2020 or 2019. Unit Warrants On June 20, 2018, in connection with the special warrant offering, the Company issued Canaccord Genuity Corp. 2,317,842 three-year broker warrants at an exercise price of C$0.45 per share as compensation. Each warrant entitles the holder to purchase one unit, which consists of one share of common stock and a warrant to purchase one share of common stock, for C$0.65 per share. These warrants were valued at $1,495,373, and this amount was charged to operations during the year ended May 31, 2019. On December 12, 2018, in connection with the issuance of the Canaccord Debentures, the Company issued Canaccord Genuity Corp. as compensation 1,074,720 three-year agent and advisory warrants. Each warrant entitles the holder to purchase a unit for $0.80, which unit consists of one share of common stock and a warrant to purchase one-half share of common stock at an exercise price of $1.10 per share. The Company, in connection with the issuance of the Canaccord Debentures, also issued to National Bank Financial Inc., as compensation, 268,680 three-year agent and advisory warrants. Each warrant entitles the holder to purchase a unit for $0.80, which unit consists of one share of common stock and a warrant to purchase one-half share of common stock at an exercise price of $1.10 per share. The aggregate value of these warrants was $874,457, which was charged to operations during the year ended May 31, 2019. Because the unit warrants are exercisable for Common Stock and warrants, they are not included in the warrant tables above. |
GAIN ON SETTLEMENT OF LIABILITI
GAIN ON SETTLEMENT OF LIABILITIES | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract] | ||
Other Liabilities Disclosure [Text Block] | Note 18 – Gain on Settlement of Liabilities On August 14, 2019, the Company made a payment to 4Front Advisors to settle its dispute with Alternative Solutions and its former owners and the Oasis Note was reduced in accordance with its terms. In addition, the amount of $275,000, which the Company had accrued with respect to this dispute, was extinguished resulting in a gain of $275,000. | NOTE 19 – GAIN ON SETTLEMENT OF LIABILITIES On August 14, 2019, the Company made a payment to 4Front Advisors to settle its dispute with Alternative Solutions and its former owners and the Oasis Note was reduced in accordance with its terms. In addition, the amount of $275,000, which the Company had accrued with respect to this dispute, was extinguished resulting in a gain of $275,000. |
FAIR VALUE OF FINANCIAL INSTRUM
FAIR VALUE OF FINANCIAL INSTRUMENTS | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Fair Value Disclosures [Abstract] | ||
Fair Value Disclosures [Text Block] | Note 19 – Fair Value of Financial Instruments The Company has issued convertible notes containing beneficial conversion features. One of the features is a ratchet reset provision which, in general, reduces the conversion price should the Company issue equity with an effective price per share that is lower than the stated conversion price in the note. The Company accounts for the fair value of the conversion feature in accordance with ASC 815- Accounting for Derivatives and Hedging and Emerging Issues Task Force (“EITF”) 07-05- Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity’s Own Stock (“EITF 07-05”). The Company carries the embedded derivative on its balance sheet at fair value and accounts for any unrealized change in fair value as a component of its results of operations. The following summarizes the Company’s financial liabilities that are recorded at fair value on a recurring basis at November 30, 2020 and May 31, 2020: November 30, 2020 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ - $ - May 31, 2020 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ - $ - | NOTE 20 – FAIR VALUE OF FINANCIAL INSTRUMENTS The Company has issued convertible notes containing beneficial conversion features. One of the features is a ratchet reset provision which, in general, reduces the conversion price should the Company issue equity with an effective price per share that is lower than the stated conversion price in the note. The Company accounts for the fair value of the conversion feature in accordance with ASC 815- Accounting for Derivatives and Hedging and Emerging Issues Task Force (“EITF”) 07-05- Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity’s Own Stock (“EITF 07-05”). The Company carries the embedded derivative on its balance sheet at fair value and accounts for any unrealized change in fair value as a component of its results of operations. The Company also had a contingent liability in connection with the acquisition of Alternative Solutions (see note 17). The following summarizes the Company’s financial liabilities that are recorded at fair value on a recurring basis at May 31, 2020 and 2019: May 31, 2020 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ - $ - May 31, 2019 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ - $ - |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Related Party Transactions [Abstract] | ||
Related Party Transactions Disclosure [Text Block] | Note 20 – Related Party Transactions As of November 30, 2020 and May 31, 2020, the Company had accrued salary due to Michael Abrams, a former officer of the Company prior to his September 1, 2015 termination, in the amount of $16,250 On July 31, 2018, the Company granted Ben Sillitoe, the former Chief Executive Officer of CLS Nevada, Inc. a one-time signing bonus of 500,000 shares of restricted common stock, which became fully vested one year from the effective date of his employment agreement. On July 22, 2019, the Company issued these shares to Mr. Ben Sillitoe. On July 31, 2018, the Company granted Mr. Don Decatur, the former Chief Operating Officer of CLS Nevada, Inc. a one-time signing bonus of 50,000 shares of restricted common stock, which became fully vested one year from the effective date of his employment agreement. On July 22, 2019, the Company issued these shares to Mr. Decatur. | NOTE 21 – RELATED PARTY TRANSACTIONS As of May 31, 2020 and 2019, the Company had accrued salary due to Michael Abrams, a former officer of the Company prior to his September 1, 2015 termination, in the amount of $16,250. On July 27, 2018, the Company granted 25,000 shares of restricted common stock to Frank Tarantino, its former Chief Financial Officer. These shares vested four months after issuance. The shares were valued at $17,500, and were amortized over the vesting period. These shares were issued on April 11, 2019. On July 31, 2018, the Company granted Ben Sillitoe, the former Chief Executive Officer of CLS Nevada, Inc. a one-time signing bonus of 500,000 shares of restricted common stock, which became fully vested one year from the effective date of his employment agreement. These shares were valued at $355,000 and were amortized over the vesting period. As of May 31, 2020 and 2019, $29,583 and $325,417 had been charged to operations, respectively. On July 22, 2019, the Company issued these shares to Mr. Ben Sillitoe. On July 31, 2018, the Company granted Mr. Don Decatur, the former Chief Operating Officer of CLS Nevada, Inc. a one-time signing bonus of 50,000 shares of restricted common stock, which became fully vested one year from the effective date of his employment agreement. These shares were valued at $35,000 and were amortized over the vesting period. As of May 31, 2020 and 2019, $2,958 and $32,542 had been charged to operations, respectively. On July 22, 2019, the Company issued these shares to Mr. Decatur. On July 24, 2018, the Company awarded Star Associates, LLC, a limited liability company owned by Andrew Glashow, a director of the Company, a cash payment in the amount of $250,000 and 700,000 shares of restricted common stock in recognition of Mr. Glashow’s efforts, through Star Associates, in successfully assisting the Company in negotiating and obtaining the financing necessary to acquire Alternative Solutions. The shares were valued at $490,000 and were charged to operations during the year ended May 31, 2019. Related Party Notes Payable During the year ended May 31, 2019, the Company made principal and interest payments to Mr. Binder in the amount of $37,500 and $3,903, respectively. At May 31, 2020 and 2019, the Company had no principal or accrued interest payable to Mr. Binder. During the year ended May 31, 2019, David Lamadrid converted principal in the amount of $31,250 and accrued interest in the amount of $1,247 into a total of 103,989 shares of common stock. At May 31, 2020 and 2019, the Company had no principal or accrued interest payable to Mr. Lamadrid. During the year ended May 31, 2019, Newcan Investment Partners, LLC, converted principal in the amount of $75,000 and accrued interest in the amount of $3,534 into a total of 196,336 shares of common stock. At May 31, 2020 and 2019, the Company had no principal or accrued interest payable to Newcan Investment Partners, LLC. |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
May 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Tax Disclosure [Text Block] | NOTE 22 – INCOME TAXES The Company accounts for income taxes under FASB ASC 740-10, which provides for an asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized based on anticipated future tax consequences, using currently enacted tax laws, attributed to temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts calculated for income tax purposes. As of May 31, 2020 and 2019, the Company had incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. The Company’s tax rate was reduced from 34% for the year ended May 31, 2018 to 21% for the year ended May 31, 2020 and 2019 due to changes in the federal income tax rate enacted by the 2018 Tax Cuts and Jobs Act. The tax effects of the temporary differences that give rise to the Company’s estimated deferred tax assets and liabilities are as follows: May 31, May 31, 2020 2019 Federal and state statutory rate 21 % 21 % Net operating loss carry forwards 2,538,429 3,001,749 Valuation allowance for deferred tax assets (2,538,429 ) (3,001,749 ) Net deferred tax assets - - Section 280E of the Internal Revenue Code, as amended, prohibits businesses from deducting certain expenses associated with trafficking controlled substances (within the meaning of Schedule I and II of the Controlled Substances Act). The IRS has invoked Section 280E in tax audits against various cannabis businesses in the U.S. that are permitted under applicable state laws. Although the IRS has issued a clarification allowing the deduction of certain expenses, the bulk of operating costs and general administrative costs are generally not permitted to be deducted. The operations of certain of the Company’s subsidiaries are subject to Section 280E. This results in permanent differences between ordinary and necessary business expenses deemed non-deductible under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income or loss. As of May 31, 2020 and 2019, the Company had net operating loss carry forwards of approximately $12,087,758 and $14,294,045 available to offset future taxable income. The net operating loss carry forwards, if not utilized, will begin to expire in 2037. Based on the available objective evidence, including the Company’s history of losses, management believes it is more likely than not that the net deferred tax assets will not be fully realized. Accordingly, the Company has provided for a full valuation allowance against its net deferred tax assets at May 31, 2020 and 2019. The Company had no uncertain tax positions as of May 31, 2020. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Commitments and Contingencies Disclosure [Text Block] | Note 21 – Commitments and Contingencies Lease Arrangements The Company leases several facilities for office, warehouse, and retail space. Currently lease commitments are as follows: A lease which commenced February 2019 for 1,400 square feet of office space located at 1718 Industrial Road, Las Vegas, NV 89102 initially for a term of eighteen months, for the initial amount of $1,785 per month. In February 2020, this lease was extended to August 31, 2022, with the monthly amount increasing to $1,866.70 until September 2021, after which it will be subject to annual increases of 3%. A lease which commenced January 2018 for 1,000 square feet of storefront plus 5,900 square feet of warehouse space located at 1800 Industrial Road, Suites 102, 160, and 180, Las Vegas, NV 89102 initially for a term of five years for the base amount of $7,500 per month, with annual increases of 3%. In February 2020, this lease was extended to February 28, 2030 and the monthly payment amount was increased by $600. A lease which commenced February 2019 for 2,504 square feet of office space located at 1800 Industrial Road, Suite 100, Las Vegas, NV 89102 for the initial amount of $3,210 per month, with annual increases of 4%. In February 2020, this lease was extended to February 28, 2030, and the lease was modified to include annual increases of 3%. A lease which commenced January 2016 for 22,000 square feet of warehouse space located at 203 E. Mayflower Avenue, North Las Vegas, NV 89030 for an initial term of five years and an initial amount of $11,000 per month, increasing to $29,000 per month. In connection with the Company’s planned Colorado operations, on April 17, 2015, pursuant to an Industrial Lease Agreement (the “Lease”), CLS Labs Colorado leased 14,392 square feet of warehouse and office space (the “Leased Real Property”) in a building in Denver, Colorado where certain intended activities, including growing, extraction, conversion, assembly and packaging of cannabis and other plant materials, are permitted by and in compliance with state, city and local laws, rules, ordinances and regulations. The Lease had an initial term of seventy-two (72) months and provided CLS Labs Colorado with two options to extend the term of the lease by up to an aggregate of ten (10) additional years. In August 2017, as a result of the Company’s decision to suspend its proposed operations in Colorado, CLS Labs Colorado asked its landlord to be relieved from its obligations under the Lease, but the parties have not yet reached an agreement on how to proceed. In August 2017, the Company’s Colorado subsidiary received a demand letter from its Colorado landlord requesting the forfeiture of the $50,000 security deposit, $10,000 in expenses, $15,699 in remaining rent due under the lease agreement and $30,000 to buy out the remaining amounts due under the lease. These expenses, which are a liability of the Company’s Colorado subsidiary, have been accrued on the balance sheet as of November 30, 2020. Contingent Liability At the time of closing of the Acquisition Agreement, Alternative Solutions owed certain amounts to a consultant known as 4Front Advisors, which amount was in dispute. In August 2019, the Company made a payment to this company to settle this dispute and the Oasis Note was reduced accordingly. | NOTE 23 – COMMITMENTS AND CONTINGENCIES Lease Arrangements The Company leases several facilities for office, warehouse, and retail space. Currently lease commitments are as follows: A lease which commenced February 2019 for 1,400 square feet of office space located at 1718 Industrial Road, Las Vegas, NV 89102 initially for a term of eighteen months, for the initial amount of $1,785 per month. In February 2020, this lease was extended to August 31, 2022, with the monthly amount increasing to $1,866.70 until September 2021, after which it will be subject to annual increases of 3%. A lease which commenced January 2018 for 1,000 square feet of storefront plus 5,900 square feet of warehouse space located at 1800 Industrial Road, Suites 102, 160, and 180, Las Vegas, NV 89102 initially for a term of five years for the base amount of $7,500 per month, with annual increases of 3%. In February 2020, this lease was extended to February 28, 2030 and the monthly payment amount was increased by $600. A lease which commenced February 2019 for 2,504 square feet of office space located at 1800 Industrial Road, Suite 100, Las Vegas, NV 89102 for the initial amount of $3,210 per month, with annual increases of 4%. In February 2020, this lease was extended to February 28, 2030, and the lease was modified to include annual increases of 3%. A lease which commenced January 2016 for 22,000 square feet of warehouse space located at 203 E. Mayflower Avenue, North Las Vegas, NV 89030 for an initial term of five years and an initial amount of $11,000 per month, increasing to $29,000 per month. In connection with the Company’s planned Colorado operations, on April 17, 2015, pursuant to an Industrial Lease Agreement (the “Lease”), CLS Labs Colorado leased 14,392 square feet of warehouse and office space (the “Leased Real Property”) in a building in Denver, Colorado where certain intended activities, including growing, extraction, conversion, assembly and packaging of cannabis and other plant materials, are permitted by and in compliance with state, city and local laws, rules, ordinances and regulations. The Lease had an initial term of seventy-two (72) months and provided CLS Labs Colorado with two options to extend the term of the lease by up to an aggregate of ten (10) additional years. In August 2017, as a result of the Company’s decision to suspend its proposed operations in Colorado, CLS Labs Colorado asked its landlord to be relieved from its obligations under the Lease, but the parties have not yet reached an agreement on how to proceed. In August 2017, the Company’s Colorado subsidiary received a demand letter from its Colorado landlord requesting the forfeiture of the $50,000 security deposit, $10,000 in expenses, $15,699 in remaining rent due under the lease agreement and $30,000 to buy out the remaining amounts due under the lease. These expenses, which are a liability of the Company’s Colorado subsidiary, have been accrued on the balance sheet as of May 31, 2020. Contingent Liability At the time of closing of the Acquisition Agreement, Alternative Solutions owed certain amounts to a consultant known as 4Front Advisors, which amount was in dispute. In August 2019, the Company made a payment to this company to settle this dispute and the Oasis Note was reduced accordingly. Employment Agreements CLS Labs and Jeffrey Binder entered into a five-year employment agreement effective October 1, 2014. Under the agreement, Mr. Binder serves as CLS Labs’ Chairman and Chief Executive Officer and is entitled to receive an annual salary of $150,000. Under the agreement, Mr. Binder is also entitled to receive a performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million. On April 28, 2015, CLS Labs and the Company entered into an addendum to Mr. Binder’s employment agreement whereby Mr. Binder agreed that following the merger of CLS Labs and a subsidiary of the Company, in addition to his obligations to CLS Labs, he would serve the Company and its subsidiaries in such roles as the Company may request. In exchange, the Company agreed to assume the obligations of CLS Labs to grant Mr. Binder annual stock options, as referenced above. On July 20, 2016, March 31, 2017, August 23, 2017, October 9, 2017, January 5, 2018 and April 6, 2018, the Company issued Mr. Binder convertible notes in exchange for $250,000, $112,500, $62,500, $39,521, $37,500 and $37,500 respectively, in deferred salary, among other amounts owed to Mr. Binder by the Company. On October 14, 2019 but effective October 1, 2019, CLS Labs, Inc., the Company, and Jeffrey Binder entered into an amendment to Mr. Binder’s employment agreement to provide that the Company would assume all obligations of CLS Labs under the employment agreement. The amendment also extends the term of Mr. Binder’s employment agreement by three years instead of relying on the automatic one-year renewal provision in the employment agreement, and increases Mr. Binder’s annual base salary to $200,000. Additionally, the amendment provides for certain change of control provisions, including a payment of up to three years base salary and bonuses up to a maximum of $1,000,000, if Mr. Binder resigns or is terminated in connection with a change in control of the Company. In connection with the amendment, the parties also amended and restated that certain Confidentiality, Non-Compete and Property Rights Agreement entered into by and between RJF Labs, Inc. (now CLS Labs), and Mr. Binder effective as of July 16, 2014. Effective November 30, 2017, the Company and Mr. Lamadrid entered into a one-year employment agreement. Pursuant to the agreement, Mr. Lamadrid commenced serving as the Company’s President and Chief Financial Officer on December 1, 2017. Under the agreement, Mr. Lamadrid was entitled to receive an annual salary of $175,000. Further, he was entitled to receive a performance bonus equal to 2% of the Company’s annual EBITDA, and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA. Additionally, Mr. Lamadrid was entitled to a one-time signing bonus of 500,000 shares of restricted common stock of the Company, which were to become fully vested one year from the effective date of the agreement. On July 24, 2018, the Company and Mr. Lamadrid mutually agreed to terminate the employment agreement. Mr. Lamadrid resigned as President and Chief Financial Officer effective as of July 13, 2018. In connection with a severance agreement between the Company and Mr. Lamadrid, the Company paid certain amounts and issued 600,000 shares of common stock to Mr. Lamadrid, and the parties further agreed that neither party would have any further obligations under the Employment Agreement or otherwise after such date. On July 31, 2018, the Company and Mr. Sillitoe entered into a one-year employment agreement. Pursuant to the agreement, Mr. Sillitoe commenced serving as the Chief Executive Officer of CLS Nevada, Inc. effective July 1, 2018. Under the agreement, Mr. Sillitoe is entitled to receive an annual salary of $150,000. Further, he is entitled to receive a performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of the annual EBITDA of CLS Nevada, Inc. Additionally, Mr. Sillitoe received a one-time signing bonus of 500,000 shares of restricted common stock, which became fully vested one year from the effective date of his employment agreement. On July 31, 2019, CLS Nevada, Inc. and Mr. Sillitoe amended Mr. Sillitoe’s employment agreement to effect the original intention of the parties that the performance bonus would be based on the results of Alternative Solutions and not CLS Nevada, Inc. On April 16, 2020, CLS Nevada, Inc. notified Mr. Sillitoe of its intent not to renew the employment agreement upon its termination on June 30, 2020. CLS Nevada, Inc. and Mr. Decatur entered into a one-year employment agreement effective July 31, 2018. Pursuant to the agreement, Mr. Decatur commenced serving as the Chief Operating Officer of CLS Nevada, Inc. on July 1, 2018. Under the agreement, Mr. Decatur is entitled to receive an annual salary of $150,000. Further, he is entitled to receive a performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’ common stock in an amount equal to 3% of the annual EBITDA of CLS Nevada, Inc. Additionally, Mr. Decatur received to a one-time signing bonus of 50,000 shares of restricted common stock, which became fully vested one year from the effective date of his employment agreement. On May 14, 2019, CLS Nevada and Mr. Decatur entered into an amendment to his employment agreement to extend the term of Mr. Decatur's employment agreement by two years instead of relying on the automatic one-year renewal provision in the employment agreement. On July 31, 2019, CLS Nevada, Inc. and Mr. Decatur amended Mr. Decatur’s employment agreement to effect the original intention of the parties that the performance bonus would be based on the results of Alternative Solutions and not CLS Nevada, Inc. On December 16, 2019, Mr. Decatur resigned from his position as Chief Operating Officer of CLS Nevada, Inc., effective immediately, for personal reasons. On March 1, 2019, the Company and Mr. Glashow entered into a two-year employment agreement and Mr. Glashow commenced serving as the Company’s President and Chief Operating Officer. Under the agreement, Mr. Glashow is entitled to receive an annual salary of $175,000. Further, he is entitled to receive a performance bonus equal to 1% of the Company’s annual EBITDA, and annual restricted stock awards in an amount equal to 1% of the Company’s annual EBITDA. Additionally, Mr. Glashow is entitled to a one-time signing bonus of 500,000 shares of the Company’s restricted common stock, half of which shall vest on March 1, 2020, and half of which shall vest on March 1, 2021. Effective March 1, 2019, and in connection with the employment agreement, Mr. Glashow and the Company entered into a Confidentiality, Non-Compete and Proprietary Rights Agreement. Pursuant thereto, Mr. Glashow agreed (i) not to compete with us during the term of his employment and for a period of one year thereafter, (ii) not to release or disclose our confidential information, and (iii) to assign the rights to all work product to us, among other terms. On October 14, 2019, but effective October 1, 2019, the Company and Mr. Glashow entered into an amendment to his employment agreement to extend the term by one year instead of relying on the automatic one-year renewal provision in the employment agreement, and to increase Mr. Glashow’s annual base salary to $200,000. The amendment also provides that in addition to his base salary, Mr. Glashow is entitled to receive, on an annual basis, a performance-based bonus equal to two percent (2%) of the Company’s annual EBITDA up to a maximum annual cash compensation of $1 million including base salary, and annual stock options, exercisable at the fair market value of the Company’s common stock on the effective date of grant, in an amount equal to 2% of the Company’s EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million. Additionally, the amendment provides for certain change of control provisions, including a payment of up to three years base salary and bonuses up to a maximum of $1,000,000, if Mr. Glashow resigns or is terminated in connection with a change in control of the Company. On May 2, 2019, the Company and Gregg Carlson entered into a one-year employment agreement. Pursuant to the employment agreement, Mr. Carlson commenced serving as the Company’s Chief financial Officer on May 1, 2019 and will continue his employment with us pursuant to the terms of his one-year employment agreement with Alternative Solutions effective April 8, 2019. Mr. Carlson receives an annual salary of $110,000, and received a one-time signing bonus of 50,000 shares of restricted common stock of the Company, which shall become fully vested one year from the effective date of his employment agreement assuming Mr. Carlson remains employed by the Company on such date. At May 31, 2020 and 2019, the Company had accrued salary due to Michael Abrams, a former officer of the Company, prior to his September 1, 2015 termination, in the amount of $16,250. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Subsequent Events [Abstract] | ||
Subsequent Events [Text Block] | Note 22 – Subsequent Events Resignation of Chief Financial Officer On December 16, 2020, Gregg Carlson resigned from his position as Chief Financial Officer of CLS Holdings USA, Inc., effective immediately, for personal reasons. Resignation of Director On January 1, 2021, Frank Koretsky resigned as a Director of CLS Holdings USA, Inc., effective immediately, to pursue other interests. The Company has evaluated events through the date the financial statements and has determined that there were no additional material subsequent events. | NOTE 24 – SUBSEQUENT EVENTS The Company has evaluated events through the date the financial statements and has determined that there were no material subsequent events. |
Nature of Business and Signific
Nature of Business and Significant Accounting Policies | 6 Months Ended |
Nov. 30, 2020 | |
Accounting Policies [Abstract] | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | Note 1 – Nature of Business and Significant Accounting Policies Basis of Presentation These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in US dollars. The Company has adopted a fiscal year end of May 31st. Principals of Consolidation The accompanying consolidated financial statements include the accounts of CLS Holdings USA, Inc., and its wholly owned operating subsidiaries, CLS Nevada, Inc., (“CLS Nevada”), CLS Labs, Inc. (“CLS Labs”), CLS Labs Colorado, Inc. (“CLS Colorado”), CLS Massachusetts, Inc. (“CLS Massachusetts”), and Alternative Solutions, LLC (“Alternative Solutions”). Alternative Solutions is the sole owner of the following three entities (collectively, the “Oasis LLCs”): Serenity Wellness Center, LLC (“Serenity Wellness Center”); Serenity Wellness Products, LLC (“Serenity Wellness Products”); and Serenity Wellness Growers, LLC (“Serenity Wellness Growers”). All material intercompany transactions have been eliminated upon consolidation of these entities. Nature of Business CLS Holdings USA, Inc. (the “Company”) was originally incorporated as Adelt Design, Inc. (“Adelt”) on March 31, 2011 to manufacture and market carpet binding art. Production and marketing of carpet binding art never commenced. On November 12, 2014, CLS Labs, Inc. (“CLS Labs”) acquired 10,000,000 shares, or 55.6%, of the outstanding shares of common stock of Adelt from its founder, Larry Adelt. On that date, Jeffrey Binder, the Chairman, President and Chief Executive Officer of CLS Labs, was appointed Chairman, President and Chief Executive Officer of the Company. On November 20, 2014, Adelt adopted amended and restated articles of incorporation, thereby changing its name to CLS Holdings USA, Inc. Effective December 10, 2014, the Company effected a reverse stock split of its issued and outstanding common stock at a ratio of 1-for-0.625 (the “Reverse Split”), wherein 0.625 shares of the Company’s common stock were issued in exchange for each share of common stock issued and outstanding. As a result, 6,250,000 shares of the Company’s common stock were issued to CLS Labs in exchange for the 10,000,000 shares that it owned by virtue of the above-referenced purchase from Larry Adelt. On April 29, 2015, the Company, CLS Labs and CLS Merger Inc., a Nevada corporation and wholly owned subsidiary of CLS Holdings (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) and completed a merger, whereby CLS Merger Inc. merged with and into CLS Labs, with CLS Labs remaining as the surviving entity (the “Merger”). Upon the consummation of the Merger, the shares of the common stock of CLS Holdings owned by CLS Labs were extinguished and the former stockholders of CLS Labs were issued an aggregate of 15,000,000 (post Reverse Split) shares of common stock in CLS Holdings in exchange for their shares of common stock in CLS Labs. As a result of the Merger, the Company acquired the business of CLS Labs and abandoned its previous business. The Company has been issued a U.S. patent with respect to its proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter. These concentrates may be ingested in a number of ways, including through vaporization via electronic cigarettes (“e-cigarettes”), and used for a variety of pharmaceutical and other purposes. Internal testing of this extraction method and conversion process has revealed that it produces a cleaner, higher quality product and a significantly higher yield than the cannabinoid extraction processes currently existing in the marketplace. The Company has not commercialized its patented proprietary process or otherwise earned any revenues from it. The Company plans to generate revenues through licensing, fee-for-service and joint venture arrangements related to its patented proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into saleable concentrates. On December 4, 2017, the Company and Alternative Solutions, entered into a Membership Interest Purchase Agreement (the “Acquisition Agreement”), as amended, for the Company to acquire the Oasis LLCs from Alternative Solutions. Pursuant to the Acquisition Agreement, the Company initially contemplated acquiring all of the membership interests in the Oasis LLCs from Alternative Solutions. Just prior to closing, the parties agreed that the Company would instead acquire all of the membership interests in Alternative Solutions, the parent of the Oasis LLCs, from its members, and the membership interests in the Oasis LLCs owned by members other than Alternative Solutions. Pursuant to the Acquisition Agreement, the Company paid a non-refundable deposit of $250,000 upon signing, which was followed by an additional payment of $1,800,000 paid in February 2018, for an initial 10% of each of the Oasis LLCs. At that time, the Company applied for regulatory approval to own an interest in the Oasis LLCs, which approval was received. On June 27, 2018, the Company made the payments to indirectly acquire the remaining 90% of the Oasis LLCs, which were equal to cash in the amount of $5,995,543, a $4.0 million promissory note due in December 2019 (the “Oasis Note”), and 22,058,823 shares of its common stock (the “Purchase Price Shares”) (collectively, the “Closing Consideration”). The cash payment of $5,995,543 was less than the $6,200,000 payment originally contemplated because the Company assumed an additional $204,457 of liabilities. The Company used the proceeds of a Canadian private securities offering to fund the cash portion of the Closing Consideration. The Company then applied for regulatory approval to own the additional 90% in membership interests in the Oasis LLCs, which it received on December 12, 2018. On October 31, 2018, the Company, CLS Massachusetts, Inc., a Massachusetts corporation and a wholly-owned subsidiary of the Company (“CLS Massachusetts”), and In Good Health, Inc., a Massachusetts corporation (“IGH”), entered into an Option Agreement (the “IGH Option Agreement”). Under the terms of the IGH Option Agreement, CLS Massachusetts had an exclusive option to acquire all of the outstanding capital stock of IGH (the “IGH Option”) during the period beginning on the earlier of the date that is one year after the effective date of the conversion and December 1, 2019 and ending on the date that is 60 days after such date. If CLS Massachusetts exercised the IGH Option, the Company, a wholly-owned subsidiary of the Company and IGH would enter into a merger agreement (the form of which had been agreed to by the parties) (the “IGH Merger Agreement”). At the effective time of the merger contemplated by the IGH Merger Agreement, CLS Massachusetts would pay a purchase price of $47,500,000, subject to reduction as provided in the IGH Merger Agreement, payable as follows: $35 million in cash, $7.5 million in the form of a five-year promissory note, and $5 million in the form of restricted common stock of the Company, plus $2.5 million as consideration for a non-competition agreement with IGH’s President, payable in the form of a five-year promissory note. IGH and certain IGH stockholders holding sufficient aggregate voting power to approve the transactions contemplated by the IGH Merger Agreement entered into agreements pursuant to which such stockholders, among other things, agreed to vote in favor of such transactions. On October 31, 2018, as consideration for the IGH Option, the Company made a loan to IGH, in the principal amount of $5,000,000, subject to the terms and conditions set forth in that certain loan agreement, dated as of October 31, 2018 between IGH as the borrower and the Company as the lender. The loan is evidenced by a secured promissory note of IGH, which bears interest at the rate of 6% per annum and matures on October 31, 2021. To secure the obligations of IGH to the Company under the loan agreement and the promissory note, the Company and IGH entered into a security agreement dated as of October 31, 2018, pursuant to which IGH granted to the Company a first priority lien on and security interest in all personal property of IGH. If the Company did not exercise the Option on or prior to the date that is 30 days following the end of the option period, the loan amount would be reduced to $2,500,000 as a break-up fee, subject to certain exceptions set forth in the IGH Option Agreement. On August 26, 2019, the parties amended the IGH Option Agreement to, among other things, delay closing until January 2020. By letter agreement dated January 31, 2020, the Company, CLS Massachusetts and IGH extended the IGH Option Agreement to February 4, 2020. On February 4, 2020, CLS Massachusetts exercised the IGH Option. By letter dated February 26, 2020, the Company informed IGH that as a result of its breaches of the IGH Option, which remained uncured, an event of default had occurred under the IGH Note. The Company advised IGH that it was electing to cause the IGH Note to bear interest at the default rate of 15% per annum effective February 26, 2020 and to accelerate all amounts due under the Note. This dispute, including whether IGH breached the IGH Option and whether CLS is entitled to collect default interest, is now in litigation. At November 30, 2020, the Company had collected a total of $2,743,229 of principal and $181,771 of interest on the IGH Note. On January 29, 2019, the Company made a line of credit loan to CannAssist, LLC (“CannAssist”), in the principal amount of up to $500,000, subject to the terms and conditions set forth in that certain Loan Agreement, dated as of January 29, 2019 between CannAssist as the Borrower and the Company as the Lender (the “CannAssist Loan Agreement”). Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company. The loan is evidenced by a secured promissory note of CannAssist (the “CannAssist Note”), which bears interest at the rate of 8% per annum and is personally guaranteed by the two equity owners of CannAssist. To secure the obligations of CannAssist to the Company under the CannAssist Loan Agreement and the CannAssist Note, the Company and CannAssist entered into a security agreement dated as of January 29, 2019, pursuant to which CannAssist granted to the Company a first priority lien on and security interest in all personal property of CannAssist. On March 11, 2019, the Company, through its wholly-owned subsidiary, CLS Massachusetts, entered into a membership interest purchase agreement (the “CannAssist Purchase Agreement”) with CannAssist, each of the members of CannAssist, and David Noble, as the members’ representative, to acquire an 80% ownership interest in CannAssist. After conducting diligence, the parties decided to terminate the CannAssist Purchase Agreement effective August 26, 2019. On August 26, 2019, the Company and CannAssist entered into an agreement to amend the CannAssist Note. Pursuant to the amendment, there will be no additional advances under the CannAssist Note beyond the $150,000 advanced on February 4, 2019, and the $175,000 advanced on June 24, 2019. In addition, the CannAssist Note shall become due and payable in full on or before February 28, 2020. See note 8. On December 23, 2019, the Company received payment in full on the CannAssist loan in the amount of $342,567, which was made up of $325,000 of principal and $17,567 of interest. At November 30, 2020, the Company was owed $0 pursuant to the CannAssist Note. On January 4, 2018, the Attorney General of the United States issued new written guidance concerning the enforcement of federal laws relating to marijuana. The Attorney General’s memorandum stated that previous DOJ guidance specific to marijuana enforcement, including the memorandum issued by former Deputy Attorney General James Cole on August 29, 2013 (as amended on February 14, 2014, the “Cole Memo”) is unnecessary and is rescinded, effective immediately. The Cole Memo told federal prosecutors that in states that had legalized marijuana, they should use their prosecutorial discretion to focus not on businesses that comply with state regulations, but on illicit enterprises that create harms like selling drugs to children, operating with criminal gangs, and selling across state lines. While the rescission did not change federal law, as the Cole Memo and other DOJ guidance documents were not themselves laws, the rescission removed the DOJ’s formal policy that state-regulated cannabis businesses in compliance with the Cole Memo guidelines should not be a prosecutorial priority. Notably, former Attorney General Sessions’ rescission of the Cole Memo has not affected the status of the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (“FinCEN”) memorandum issued by the Department of Treasury, which remains in effect. This memorandum outlines Bank Secrecy Act-compliant pathways for financial institutions to service state-sanctioned cannabis businesses, which echoed the enforcement priorities outlined in the Cole Memo. In addition to his rescission of the Cole Memo, Attorney General Sessions issued a one-page memorandum known as the “Sessions Memorandum”. The Sessions Memorandum explains the DOJ’s rationale for rescinding all past DOJ cannabis enforcement guidance, claiming that Obama-era enforcement policies are “unnecessary” due to existing general enforcement guidance adopted in the 1980s, in chapter 9.27.230 of the U.A. Attorneys’ Manual (“USAM”). The USAM enforcement priorities, like those of the Cole Memo, are based on the use of the federal government’s limited resources and include “law enforcement priorities set by the Attorney General,” the “seriousness” of the alleged crimes, the “deterrent effect of criminal prosecution,” and “the cumulative impact of particular crimes on the community.” Although the Sessions Memorandum emphasizes that cannabis is a federally illegal Schedule I controlled substance, it does not otherwise instruct U.S. Attorneys to consider the prosecution of cannabis-related offenses a DOJ priority, and in practice, most U.S. Attorneys have not changed their prosecutorial approach to date. However, due to the lack of specific direction in the Sessions Memorandum as to the priority federal prosecutors should ascribe to such cannabis activities, there can be no assurance that the federal government will not seek to prosecute cases involving cannabis businesses that are otherwise compliant with state law. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with maturities of three months or less to be cash equivalents. The Company had cash and cash equivalents of $2,805,516 and $2,925,568 as of November 30, 2020 and May 31, 2020, respectively. Allowance for Doubtful Accounts The Company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products. The Company evaluates the collectability of its accounts receivable considering a combination of factors. In circumstances where it is aware of a specific customer’s inability to meet its financial obligations to it, the Company records a specific reserve for bad debts against amounts due in order to reduce the net recognized receivable to the amount it reasonably believe will be collected. For all other customers, the Company recognizes reserves for bad debts based on past write-off experience and the length of time the receivables are past due. The Company had $0 and $0 of bad debt expense during the three months ended November 30, 2020 and 2019, respectively. The Company had $5,992 and $0 of bad debt expense during the six months ended November 30, 2020 and 2019, respectively. Inventory Inventories are stated at the lower of cost or market. Cost is determined using a perpetual inventory system whereby costs are determined by acquisition costs of individual items included in inventory. Market is determined based on net realizable value. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable values. Our cannabis products consist of prepackaged purchased goods ready for resale, along with produced edibles and extracts developed under our production license. Property, Plant and Equipment Property and equipment is recorded at the lower of cost or estimated net recoverable amount, and is depreciated using the straight-line method over its estimated useful life. Property acquired in a business combination is recorded at estimated initial fair value. Property, plant, and equipment are depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based upon the following life expectancy: Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease Long-Lived Assets The Company reviews its property and equipment and any identifiable intangibles including goodwill for impairment on an annual basis utilizing the guidance set forth in the Statement of Financial Accounting Standards Board ASC 350 “Intangibles – Goodwill and Other” and ASC 360 “Property, Plant, and Equipment”. As a result of the impairment test, it was calculated that the net carrying value of goodwill exceeded the fair value by $25,185,003, and the Company recorded an impairment charge to operations during the year ended May 31, 2020. At November 30, 2020, the net carrying value of goodwill on the Company’s balance sheet was $557,896. Comprehensive Income ASC 220-10-15 “Reporting Comprehensive Income,” establishes standards for reporting and displaying of comprehensive income, its components and accumulated balances. Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, ASC 220-10-15 requires that all items that are required to be recognized under current accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The Company does not have any items of comprehensive income in any of the periods presented. Concentrations of Credit Risk The Company maintains its cash in bank deposit accounts and other accounts, the balances of which at times may be uninsured or exceed federally insured limits. From time to time, some of the Company’s funds are also held by escrow agents; these funds may not be federally insured. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. Advertising and Marketing Costs All costs associated with advertising and promoting products are expensed as incurred. Total recognized advertising and marketing expenses were $311,707 and $218,041 for the three months ended November 30 2020 and 2019, respectively. Total recognized advertising and marketing expenses were $443,739 and $424,019 for the six months ended November 30, 2020 and 2019, respectively. Research and Development Research and development expenses are charged to operations as incurred. Total recognized research and development expenses were $5,385 and $0 for the three months ended November 30, 2020 and 2019, respectively. Total recognized research and development expenses were $12,392 and $0 for the six months ended November 30, 2020 and 2019, respectively. Fair Value of Financial Instruments Pursuant to Accounting Standards Codification (“ASC”) No. 825 - Financial Instruments A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows: Level 1 - Quoted prices in active markets for identical assets or liabilities. Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly. Level 3 - Significant unobservable inputs that cannot be corroborated by market data. Derivative Financial Instruments Derivatives are recorded on the condensed consolidated balance sheets at fair value. The conversion features of the convertible notes are embedded derivatives and are separately valued and accounted for on the consolidated balance sheets with changes in fair value recognized during each period of change as a separate component of other income/expense. Fair values for exchange-traded securities and derivatives are based on quoted market prices. The pricing model the Company uses for determining the fair value of its derivatives is the Lattice Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income (see note 19). There were no reset provisions triggered or derivative liabilities revalued during the three and six months ended November 30, 2020 or 2019. Revenue Recognition Revenue is primarily generated through the Company’s subsidiary, Serenity Wellness Center LLC, d/b/a Oasis Cannabis (“Oasis”). Oasis operates a cannabis dispensary that recognizes revenue from the sale of medical and recreational cannabis products within the State of Nevada. Revenue from the sale of cannabis products is recognized by Oasis at the point of sale, at which time payment is received. Management estimates an allowance for sales returns. The Company also recognizes revenue from Serenity Wellness Products LLC and Serenity Wellness Growers LLC, d/b/a City Trees (“City Trees”). City Trees recognizes revenue from the sale of the following cannabis products and services to licensed dispensaries within the State of Nevada: ● Premium organic medical cannabis sold wholesale to licensed retailers ● Recreational marijuana cannabis products sold wholesale to licensed distributors and retailers ● Extraction products such as oils and waxes derived from in-house cannabis production ● Processing and extraction services for licensed medical cannabis cultivators in Nevada ● High quality cannabis strains in the form of vegetative cuttings for sale to licensed medical cannabis cultivators in Nevada Effective June 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from commercial sales of products and licensing agreements by applying the following steps: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to each performance obligation in the contract; and (5) recognizing revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of the service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. At times, the Company may accept payment for its processing and extraction services in the form of the product extracted, which is then added to inventory. These transactions are valued at the market price of the product. There was no impact on the Company’s financial statements as a result of adopting Topic 606. Disaggregation of Revenue The following table represents a disaggregation of revenue for the three and six months ended November 30, 2020 and 2019: For the Six For the Six For the Three For the Three Months Ended Months Ended Months Ended Months Ended November 30, 2020 November 30, 2019 November 30, 2020 November 30, 2019 Cannabis Dispensary 6,818,499 4,398,262 3,732,974 2,312,362 Cannabis Production 1,870,259 1,517,184 1,174,915 744,069 8,688,758 5,915,446 4,907,889 3,056,431 Basic and Diluted Earnings or Loss Per Share Basic net earnings per share is based on the weighted average number of shares outstanding during the period, while fully diluted net earnings per share is based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of options and warrants to purchase common stock, and convertible debt. Basic and diluted net loss per share are computed based on the weighted average number of shares of common stock outstanding during the period. At November 30, 2020 and 2019, the Company excluded from the calculation of fully diluted shares outstanding the following shares because the result would have been anti-dilutive: At November 30, 2020, a total of 88,474,321 shares (54,835,145 issuable upon the exercise of warrants; 7,676,974 issuable upon the exercise of unit warrants; 25,454,696 issuable upon the conversion of convertible notes payable and accrued interest; and 507,506 in stock to be issued); at November 30, 2019, a total of 86,932,861 shares (54,835,145 issuable upon the exercise of warrants; 7,676,974 issuable upon the exercise of unit warrants; 24,184,074 issuable upon the conversion of convertible notes payable and accrued interest; and 236,668 in stock to be issued). The Company uses the treasury stock method to calculate the impact of outstanding stock options and warrants. Stock options and warrants for which the exercise price exceeds the average market price over the period have an anti-dilutive effect on earnings per common share and, accordingly, are excluded from the calculation. A net loss causes all outstanding stock options and warrants to be anti-dilutive. As a result, the basic and dilutive losses per common share are the same for the three and six months ended November 30, 2020 and 2019. Income Taxes The Company accounts for income taxes under the asset and liability method in accordance with ASC 740. The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The components of the deferred tax assets and liabilities are classified as current and non-current based on their characteristics. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. Section 280E of the Internal Revenue Code, as amended, prohibits businesses from deducting certain expenses associated with trafficking controlled substances (within the meaning of Schedule I and II of the Controlled Substances Act). The IRS has invoked Section 280E in tax audits against various cannabis businesses in the U.S. that are permitted under applicable state laws. Although the IRS has issued a clarification allowing the deduction of certain expenses, the bulk of operating costs and general administrative costs are generally not permitted to be deducted. The operations of certain of the Company’s subsidiaries are subject to Section 280E. This results in permanent differences between ordinary and necessary business expenses deemed non-deductible under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income or loss. Commitments and Contingencies Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims brought to such legal counsel’s attention as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the nature of the guarantee would be disclosed. Recent Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Codification (“ASC”) No. 2016-02, Leases (Topic 842): Accounting for Leases. This update requires that lessees recognize right-of-use assets and lease liabilities that are measured at the present value of the future lease payments at the lease commencement date. The recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee will largely remain unchanged and shall continue to depend on its classification as a finance or operating lease. The Company performed a comprehensive review in order to determine what changes were required to support the adoption of this new standard. The Company adopted the ASU and related amendments on June 1, 2019 and elected certain practical expedients permitted under the transition guidance. The Company elected the optional transition method that allows for a cumulative-effect adjustment in the period of adoption and did not restate prior periods. Under the new guidance, the majority of the Company’s leases continue to be classified as operating. During the first quarter of fiscal 2020, the Company completed its implementation of its processes and policies to support the new lease accounting and reporting requirements. This resulted in an initial increase in both its total assets of $2,703,821 and total liabilities in the amount of $2,675,310. In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this update changed the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarified existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer is accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments required entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That ef |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Accounting Policies [Abstract] | ||
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in US dollars. The Company has adopted a fiscal year end of May 31st. | Basis of Presentation These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in US dollars. The Company has adopted a fiscal year end of May 31st. |
Consolidation, Policy [Policy Text Block] | Principals of Consolidation The accompanying consolidated financial statements include the accounts of CLS Holdings USA, Inc., and its wholly owned operating subsidiaries, CLS Nevada, Inc., (“CLS Nevada”), CLS Labs, Inc. (“CLS Labs”), CLS Labs Colorado, Inc. (“CLS Colorado”), CLS Massachusetts, Inc. (“CLS Massachusetts”), and Alternative Solutions, LLC (“Alternative Solutions”). Alternative Solutions is the sole owner of the following three entities (collectively, the “Oasis LLCs”): Serenity Wellness Center, LLC (“Serenity Wellness Center”); Serenity Wellness Products, LLC (“Serenity Wellness Products”); and Serenity Wellness Growers, LLC (“Serenity Wellness Growers”). All material intercompany transactions have been eliminated upon consolidation of these entities. | Principals of Consolidation The accompanying consolidated financial statements include the accounts of CLS Holdings USA, Inc., and its direct and indirect wholly owned operating subsidiaries, CLS Nevada, Inc., (“CLS Nevada”), CLS Labs, Inc. (“CLS Labs”), CLS Labs Colorado, Inc. (“CLS Colorado”), CLS Massachusetts, Inc. (“CLS Massachusetts”), and Alternative Solutions, LLC (“Alternative Solutions”). Alternative Solutions is the sole owner of the following three entities (collectively, the “Oasis LLCs”): Serenity Wellness Center, LLC (“Serenity Wellness Center”); Serenity Wellness Products, LLC (“Serenity Wellness Products”); and Serenity Wellness Growers, LLC (“Serenity Wellness Growers”). All material intercompany transactions have been eliminated upon consolidation of these entities. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. | Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents The Company considers all highly liquid investments with maturities of three months or less to be cash equivalents. The Company had cash and cash equivalents of $2,805,516 and $2,925,568 as of November 30, 2020 and May 31, 2020, respectively. | Cash and Cash Equivalents The Company considers all highly liquid investments with maturities of three months or less to be cash equivalents. The Company had cash and cash equivalents of $2,925,568 and $10,525,791 as of May 31, 2020 and 2019. |
Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block] | Allowance for Doubtful Accounts The Company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products. The Company evaluates the collectability of its accounts receivable considering a combination of factors. In circumstances where it is aware of a specific customer’s inability to meet its financial obligations to it, the Company records a specific reserve for bad debts against amounts due in order to reduce the net recognized receivable to the amount it reasonably believe will be collected. For all other customers, the Company recognizes reserves for bad debts based on past write-off experience and the length of time the receivables are past due. The Company had $0 and $0 of bad debt expense during the three months ended November 30, 2020 and 2019, respectively. The Company had $5,992 and $0 of bad debt expense during the six months ended November 30, 2020 and 2019, respectively. | Allowance for Doubtful Accounts The Company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products. The Company evaluates the collectability of its accounts receivable considering a combination of factors. In circumstances where it is aware of a specific customer’s inability to meet its financial obligations to it, the Company records a specific reserve for bad debts against amounts due in order to reduce the net recognized receivable to the amount it reasonably believe will be collected. For all other customers, the Company recognizes reserves for bad debts based on past write-off experience and the length of time the receivables are past due. The Company had $108,392 and $0 bad debts expense during the years ended May 31, 2020 and 2019, respectively. |
Inventory, Policy [Policy Text Block] | Inventory Inventories are stated at the lower of cost or market. Cost is determined using a perpetual inventory system whereby costs are determined by acquisition costs of individual items included in inventory. Market is determined based on net realizable value. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable values. Our cannabis products consist of prepackaged purchased goods ready for resale, along with produced edibles and extracts developed under our production license. | Inventory Inventories are stated at the lower of cost or market. Cost is determined using a perpetual inventory system whereby costs are determined by acquisition costs of individual items included in inventory. Market is determined based on net realizable value. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable values. Our cannabis products consist of prepackaged purchased goods ready for resale, along with produced edibles and extracts developed under our production license. |
Property, Plant and Equipment, Policy [Policy Text Block] | Property, Plant and Equipment Property and equipment is recorded at the lower of cost or estimated net recoverable amount, and is depreciated using the straight-line method over its estimated useful life. Property acquired in a business combination is recorded at estimated initial fair value. Property, plant, and equipment are depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based upon the following life expectancy: Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease | Property, Plant, and Equipment Property and equipment is recorded at the lower of cost or estimated net recoverable amount, and is depreciated using the straight-line method over its estimated useful life. Property acquired in a business combination is recorded at estimated initial fair value. Property, plant, and equipment are depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based upon the following life expectancy: Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which extend the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation are eliminated and any resulting gain or loss is reflected in operations |
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | Long-Lived Assets The Company reviews its property and equipment and any identifiable intangibles including goodwill for impairment on an annual basis utilizing the guidance set forth in the Statement of Financial Accounting Standards Board ASC 350 “Intangibles – Goodwill and Other” and ASC 360 “Property, Plant, and Equipment”. As a result of the impairment test, it was calculated that the net carrying value of goodwill exceeded the fair value by $25,185,003, and the Company recorded an impairment charge to operations during the year ended May 31, 2020. At November 30, 2020, the net carrying value of goodwill on the Company’s balance sheet was $557,896. | Long-Lived Assets The Company reviews its property and equipment and any identifiable intangibles including goodwill for impairment on an annual basis utilizing the guidance set forth in the Statement of Financial Accounting Standards Board ASC 350 “Intangibles – Goodwill and Other” and ASC 360 “Property, Plant, and Equipment”. As a result of the impairment test, it was calculated that the net carrying value of goodwill exceeded the fair value by $25,185,003, and the Company recorded an impairment charge to operations during the year ended May 31, 2020. At May 31, 2020, the net carrying value of goodwill on the Company’s balance sheet was $557,896. |
Comprehensive Income, Policy [Policy Text Block] | Comprehensive Income ASC 220-10-15 “Reporting Comprehensive Income,” establishes standards for reporting and displaying of comprehensive income, its components and accumulated balances. Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, ASC 220-10-15 requires that all items that are required to be recognized under current accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The Company does not have any items of comprehensive income in any of the periods presented. | Comprehensive Income ASC 220-10-15 “Reporting Comprehensive Income,” establishes standards for reporting and displaying of comprehensive income, its components and accumulated balances. Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, ASC 220-10-15 requires that all items that are required to be recognized under current accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The Company does not have any items of comprehensive income in any of the periods presented. |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentrations of Credit Risk The Company maintains its cash in bank deposit accounts and other accounts, the balances of which at times may be uninsured or exceed federally insured limits. From time to time, some of the Company’s funds are also held by escrow agents; these funds may not be federally insured. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. | Concentrations of Credit Risk The Company maintains its cash in bank deposit accounts and other accounts, the balances of which at times may be uninsured or exceed federally insured limits. From time to time, some of the Company’s funds are also held by escrow agents; these funds may not be federally insured. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. |
Advertising Cost [Policy Text Block] | Advertising and Marketing Costs All costs associated with advertising and promoting products are expensed as incurred. Total recognized advertising and marketing expenses were $311,707 and $218,041 for the three months ended November 30 2020 and 2019, respectively. Total recognized advertising and marketing expenses were $443,739 and $424,019 for the six months ended November 30, 2020 and 2019, respectively. | Advertising and Marketing Costs All costs associated with advertising and promoting products are expensed as incurred. Total recognized advertising and marketing expenses were $836,000 and $1,655,374 for the years ended May 31, 2020 and 2019, respectively. |
Research, Development, and Computer Software, Policy [Policy Text Block] | Research and Development Research and development expenses are charged to operations as incurred. Total recognized research and development expenses were $5,385 and $0 for the three months ended November 30, 2020 and 2019, respectively. Total recognized research and development expenses were $12,392 and $0 for the six months ended November 30, 2020 and 2019, respectively. | Research and Development Research and development expenses are charged to operations as incurred. The Company incurred research and development costs of $0 for the years ended May 31, 2020 and 2019. |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value of Financial Instruments Pursuant to Accounting Standards Codification (“ASC”) No. 825 - Financial Instruments A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows: Level 1 - Quoted prices in active markets for identical assets or liabilities. Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly. Level 3 - Significant unobservable inputs that cannot be corroborated by market data. | Fair Value of Financial Instruments Pursuant to Accounting Standards Codification (“ASC”) No. 825 - Financial Instruments A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows: Level 1 - Quoted prices in active markets for identical assets or liabilities. Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly. Level 3 - Significant unobservable inputs that cannot be corroborated by market data. |
Derivatives, Policy [Policy Text Block] | Derivative Financial Instruments Derivatives are recorded on the condensed consolidated balance sheets at fair value. The conversion features of the convertible notes are embedded derivatives and are separately valued and accounted for on the consolidated balance sheets with changes in fair value recognized during each period of change as a separate component of other income/expense. Fair values for exchange-traded securities and derivatives are based on quoted market prices. The pricing model the Company uses for determining the fair value of its derivatives is the Lattice Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income (see note 19). There were no reset provisions triggered or derivative liabilities revalued during the three and six months ended November 30, 2020 or 2019. | Derivative Financial Instruments Derivatives are recorded on the condensed consolidated balance sheets at fair value. The conversion features of the convertible notes are embedded derivatives and are separately valued and accounted for on the consolidated balance sheets with changes in fair value recognized during each period of change as a separate component of other income/expense. Fair values for exchange-traded securities and derivatives are based on quoted market prices. The pricing model the Company uses for determining the fair value of its derivatives is the Lattice Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income (see note 20). On June 1, 2018, the Company adopted ASU 2017-11 and accordingly reclassified the fair value of the reset provisions embedded in convertible notes payable and certain warrants with embedded anti-dilutive provisions from liability to equity in the aggregate amount of $1,265,751. The following assumptions were used for the valuation of the derivative liability related to the convertible notes that contain a derivative component: There were no derivative liabilities on the Company’s balance sheet during the year ended May 31, 2020 which required valuation. For the year ended May 31, 2019 - That the quoted market price of the common stock, which decreased from $0.6865 as of June 1, 2018 to $0.2999 as of May 31, 2019, would fluctuate with the Company’s projected volatility; - That the conversion price of the YAN II PN Convertible Notes would be equal to $0.40 with a full reset feature, and upon default, 75% of the lowest Volume Weighted Average Price (the “VWAP”) in the 15 consecutive trading days ending on the trading day that is immediately prior to the applicable conversion date; - That the new convertible notes issued during this period with full resets would be initially issued with conversion prices of $0.40, which were not reset as a result of subsequent transactions; - That an event of default at 24% or 15% interest rate would occur 0% of the time, increasing 1.00% per month to a maximum of 25%, and that instead of a penalty, there would be an alternative conversion price; - That the projected volatility curve from an annualized analysis for each valuation period would be based on the historical volatility of the Company and the remaining term for each convertible note. The projected volatility was in the range of 97.4% to 242.8% during the year ended May 31, 2019; - That the Company would redeem the convertible notes, projected initially at 0% of the time and increasing monthly by 1.00% to a maximum of 10.0%; - That the holder would automatically convert the notes at the maximum of 2 times the conversion price or the stock price if the common stock underlying the 2017 Convertible Notes was eligible for sale in compliance with securities laws and the Company was not in default; - That unless an Event of Default occurred, the holder would sell, per trading day, an amount of Common Stock up to the greater of (i) $5,000 or (ii) 25% multiplied by the “Aggregate Amount,” as defined in the YAN II PN Convertible Notes. |
Revenue [Policy Text Block] | Revenue Recognition Revenue is primarily generated through the Company’s subsidiary, Serenity Wellness Center LLC, d/b/a Oasis Cannabis (“Oasis”). Oasis operates a cannabis dispensary that recognizes revenue from the sale of medical and recreational cannabis products within the State of Nevada. Revenue from the sale of cannabis products is recognized by Oasis at the point of sale, at which time payment is received. Management estimates an allowance for sales returns. The Company also recognizes revenue from Serenity Wellness Products LLC and Serenity Wellness Growers LLC, d/b/a City Trees (“City Trees”). City Trees recognizes revenue from the sale of the following cannabis products and services to licensed dispensaries within the State of Nevada: ● Premium organic medical cannabis sold wholesale to licensed retailers ● Recreational marijuana cannabis products sold wholesale to licensed distributors and retailers ● Extraction products such as oils and waxes derived from in-house cannabis production ● Processing and extraction services for licensed medical cannabis cultivators in Nevada ● High quality cannabis strains in the form of vegetative cuttings for sale to licensed medical cannabis cultivators in Nevada Effective June 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from commercial sales of products and licensing agreements by applying the following steps: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to each performance obligation in the contract; and (5) recognizing revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of the service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. At times, the Company may accept payment for its processing and extraction services in the form of the product extracted, which is then added to inventory. These transactions are valued at the market price of the product. There was no impact on the Company’s financial statements as a result of adopting Topic 606. Disaggregation of Revenue The following table represents a disaggregation of revenue for the three and six months ended November 30, 2020 and 2019: For the Six For the Six For the Three For the Three Months Ended Months Ended Months Ended Months Ended November 30, 2020 November 30, 2019 November 30, 2020 November 30, 2019 Cannabis Dispensary 6,818,499 4,398,262 3,732,974 2,312,362 Cannabis Production 1,870,259 1,517,184 1,174,915 744,069 8,688,758 5,915,446 4,907,889 3,056,431 | Revenue Recognition Revenue from the sale of cannabis products is recognized by Oasis at the point of sale, at which time payment is received. Management estimates an allowance for sales returns. The Company also recognizes revenue from Serenity Wellness Products LLC and Serenity Wellness Growers LLC, d/b/a City Trees (“City Trees”). City Trees recognizes revenue from the sale of the following cannabis products and services to licensed dispensaries within the State of Nevada: ● Premium organic medical cannabis sold wholesale to licensed retailers ● Recreational marijuana cannabis products sold wholesale to licensed distributors and retailers ● Extraction products such as oils and waxes derived from in-house cannabis production ● Processing and extraction services for licensed medical cannabis cultivators in Nevada ● High quality cannabis strains in the form of vegetative cuttings for sale to licensed medical cannabis cultivators in Nevada Effective June 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from commercial sales of products and licensing agreements by applying the following steps: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to each performance obligation in the contract; and (5) recognizing revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of the service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. There was no impact on the Company’s financial statements as a result of adopting Topic 606 for the years ended May 31, 2020 and 2019. Disaggregation of Revenue The following table represents a disaggregation of revenue for the years ended May 31, 2020 and 2019: 2020 2019 Cannabis Dispensary $ 9,365,105 $ 5,492,312 Cannabis Production 2,552,524 2,966,736 $ 11,917,629 $ 8,459,048 |
Earnings Per Share, Policy [Policy Text Block] | Basic and Diluted Earnings or Loss Per Share Basic net earnings per share is based on the weighted average number of shares outstanding during the period, while fully diluted net earnings per share is based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of options and warrants to purchase common stock, and convertible debt. Basic and diluted net loss per share are computed based on the weighted average number of shares of common stock outstanding during the period. At November 30, 2020 and 2019, the Company excluded from the calculation of fully diluted shares outstanding the following shares because the result would have been anti-dilutive: At November 30, 2020, a total of 88,474,321 shares (54,835,145 issuable upon the exercise of warrants; 7,676,974 issuable upon the exercise of unit warrants; 25,454,696 issuable upon the conversion of convertible notes payable and accrued interest; and 507,506 in stock to be issued); at November 30, 2019, a total of 86,932,861 shares (54,835,145 issuable upon the exercise of warrants; 7,676,974 issuable upon the exercise of unit warrants; 24,184,074 issuable upon the conversion of convertible notes payable and accrued interest; and 236,668 in stock to be issued). The Company uses the treasury stock method to calculate the impact of outstanding stock options and warrants. Stock options and warrants for which the exercise price exceeds the average market price over the period have an anti-dilutive effect on earnings per common share and, accordingly, are excluded from the calculation. A net loss causes all outstanding stock options and warrants to be anti-dilutive. As a result, the basic and dilutive losses per common share are the same for the three and six months ended November 30, 2020 and 2019. | Basic and Diluted Earnings or Loss Per Share Basic net earnings per share is based on the weighted average number of shares outstanding during the period, while fully diluted net earnings per share is based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of options and warrants to purchase common stock, and convertible debt. Basic and diluted net loss per share are computed based on the weighted average number of shares of common stock outstanding during the period. At May 31, 2020 and 2019, the Company excluded from the calculation of fully diluted shares outstanding the following shares because the result would have been anti-dilutive: At May 31, 2020 a total of 88,130,526 shares (54,835,145 issuable upon the exercise of warrants; 7,676,974 issuable upon the exercise of unit warrants; 25,131,739 issuable upon the conversion of convertible notes payable and accrued interest; and 486,668 in stock to be issued). At May 31, 2019, the Company excluded from the calculation of fully diluted shares outstanding a total of 86,439,117 shares (54,818,985 issuable upon the exercise of warrants; 7,676,974 issuable upon the exercise of unit warrants; 23,261,393 issuable upon the conversion of convertible notes payable and accrued interest; and 681,764 in stock to be issued). The Company uses the treasury stock method to calculate the impact of outstanding stock options and warrants. Stock options and warrants for which the exercise price exceeds the average market price over the period have an anti-dilutive effect on earnings per common share and, accordingly, are excluded from the calculation. A net loss causes all outstanding stock options and warrants to be antidilutive. As a result, the basic and dilutive losses per common share are the same for the years ended May 31, 2020 and 2019. |
Income Tax, Policy [Policy Text Block] | Income Taxes The Company accounts for income taxes under the asset and liability method in accordance with ASC 740. The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The components of the deferred tax assets and liabilities are classified as current and non-current based on their characteristics. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. Section 280E of the Internal Revenue Code, as amended, prohibits businesses from deducting certain expenses associated with trafficking controlled substances (within the meaning of Schedule I and II of the Controlled Substances Act). The IRS has invoked Section 280E in tax audits against various cannabis businesses in the U.S. that are permitted under applicable state laws. Although the IRS has issued a clarification allowing the deduction of certain expenses, the bulk of operating costs and general administrative costs are generally not permitted to be deducted. The operations of certain of the Company’s subsidiaries are subject to Section 280E. This results in permanent differences between ordinary and necessary business expenses deemed non-deductible under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income or loss. | Income Taxes The Company accounts for income taxes under the asset and liability method in accordance with ASC 740. The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The components of the deferred tax assets and liabilities are classified as current and non-current based on their characteristics. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. |
Commitments and Contingencies, Policy [Policy Text Block] | Commitments and Contingencies Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims brought to such legal counsel’s attention as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the nature of the guarantee would be disclosed. | Commitments and Contingencies Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims brought to such legal counsel’s attention as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the nature of the guarantee would be disclosed. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recent Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Codification (“ASC”) No. 2016-02, Leases (Topic 842): Accounting for Leases. This update requires that lessees recognize right-of-use assets and lease liabilities that are measured at the present value of the future lease payments at the lease commencement date. The recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee will largely remain unchanged and shall continue to depend on its classification as a finance or operating lease. The Company performed a comprehensive review in order to determine what changes were required to support the adoption of this new standard. The Company adopted the ASU and related amendments on June 1, 2019 and elected certain practical expedients permitted under the transition guidance. The Company elected the optional transition method that allows for a cumulative-effect adjustment in the period of adoption and did not restate prior periods. Under the new guidance, the majority of the Company’s leases continue to be classified as operating. During the first quarter of fiscal 2020, the Company completed its implementation of its processes and policies to support the new lease accounting and reporting requirements. This resulted in an initial increase in both its total assets of $2,703,821 and total liabilities in the amount of $2,675,310. In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this update changed the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarified existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer is accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments required entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the codification, to a scope exception. Those amendments do not have an accounting effect. The amendments in Part I of this update became effective for the Company on June 1, 2019. The adoption of ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815), did not have a material effect on the Company’s financial statements. There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s consolidated financial position, results of operations or cash flows. | Recent Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Codification (“ASC”) No. 2016-02, Leases (Topic 842): Accounting for Leases. This update requires that lessees recognize right-of-use assets and lease liabilities that are measured at the present value of the future lease payments at the lease commencement date. The recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee will largely remain unchanged and shall continue to depend on its classification as a finance or operating lease. The Company has performed a comprehensive review in order to determine what changes were required to support the adoption of this new standard. The Company adopted the ASU and related amendments on June 1, 2019 and has elected certain practical expedients permitted under the transition guidance. The Company has elected the optional transition method that allows for a cumulative-effect adjustment in the period of adoption and will not restate prior periods. Under the new guidance, the majority of the Company’s leases continue to be classified as operating. During the first quarter of fiscal 2020, the Company completed its implementation of its processes and policies to support the new lease accounting and reporting requirements. This resulted in an initial increase in both its total assets of $2,703,821 and total liabilities in the amount of $2,675,310. In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment, which simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, current U.S. GAAP requires the performance of procedures to determine the fair value at the impairment testing date of assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, the amendments under this ASU require the goodwill impairment test to be performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The ASU became effective for the Company on January 1, 2020. The adoption of this ASU did not have a material impact on our consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230). The update addresses eight specific cash flow issues and is intended to reduce diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This update is effective for reporting periods beginning after December 15, 2017, including interim periods within the reporting period. Adoption of ASU 2016-15 did not have a material effect on our financial statements. In May 2017, the FASB issued ASU No. 2017-09, Stock Compensation - Scope of Modification Accounting, which provides guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The ASU requires that an entity account for the effects of a modification unless the fair value (or calculated value or intrinsic value, if used), vesting conditions and classification (as equity or liability) of the modified award are all the same as for the original award immediately before the modification. The ASU became effective for the Company on January 1, 2018, and is applied to an award modified on or after the adoption date. Adoption of ASU 2017-09 did not have a material effect on the Company’s financial statements. Effective June 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products and licensing agreements by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of a service has been rendered to a customer or delivery has occurred; (3) the amount of the fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. There was no impact on the Company’s financial statements as a result of adopting ASC 606. In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the codification, to a scope exception. Those amendments do not have an accounting effect. The amendments in Part I of this update became effective the Company on June 1, 2019. The adoption of ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815) did not have a material effect on the Company’s financial statements. On June 1, 2018, the Company adopted ASU 2017-11 and accordingly reclassified the fair value of the reset provisions embedded in convertible notes payable and certain warrants with embedded anti-dilutive provisions from liability to equity in the aggregate amount of $1,265,751. There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s consolidated financial position, results of operations or cash flows. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) [Line Items] | ||
Property, Plant and Equipment [Table Text Block] | Property, plant and equipment consisted of the following at November 30, 2020 and May 31, 2020. November 30, 2020 May 31, 2020 Office equipment $ 116,090 $ 94,887 Furniture and fixtures 145,103 144,025 Machinery & Equipment 1,776,316 1,741,830 Leasehold improvements 2,769,219 2,662,967 Less: accumulated depreciation (1,151,948 ) (868,200 ) Property, plant, and equipment, net $ 3,654,780 $ 3,775,509 | Property, plant and equipment consisted of the following at May 31, 2020 and 2019: May 31, May 31, 2020 2019 Office equipment $ 94,887 $ 53,152 Furniture & fixtures 144,025 140,701 Machinery & equipment 1,741,830 969,196 Leasehold improvements 2,662,967 1,293,660 Less: accumulated depreciation (868,200 ) (546,408 ) Property and equipment, net $ 3,775,509 $ 1,910,301 |
Disaggregation of Revenue [Table Text Block] | The following table represents a disaggregation of revenue for the three and six months ended November 30, 2020 and 2019: For the Six For the Six For the Three For the Three Months Ended Months Ended Months Ended Months Ended November 30, 2020 November 30, 2019 November 30, 2020 November 30, 2019 Cannabis Dispensary 6,818,499 4,398,262 3,732,974 2,312,362 Cannabis Production 1,870,259 1,517,184 1,174,915 744,069 8,688,758 5,915,446 4,907,889 3,056,431 | The following table represents a disaggregation of revenue for the years ended May 31, 2020 and 2019: 2020 2019 Cannabis Dispensary $ 9,365,105 $ 5,492,312 Cannabis Production 2,552,524 2,966,736 $ 11,917,629 $ 8,459,048 |
Estimated Useful LIfe [Member] | ||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) [Line Items] | ||
Property, Plant and Equipment [Table Text Block] | Property and equipment is recorded at the lower of cost or estimated net recoverable amount, and is depreciated using the straight-line method over its estimated useful life. Property acquired in a business combination is recorded at estimated initial fair value. Property, plant, and equipment are depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based upon the following life expectancy: Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease | Property and equipment is recorded at the lower of cost or estimated net recoverable amount, and is depreciated using the straight-line method over its estimated useful life. Property acquired in a business combination is recorded at estimated initial fair value. Property, plant, and equipment are depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based upon the following life expectancy: Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease |
ACQUISITION OF ALTERNATIVE SO_2
ACQUISITION OF ALTERNATIVE SOLUTIONS (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Business Combinations [Abstract] | ||
Schedule of Business Acquisitions, by Acquisition [Table Text Block] | The acquisition date estimated fair value of the consideration transferred totaled $27,975,650, which consisted of the following: Initial purchase price $ 2,050,000 Cash paid in connection with transaction 5,995,543 Note payable 3,810,820 Contingent consideration 678,111 Common stock 15,441,176 Total purchase price $ 27,975,650 Net tangible assets $ 595,151 Intangible assets 1,637,600 Goodwill 25,742,899 Total purchase price $ 27,975,650 | The acquisition date estimated fair value of the consideration transferred totaled $27,975,650, which consisted of the following: Initial purchase price $ 2,050,000 Cash paid in connection with transaction 5,995,543 Note payable 3,810,820 Contingent consideration 678,111 Common stock 15,441,176 Total purchase price $ 27,975,650 Net tangible assets $ 595,151 Intellectual property 319,600 License & customer relationships 990,000 Tradenames 301,000 Non-compete agreements 27,000 Goodwill 25,742,899 Total purchase price $ 27,975,650 |
Business Acquisition, Pro Forma Information [Table Text Block] | These combined results are not necessarily indicative of the results that may have been achieved had the companies always been combined. Twelve months ended May 31, 2019 (unaudited) Revenues $ 9,759,956 Net loss $ (26,671,841 ) Basic net loss per share $ (0.26 ) Diluted net loss per share $ (0.26 ) Weighted average shares - basic 102,869,612 Weighted average shares - diluted 102,869,612 |
PREPAID EXPENSES AND OTHER CU_2
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Disclosure Text Block Supplement [Abstract] | ||
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] | Prepaid expenses and other current assets consisted of the following: November 30, 2020 May 31, 2020 Deposits $ 2,262 $ 2,315 Prepaid expenses 295,058 231,777 Total $ 297,320 $ 234,092 | Prepaid expenses and other current assets consisted of the following at May 31, 2020 and 2019: May 31, May 31, 2020 2019 Deposits $ 2,315 211,493 Prepaid expenses 231,777 178,920 Total $ 234,092 $ 390,413 |
INVENTORY (Tables)
INVENTORY (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Inventory Disclosure [Abstract] | ||
Schedule of Inventory, Current [Table Text Block] | Inventory, consisting of material, overhead, labor, and manufacturing overhead, is stated at the lower of cost (first-in, first-out) or market, and consists of the following: November 30, May 31, 2020 2020 Raw materials $ 527,984 $ 134,697 Finished goods 860,416 440,545 Total $ 1,388,400 $ 575,242 | Inventory, consisting of material, overhead, labor, and manufacturing overhead, is stated at the lower of cost (first-in, first-out) or market, and consists of the following: May 31, May 31, 2020 2019 Raw materials $ 134,697 $ 323,635 Finished goods 440,545 423,198 Total $ 575,242 $ 746,833 |
PROPERTY, PLANT AND EQUIPMENT (
PROPERTY, PLANT AND EQUIPMENT (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Property, Plant and Equipment [Abstract] | ||
Property, Plant and Equipment [Table Text Block] | Property, plant and equipment consisted of the following at November 30, 2020 and May 31, 2020. November 30, 2020 May 31, 2020 Office equipment $ 116,090 $ 94,887 Furniture and fixtures 145,103 144,025 Machinery & Equipment 1,776,316 1,741,830 Leasehold improvements 2,769,219 2,662,967 Less: accumulated depreciation (1,151,948 ) (868,200 ) Property, plant, and equipment, net $ 3,654,780 $ 3,775,509 | Property, plant and equipment consisted of the following at May 31, 2020 and 2019: May 31, May 31, 2020 2019 Office equipment $ 94,887 $ 53,152 Furniture & fixtures 144,025 140,701 Machinery & equipment 1,741,830 969,196 Leasehold improvements 2,662,967 1,293,660 Less: accumulated depreciation (868,200 ) (546,408 ) Property and equipment, net $ 3,775,509 $ 1,910,301 |
RIGHT TO USE ASSETS AND LIABI_2
RIGHT TO USE ASSETS AND LIABILITIES - OPERATING LEASES (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Disclosure Text Block [Abstract] | ||
Lessee, Operating Lease, Disclosure [Table Text Block] | Right to use assets – operating leases are summarized below: November 30, 2020 Amount at inception of leases $ 2,703,821 Amount amortized (1,476,119 ) Balance – November 30, 2020 $ 1,227,702 | Right to use assets – operating leases are summarized below: May 31, 2020 Amount at inception of leases $ 2,703,821 Amount amortized (1,300,392 ) Balance – May 31, 2020 $ 1,403,429 |
Lease, Cost [Table Text Block] | Operating lease liabilities are summarized below: Amount at inception of leases $ 2,675,310 Amount amortized (1,409,668 ) Balance – November 30, 2020 $ 1,265,642 November 30, 2020 Warehouses and offices $ 1,265,642 Lease liability $ 1,265,642 Less: current portion (176,275 ) Lease liability, non-current $ 1,089,367 | Operating lease liabilities are summarized below: Amount at inception of leases $ 2,675,310 Amount amortized (1,202,259 ) Balance – May 31, 2020 $ 1,473,051 May 31, 2020 Warehouses and offices $ 1,473,051 Lease liability $ 1,473,051 Less: current portion (336,900 ) Lease liability, non-current $ 1,136,151 |
Lessee, Operating Lease, Liability, Maturity [Table Text Block] | Maturity analysis under these lease agreements is as follows: Twelve months ended November 30, 2021 $ 268,577 Twelve months ended November 30, 2022 178,570 Twelve months ended November 30, 2023 167,234 Twelve months ended November 30, 2024 172,035 Twelve months ended November 30, 2025 176,980 Thereafter 810,327 Total $ 1,773,723 Less: Present value discount (508,081 ) Lease liability $ 1,265,642 | Maturity analysis under these lease agreements is as follows: Twelve months ended May 31, 2021 $ 440,022 Twelve months ended May 31, 2022 184,172 Twelve months ended May 31, 2023 168,886 Twelve months ended May 31, 2024 169,617 Twelve months ended May 31, 2025 174,489 Thereafter 899,441 Total $ 2,036,627 Less: Present value discount (563,576 ) Lease liability $ 1,473,051 |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Schedule of Finite-Lived Intangible Assets [Table Text Block] | Intangible assets consisted of the following at November 30, 2020 and May 31, 2020: Accumulated November 30, 2020 Gross Amortization Net Intellectual Property $ 319,600 $ (77,237 ) $ 242.363 License & Customer Relations 990,000 (119,625 ) 870,375 Tradenames - Trademarks 301,000 (72,742 ) 228,258 Non-Compete Agreements 27,000 (27,000 ) - Domain Names 26,512 (4,887 ) 21,625 Total $ 1,664,112 $ (301,491 ) $ 1,362,621 Accumulated May 31, 2020 Gross Amortization Net Intellectual Property $ 319,600 $ (61,257 ) $ 258,343 License & Customer Relations 990,000 (94,875 ) 895,125 Tradenames - Trademarks 301,000 (57,692 ) 243,308 Non-Compete Agreements 27,000 (25,882 ) 1,118 Domain names 26,512 (3,302 ) 23,310 Total $ 1,664,112 $ (242,908 ) $ 1,421,204 | Intangible assets consisted of the following at May 31, 2020 and 2019: May 31, 2020 Accumulated Gross Amortization Net Intellectual Property $ 319,600 $ (61,257 ) $ 258,343 License & Customer Relations 990,000 (94,875 ) 895,125 Tradenames - Trademarks 301,000 (57,692 ) 243,308 Non-compete Agreements 27,000 (25,882 ) 1,118 Domain Names 25,993 (2,683 ) 23,310 Total $ 1,663,593 $ (242,389 ) $ 1,421,204 May 31, 2019 Accumulated Gross Amortization Net Intellectual Property $ 319,600 $ (29,297 ) $ 290,303 License & Customer Relations 990,000 (45,375 ) 944,625 Tradenames - Trademarks 301,000 (27,592 ) 273,408 Non-compete Agreements 27,000 (12,378 ) 14,622 Domain Names 3,963 (1,834 ) 2,129 Total $ 1,641,563 $ (116,476 ) $ 1,525,087 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | Total amortization expense charged to operations for the three months ended November 30, 2020 and 2019 was $28,715 and $28,030, respectively. Total amortization expense charged to operations for the six months ended November 30, 2020 and 2019 was $58,583 and $58,304, respectively. Amount to be amortized during the twelve months ended November 30, 2021 $ 111,989 2022 111,989 2023 111,989 2024 111,989 2025 111,989 Thereafter 802,676 $ 1,362,621 | Total amortization expense charged to operations for the years ended May 31, 2020 and 2019 was $125,913 and $115,074, respectively. Amount to be amortized during the twelve months ended May 31, 2021 $ 113,080 2022 111,962 2023 111,962 2024 111,962 2025 111,962 Thereafter 860,276 $ 1,421,204 |
OTHER ASSETS (Tables)
OTHER ASSETS (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Other Non-current Assets Disclosure [Abstract] | ||
Schedule of Other Assets [Table Text Block] | Other assets consisted of the following at November 30, 2020 and May 31, 2020: November 30, May 31, 2020 2020 Security deposits $ 167,455 $ 167,455 $ 167,455 $ 167,455 | Other assets included the following as of May 31, 2020 and May 31, 2019: May 31 May 31, 2020 2019 Security deposits 167,455 167,455 $ 167,455 $ 167,455 |
ACCOUNTS PAYABLE AND ACCRUED _2
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Payables and Accruals [Abstract] | ||
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] | Accrued accounts payable and accrued liabilities consisted of the following at November 30, 2020 and May 31, 2020: November 30, 2020 May 31, 2020 Trade accounts payable $ 723,573 $ 591,060 Accrued payroll and payroll taxes 226,272 212,361 Accrued liabilities 480,920 369,462 Total $ 1,430,765 $ 1,172,883 | Accounts payable and accrued liabilities consisted of the following at May 31, 2020 and 2019: May 31, May 31, 2020 2019 Trade accounts payable $ 591,060 $ 510,210 Accrued payroll and payroll taxes 212,361 230,119 Accrued liabilities 369,462 625,399 Deferred rent liability - 151,399 Total $ 1,172,883 $ 1,517,127 |
NOTES PAYABLE AND CONVERTIBLE_2
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Debt Disclosure [Abstract] | ||
Schedule of Debt [Table Text Block] | May 31, May 31, 2020 2019 The Company issued a secured note payable to Serenity Wellness Enterprises, LLC, as nominee (“Oasis Note”) dated June 27, 2018 in the principal amount of $4,000,000 and bearing interest at a rate of 6% per annum pursuant to the Membership Interest Purchase Agreement with Alternative Solutions. The note is due on December 4, 2019, but may be prepaid at any time without penalty. The Oasis Note is secured by all of the membership interests in Alternative Solutions and the Oasis LLCs and by the assets of the Oasis LLCs. The Company recognized an original issue discount of $189,180 on the Oasis Note. During the year ended May 31, 2020 and 2019, $67,384 and $121,796, respectively, of this discount was charged to operations. On August 14, 2019, the Company made a prepayment in the amount of $2,500,000, which was applied to the amount due under the Oasis Note; in addition, principal due under the Oasis note was further reduced by $133,389 for legal fees and $5,395 for other costs incurred by the Company in connection with a settlement agreement (see note 19). During the years ended May 31, 2020 and 2019, the Company accrued interest in the amounts of $82,037 and $225,333, respectively, on the Oasis Note. On December 31, 2019, the Company repaid the remaining amount of the note, $1,671,296, which comprised $1,363,925 of principal and $370,370 of interest. - 4,000,000 Total – Notes Payable $ - $ 4,000,000 Less: Discount - (67,384 ) Notes Payable, Net of Discounts $ - $ 3,932,616 Current portion $ - $ 3,932,616 Long term portion $ - $ - | |
Convertible Debt [Table Text Block] | November 30, 2020 May 31, 2020 Convertible debenture in the principal amount of $4,000,000 (the “U.S. Convertible Debenture 1”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 1. The U.S. Convertible Debenture 1 matures on a date that is three years following issuance. The U.S. Convertible Debenture 1 is convertible into units (the “Convertible Debenture Units”) at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 1 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 1, the conversion price of U.S. Convertible Debenture 1 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with U.S. Convertible Debenture 1 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 1 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 1 is an unsecured obligation of the Company and ranks pari passu $ 4,504,457 $ 4,504,457 Convertible debenture in the principal amount of $1,000,000 (the “U.S. Convertible Debenture 2”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 2. The U.S. Convertible Debenture 2 matures on a date that is three years following issuance. The U.S. Convertible Debenture 2 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 2 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 2, the conversion price of U.S. Convertible Debenture 2 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with U.S. Convertible Debenture 2 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 2 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 2 is an unsecured obligation of the Company and ranks pari passu 1,126,114 1,126,114 November 30, 2020 May 31, 2020 Convertible debenture in the principal amount of $100,000 (the “U.S. Convertible Debenture 3”) dated October 24, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 3. The U.S. Convertible Debenture 3 matures on a date that is three years following issuance. The U.S. Convertible Debenture 3 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 3 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 3, the conversion price of U.S. Convertible Debenture 3 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with U.S. Convertible Debenture 3 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 3 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 3 is an unsecured obligation of the Company and ranks pari passu 112,613 112,613 Convertible debenture in the principal amount of $532,000 (the “U.S. Convertible Debenture 4”) dated October 25, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 4. The U.S. Convertible Debenture 4 matures on a date that is three years following issuance. The U.S. Convertible Debenture 4 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 4 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 4, the conversion price of U.S. Convertible Debenture 4 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with U.S. Convertible Debenture 4 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 4 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 4 is an unsecured obligation of the Company and ranks pari passu 599,101 599,101 November 30, 2020 May 31, 2020 Convertible debenture in the principal amount of $150,000 (the “U.S. Convertible Debenture 5”) dated October 26, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 5. The U.S. Convertible Debenture 5 matures on a date that is three years following issuance. The U.S. Convertible Debenture 5 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The U.S. Convertible Debenture 5 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 5 is an unsecured obligation of the Company and ranks pari passu 168,919 168,919 Convertible debenture payable in the principal amount of $75,000 (the “U.S. Convertible Debenture 6”) dated October 26, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 6. The U.S. Convertible Debenture 6 matures on a date that is three years following issuance. The U.S. Convertible Debenture 6 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The U.S. Convertible Debenture 6 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 6 is an unsecured obligation of the Company and ranks pari passu 84,459 84,459 November 30, 2020 May 31, 2020 Convertible debentures payable in the aggregate principal amount of $12,012,000 (the “Canaccord Debentures”) dated December 12, 2018, which bear interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the Canaccord Debentures. The Canaccord Debentures mature on a date that is three years following issuance. The Canaccord Debentures are convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The Canaccord Debentures have other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The Canaccord Debentures are unsecured obligations of the Company and rank pari passu 13,500,150 13,287,549 November 30, 2020 May 31, 2020 Total - Convertible Notes Payable $ 20,095,813 $ 19,883,212 Less: Discount (1,448,590 ) (2,238,730 ) Convertible Notes Payable, Net of Discounts $ 18,647,223 $ 17,644,482 Total - Convertible Notes Payable, Net of Discounts, Current Portion, net of discount of $1,448,590 and $0 $ 5,147,073 $ - Total - Convertible Notes Payable, Net of Discounts, Long-term Portion, net of discount of $0 and $2,238,730 $ 13,500,150 $ 17,644,482 | May 31, 2020 May 31, 2019 Convertible debenture in the principal amount of $4,000,000 (the “U.S. Convertible Debenture 1”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 1. The U.S. Convertible Debenture 1 matures on a date that is three years following issuance. The U.S. Convertible Debenture 1 is convertible into units (the “Convertible Debenture Units”) at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 1 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 1, the conversion price of Convertible Debenture 1 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with Convertible Debenture 1 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 1 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 1 is an unsecured obligation of the Company and ranks pari passu 4,504,457 4,134,400 Convertible debenture in the principal amount of $1,000,000 (the “U.S. Convertible Debenture 2”) dated October 31, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 2. The U.S. Convertible Debenture 2 matures on a date that is three years following issuance. The U.S. Convertible Debenture 2 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 1 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 2, the conversion price of Convertible Debenture 2 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with Convertible Debenture 2 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 2 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 2 is an unsecured obligation of the Company and ranks pari passu 1,126,114 1,033,600 May 31, 2020 May 31, 2019 Convertible debenture in the principal amount of $100,000 (the “U.S. Convertible Debenture 3”) dated October 24, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 3. The U.S. Convertible Debenture 3 matures on a date that is three years following issuance. The U.S. Convertible Debenture 3 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 3 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 3, the conversion price of Convertible Debenture 3 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with Convertible Debenture 3 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 3 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 3 is an unsecured obligation of the Company and ranks pari passu 112,613 103,496 Convertible debenture in the principal amount of $532,000 (the “U.S. Convertible Debenture 4”) dated October 25, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 4. The U.S. Convertible Debenture 4 matures on a date that is three years following issuance. The U.S. Convertible Debenture 4 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. On July 26, 2019, U.S. Convertible Debenture 4 was amended such that, should the Company issue or sell common stock or equity securities convertible into common stock at a price less than the conversion price of the U.S. Convertible Debenture 4, the conversion price of Convertible Debenture 4 will be reduced to such issuance price, and the exercise price of the warrant issuable in connection with Convertible Debenture 4 will be exercisable at a price equal to 137.5% of the adjusted conversion price at the time of conversion. The U.S. Convertible Debenture 4 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 4 is an unsecured obligation of the Company and ranks pari passu 599,101 550,478 May 31, 2020 May 31, 2019 Convertible debenture in the principal amount of $150,000 (the “U.S. Convertible Debenture 5”) dated October 26, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 5. The U.S. Convertible Debenture 5 matures on a date that is three years following issuance. The U.S. Convertible Debenture 5 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The U.S. Convertible Debenture 5 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 5 is an unsecured obligation of the Company and ranks pari passu 168,919 155,176 Convertible debenture payable in the principal amount of $75,000 (the “U.S. Convertible Debenture 6”) dated October 26, 2018, which bears interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the U.S. Convertible Debenture 6. The U.S. Convertible Debenture 6 matures on a date that is three years following issuance. The U.S. Convertible Debenture 6 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The U.S. Convertible Debenture 6 has other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The U.S. Convertible Debenture 6 is an unsecured obligation of the Company and ranks pari passu 84,459 77,588 May 31, 2020 May 31, 2019 Convertible debentures payable in the aggregate principal amount of $12,012,000 (the “Canaccord Debentures”) dated December 12, 2018, which bear interest, payable quarterly, at a rate of 8% per annum, with interest during the first eighteen months following issuance being payable by increasing the then-outstanding principal amount of the Canaccord Debentures. The Canaccord Debentures mature on a date that is three years following issuance. The Canaccord Debentures are convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company’s common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. The value of the warrants will be recorded when the issuance becomes probable. The Canaccord Debentures have other features, such as mandatory conversion in the event the common stock trades at a particular price over a specified period of time and required redemption in the event of a “Change in Control” of the Company. The Canaccord Debentures are unsecured obligations of the Company and rank pari passu 13,287,549 12,305,492 Total - Convertible Notes Payable $ 19,883,212 $ 18,360,230 Less: Discount (2,238,730 ) (3,819,010 ) Convertible Notes Payable, Net of Discounts $ 17,644,482 $ 14,541,220 Total - Convertible Notes Payable, Net of Discounts, Current Portion $ - $ - Total - Convertible Notes Payable, Net of Discounts, Long-term Portion $ 17,644,482 $ 14,541,220 |
Schedule of Amortization of Debt Discount [Table Text Block] | November 30, 2020 November 30, 2019 Discounts on notes payable amortized to interest expense – 3 months ended November 30, 2020 and 2019, respectively $ 395,070 $ 259,070 Discounts on notes payable amortized to interest expense – 6 months ended November 30, 2020 and 2019, respectively $ 790,140 $ 853,983 | Discounts on notes payable amortized to interest expense – years ended May 31, 2020 and 2019, respectively $ 1,580,280 $ 921,827 |
Schedule of Maturities of Long-term Debt [Table Text Block] | 2021 $ 6,595,663 2022 13,500,150 2023 - 2024 - 2025 - Thereafter - Total $ 20,095,813 | Aggregate maturities of notes payable and convertible notes payable as of May 31, 2020 are as follows: 2021 $ - 2022 19,883,212 2023 - 2024 - 2025 - Thereafter - Total $ 19,883,212 |
STOCKHOLDERS_ EQUITY (Tables)
STOCKHOLDERS’ EQUITY (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Stockholders' Equity Note [Abstract] | ||
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] | The Company valued warrants using the Black-Scholes valuation model utilizing the following variables: May 31, May 31, 2020 2019 Volatility - % 79.02 to 400.3 % Dividends $ - $ 0 Risk-free interest rates - % 2.68% to 2.77 % Term (years) - 3 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] | The following table summarizes the significant terms of warrants outstanding at November 30, 2020. This table does not include the unit warrants. See Unit Warrants section below. Range of exercise prices Number of warrants outstanding Weighted average remaining contractual life (years) Weighted average exercise price of outstanding warrants Number of warrants exercisable Weighted average exercise price of exercisable warrants $ 0.49 33,465,110 1.00 $ 0.49 33,465,110 $ 0.49 0.50 2,736,500 1.23 0.50 2,736,500 0.50 0.60 17,500,000 1.00 0.60 17,500,000 0.60 0.75 837,500 0.22 0.75 837,500 0.75 1.10 296,035 1.06 1.10 296,035 1.10 54,835,145 1.00 $ 0.53 54,835,145 $ 0.53 | The following table summarizes the significant terms of warrants outstanding at May 31, 2020. This table does not include the unit warrants. See Unit Warrants section below. Range of exercise Prices Number of warrants Outstanding Weighted average remaining contractual life (years) Weighted average exercise price of outstanding Warrants Number of warrants Exercisable Weighted average exercise price of exercisable Warrants $ 0.49 33,465,110 1.50 $ 0.49 33,465,110 $ 0.49 0.50 2,736,500 1.73 0.50 2,736,500 0.50 0.60 17,500,000 1.50 0.60 17,500,000 0.60 0.75 837,500 0.72 0.75 837,500 0.75 1.10 296,035 1.56 1.10 296,035 1.10 54,835,145 1.50 $ 0.53 54,835,145 $ 0.53 |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | Transactions involving warrants are summarized below. This table does not include the unit warrants. Number of Shares Weighted Average Exercise Price Warrants outstanding at May 31, 2019 54,818,985 $ 0.53 Granted 16,160 $ 1.10 Exercised - Cancelled / Expired - $ - Warrants outstanding at May 31, 2020 54,838,145 $ 0.53 Granted - $ - Exercised - $ - Cancelled / Expired - $ - Warrants outstanding at November 30, 2020 54,835,145 $ 0.53 | Transactions involving warrants are summarized as follows. This table does not include the special warrants or unit warrants. See Special Warrants and Unit Warrants sections below. Number of Shares Weighted Average Exercise Price Warrants outstanding at May 31, 2018 4,495,750 $ 0.61 Granted 50,738,235 $ 0.653 Exercised (415,000 ) $ 0.75 Cancelled / Expired - $ - Warrants outstanding at May 31, 2019 54,818,985 $ 0.53 Granted 16,160 $ 1.10 Exercised - $ - Cancelled / Expired - $ - Warrants outstanding at May 31, 2020 54,835,145 $ 0.53 |
FAIR VALUE OF FINANCIAL INSTR_2
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Fair Value Disclosures [Abstract] | ||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | The following summarizes the Company’s financial liabilities that are recorded at fair value on a recurring basis at November 30, 2020 and May 31, 2020: November 30, 2020 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ - $ - May 31, 2020 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ - $ - | The following summarizes the Company’s financial liabilities that are recorded at fair value on a recurring basis at May 31, 2020 and 2019: May 31, 2020 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ - $ - May 31, 2019 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ - $ - |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
May 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | The tax effects of the temporary differences that give rise to the Company’s estimated deferred tax assets and liabilities are as follows: May 31, May 31, 2020 2019 Federal and state statutory rate 21 % 21 % Net operating loss carry forwards 2,538,429 3,001,749 Valuation allowance for deferred tax assets (2,538,429 ) (3,001,749 ) Net deferred tax assets - - |
Nature of Business and Signif_2
Nature of Business and Significant Accounting Policies (Tables) | 6 Months Ended | 12 Months Ended |
Nov. 30, 2020 | May 31, 2020 | |
Nature of Business and Significant Accounting Policies (Tables) [Line Items] | ||
Property, Plant and Equipment [Table Text Block] | Property, plant and equipment consisted of the following at November 30, 2020 and May 31, 2020. November 30, 2020 May 31, 2020 Office equipment $ 116,090 $ 94,887 Furniture and fixtures 145,103 144,025 Machinery & Equipment 1,776,316 1,741,830 Leasehold improvements 2,769,219 2,662,967 Less: accumulated depreciation (1,151,948 ) (868,200 ) Property, plant, and equipment, net $ 3,654,780 $ 3,775,509 | Property, plant and equipment consisted of the following at May 31, 2020 and 2019: May 31, May 31, 2020 2019 Office equipment $ 94,887 $ 53,152 Furniture & fixtures 144,025 140,701 Machinery & equipment 1,741,830 969,196 Leasehold improvements 2,662,967 1,293,660 Less: accumulated depreciation (868,200 ) (546,408 ) Property and equipment, net $ 3,775,509 $ 1,910,301 |
Disaggregation of Revenue [Table Text Block] | The following table represents a disaggregation of revenue for the three and six months ended November 30, 2020 and 2019: For the Six For the Six For the Three For the Three Months Ended Months Ended Months Ended Months Ended November 30, 2020 November 30, 2019 November 30, 2020 November 30, 2019 Cannabis Dispensary 6,818,499 4,398,262 3,732,974 2,312,362 Cannabis Production 1,870,259 1,517,184 1,174,915 744,069 8,688,758 5,915,446 4,907,889 3,056,431 | The following table represents a disaggregation of revenue for the years ended May 31, 2020 and 2019: 2020 2019 Cannabis Dispensary $ 9,365,105 $ 5,492,312 Cannabis Production 2,552,524 2,966,736 $ 11,917,629 $ 8,459,048 |
Estimated Useful LIfe [Member] | ||
Nature of Business and Significant Accounting Policies (Tables) [Line Items] | ||
Property, Plant and Equipment [Table Text Block] | Property and equipment is recorded at the lower of cost or estimated net recoverable amount, and is depreciated using the straight-line method over its estimated useful life. Property acquired in a business combination is recorded at estimated initial fair value. Property, plant, and equipment are depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based upon the following life expectancy: Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease | Property and equipment is recorded at the lower of cost or estimated net recoverable amount, and is depreciated using the straight-line method over its estimated useful life. Property acquired in a business combination is recorded at estimated initial fair value. Property, plant, and equipment are depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based upon the following life expectancy: Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease |
BUSINESS ORGANIZATION AND NAT_2
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) | Feb. 26, 2020 | Dec. 23, 2019USD ($) | Jun. 24, 2019USD ($) | Feb. 04, 2019USD ($) | Jan. 29, 2019USD ($) | Oct. 31, 2018USD ($) | Jun. 27, 2018USD ($)shares | Feb. 28, 2018USD ($)shares | Dec. 04, 2017USD ($) | Apr. 29, 2015shares | Dec. 10, 2014shares | Nov. 12, 2014shares | Nov. 30, 2020USD ($) | Nov. 30, 2020USD ($) | Nov. 30, 2019USD ($) | May 31, 2020USD ($) | May 31, 2019USD ($) | Mar. 11, 2019 | May 31, 2018USD ($) |
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 0.625 | ||||||||||||||||||
Payments to Acquire Businesses, Gross | $ 2,050,000 | ||||||||||||||||||
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions | 10.00% | ||||||||||||||||||
Debt Instrument, Face Amount | $ 4,000,000 | ||||||||||||||||||
Business Combination, Consideration Transferred, Liabilities Incurred | 3,810,820 | ||||||||||||||||||
Payments to Acquire Notes Receivable | $ 175,000 | 175,000 | $ 5,150,000 | ||||||||||||||||
Proceeds from Collection of Notes Receivable | $ 1,385,951 | 1,682,278 | 0 | ||||||||||||||||
Oasis LLCs [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares) | shares | 22,058,823 | ||||||||||||||||||
Principal [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Proceeds from Collection of Notes Receivable | 1,357,278 | ||||||||||||||||||
Accrued Interest [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Proceeds from Collection of Notes Receivable | 67,722 | ||||||||||||||||||
Reverse Merger with CLS Labs [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | shares | 15,000,000 | ||||||||||||||||||
Oasis Acquisition [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Payments to Acquire Businesses, Gross | 2,050,000 | $ 6,200,000 | |||||||||||||||||
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions | 10.00% | ||||||||||||||||||
Liabilities Assumed | 204,457 | $ 204,457 | |||||||||||||||||
Business Combination, Consideration Transferred | 27,975,650 | ||||||||||||||||||
Business Combination, Consideration Transferred, Liabilities Incurred | 3,810,820 | ||||||||||||||||||
Business Combination, Contingent Consideration, Liability | $ 1,000,000 | $ 678,111 | |||||||||||||||||
Oasis Acquisition [Member] | Oasis LLCs [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Payments to Acquire Businesses, Gross | $ 5,995,543 | ||||||||||||||||||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 90.00% | ||||||||||||||||||
Debt Instrument, Face Amount | $ 4,000,000 | 4,000,000 | |||||||||||||||||
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares) | shares | 22,058,823 | ||||||||||||||||||
Oasis Acquisition [Member] | Deposit [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Payments to Acquire Businesses, Gross | $ 250,000 | ||||||||||||||||||
Oasis Acquisition [Member] | Additional Payments [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Payments to Acquire Businesses, Gross | $ 1,800,000 | $ 1,800,000 | |||||||||||||||||
In Good Health [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Payments to Acquire Businesses, Gross | $ 35,000,000 | ||||||||||||||||||
Business Combination, Consideration Transferred | 47,500,000 | ||||||||||||||||||
Business Combination, Consideration Transferred, Liabilities Incurred | 7,500,000 | ||||||||||||||||||
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | 5,000,000 | ||||||||||||||||||
Business Combination, Contingent Consideration, Liability | $ 2,500,000 | ||||||||||||||||||
Interest Rate, Default | 15.00% | ||||||||||||||||||
Proceeds from Collection of Notes Receivable | $ 750,000 | 1,500,000 | 1,425,000 | ||||||||||||||||
Financing Receivable, after Allowance for Credit Loss | 2,656,224 | 2,656,224 | 4,042,175 | ||||||||||||||||
CannAssist LLC [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Equity Method Investment, Ownership Percentage | 80.00% | ||||||||||||||||||
Debt Instrument, Face Amount | $ 500,000 | ||||||||||||||||||
Interest Rate, Default | 15.00% | ||||||||||||||||||
Line of Credit Facility, Description | Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company | ||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||||||||||||||||
Payments to Acquire Notes Receivable | $ 175,000 | $ 150,000 | |||||||||||||||||
Proceeds from Collection of Notes Receivable | $ 342,567 | ||||||||||||||||||
Financing Receivable, after Allowance for Credit Loss | $ 0 | $ 0 | $ 0 | ||||||||||||||||
CannAssist LLC [Member] | Principal [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Proceeds from Collection of Notes Receivable | 325,000 | ||||||||||||||||||
CannAssist LLC [Member] | Accrued Interest [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Proceeds from Collection of Notes Receivable | $ 17,567 | ||||||||||||||||||
CLS Labs, Inc. [Member] | Shares of CLS Holdings USA, Inc. [Member] | |||||||||||||||||||
BUSINESS ORGANIZATION AND NATURE OF OPERATIONS (Details) [Line Items] | |||||||||||||||||||
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions (in Shares) | shares | 6,250,000 | 10,000,000 | |||||||||||||||||
Equity Method Investment, Ownership Percentage | 55.60% |
GOING CONCERN (Details)
GOING CONCERN (Details) - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Retained Earnings (Accumulated Deficit) | $ (78,840,536) | $ (76,846,124) | $ (46,188,151) |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) | Jun. 01, 2018USD ($)$ / shares | Nov. 30, 2020USD ($) | Nov. 30, 2019USD ($) | Nov. 30, 2020USD ($)shares | Nov. 30, 2019USD ($)shares | May 31, 2020USD ($)$ / sharesshares | May 31, 2019USD ($)$ / sharesshares | Nov. 30, 2020USD ($) | Jun. 01, 2019USD ($) | Sep. 11, 2018$ / shares | Jul. 24, 2018$ / shares | May 31, 2018USD ($) |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Cash and Cash Equivalents, at Carrying Value | $ 2,805,516 | $ 4,937,013 | $ 2,805,516 | $ 4,937,013 | $ 2,925,568 | $ 10,525,791 | $ 2,805,516 | $ 52,964 | ||||
Accounts Receivable, Credit Loss Expense (Reversal) | 0 | 0 | 5,992 | 0 | 108,392 | 0 | ||||||
Goodwill, Impairment Loss | 0 | 0 | 0 | 0 | 25,185,003 | 0 | ||||||
Advertising Expense | 311,707 | 218,041 | $ 443,739 | 424,019 | $ 836,000 | 1,655,374 | ||||||
Research and Development Expense | 5,385 | $ 0 | $ 0 | $ 0 | 12,392 | |||||||
Share Price | $ / shares | $ 0.06 | $ 0.81 | $ 0.70 | |||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 88,474,321 | 86,932,861 | 88,130,526 | 86,439,117 | ||||||||
Operating Lease, Right-of-Use Asset | 1,227,702 | $ 1,227,702 | $ 1,403,429 | $ 0 | 1,227,702 | $ 2,703,821 | ||||||
Operating Lease, Liability | $ 1,265,642 | $ 1,265,642 | 1,473,051 | 2,675,310 | $ 1,265,642 | $ 2,675,310 | ||||||
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | $ 1,265,751 | $ 0 | $ 1,265,751 | |||||||||
Embedded Derivative Financial Instruments [Member] | ||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Share Price | $ / shares | $ 0.6865 | $ 0.2999 | ||||||||||
Debt Instrument, Convertible, Terms of Conversion Feature | That the conversion price of the YAN II PN Convertible Notes would be equal to $0.40 with a full reset feature, and upon default, 75% of the lowest Volume Weighted Average Price (the “VWAP”) in the 15 consecutive trading days ending on the trading day that is immediately prior to the applicable conversion date; - That the new convertible notes issued during this period with full resets would be initially issued with conversion prices of $0.40, which were not reset as a result of subsequent transactions | |||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 0.40 | |||||||||||
Note Redemption, Projection | That the Company would redeem the convertible notes, projected initially at 0% of the time and increasing monthly by 1.00% to a maximum of 10.0% | |||||||||||
Event of Default, Decription | That unless an Event of Default occurred, the holder would sell, per trading day, an amount of Common Stock up to the greater of (i) $5,000 or (ii) 25% multiplied by the “Aggregate Amount,” as defined in the YAN II PN Convertible Notes. | |||||||||||
Measurement Input, Default Rate [Member] | Maximum [Member] | Embedded Derivative Financial Instruments [Member] | ||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Embedded Derivative Asset (Liability) Net, Measurement Input | 0.24 | |||||||||||
Measurement Input, Default Rate [Member] | Minimum [Member] | Embedded Derivative Financial Instruments [Member] | ||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Embedded Derivative Asset (Liability) Net, Measurement Input | 0.15 | |||||||||||
Measurement Input, Price Volatility [Member] | Maximum [Member] | Embedded Derivative Financial Instruments [Member] | ||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Embedded Derivative Asset (Liability) Net, Measurement Input | 2.428 | |||||||||||
Measurement Input, Price Volatility [Member] | Minimum [Member] | Embedded Derivative Financial Instruments [Member] | ||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Embedded Derivative Asset (Liability) Net, Measurement Input | 0.974 | |||||||||||
Warrant [Member] | ||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 54,835,145 | 54,835,145 | 54,835,145 | 54,818,985 | ||||||||
Equity Unit Purchase Agreements [Member] | ||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 7,676,974 | 7,676,974 | 7,676,974 | 7,676,974 | ||||||||
Convertible Debt Securities [Member] | ||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 25,454,696 | 24,184,074 | 25,131,739 | 23,261,393 | ||||||||
Stock Payable [Member] | ||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items] | ||||||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 507,506 | 236,668 | 486,668 | 681,764 |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Property, Plant and Equipment | 12 Months Ended | |
May 31, 2020 | May 31, 2019 | |
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | Term of lease | |
Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 3 years | |
Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 7 years | |
Office Equipment [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 3 years | 3 years |
Office Equipment [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 5 years | 5 years |
Furniture and Fixtures [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 3 years | |
Furniture and Fixtures [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 7 years | |
Machinery and Equipment [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 3 years | 3 years |
Machinery and Equipment [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 10 years | 10 years |
SUMMARY OF SIGNIFICANT ACCOUN_5
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Disaggregation of Revenue - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | |
Disaggregation of Revenue [Line Items] | ||||||
Revenue | $ 4,907,889 | $ 3,056,431 | $ 8,688,758 | $ 5,915,446 | $ 11,917,629 | $ 8,459,048 |
Cannabis Dispensary [Member] | ||||||
Disaggregation of Revenue [Line Items] | ||||||
Revenue | 3,732,974 | 2,312,362 | 6,818,499 | 4,398,262 | 9,365,105 | 5,492,312 |
Cannabis Production [Member] | ||||||
Disaggregation of Revenue [Line Items] | ||||||
Revenue | $ 1,174,915 | $ 744,069 | $ 1,870,259 | $ 1,517,184 | $ 2,552,524 | $ 2,966,736 |
ACQUISITION OF ALTERNATIVE SO_3
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) | May 27, 2020USD ($) | Aug. 14, 2019USD ($) | Jun. 27, 2018USD ($)shares | Feb. 28, 2018USD ($)shares | Dec. 04, 2017USD ($) | Nov. 30, 2020USD ($) | Nov. 30, 2019USD ($) | Nov. 30, 2020USD ($) | Nov. 30, 2019USD ($) | May 31, 2020USD ($)$ / shares | May 31, 2019USD ($) | Sep. 11, 2018$ / shares | Jul. 24, 2018$ / shares | May 31, 2018USD ($) |
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) [Line Items] | ||||||||||||||
Payments to Acquire Businesses, Gross | $ 2,050,000 | |||||||||||||
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions | 10.00% | |||||||||||||
Debt Instrument, Face Amount | $ 4,000,000 | |||||||||||||
Repayments of Notes Payable | $ 2,638,784 | 3,999,168 | $ 1,060,000 | |||||||||||
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $ 0 | $ 0 | $ 0 | 0 | 0 | 321,889 | ||||||||
Payment for Contingent Consideration Liability, Operating Activities | 850,000 | 850,000 | ||||||||||||
Goodwill, Impairment Loss | 0 | 0 | 0 | 0 | 25,185,003 | 0 | ||||||||
Goodwill | 25,742,899 | 557,896 | 557,896 | $ 557,896 | 25,742,899 | |||||||||
Share Price (in Dollars per share) | $ / shares | $ 0.06 | $ 0.81 | $ 0.70 | |||||||||||
Revenues | $ 4,907,889 | $ 3,056,431 | $ 8,688,758 | $ 5,915,446 | $ 11,917,629 | 8,459,048 | ||||||||
Oasis LLCs [Member] | ||||||||||||||
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) [Line Items] | ||||||||||||||
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares) | shares | 22,058,823 | |||||||||||||
Oasis Acquisition [Member] | ||||||||||||||
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) [Line Items] | ||||||||||||||
Number of Subsidiaries | 3 | |||||||||||||
Payments to Acquire Businesses, Gross | 2,050,000 | $ 6,200,000 | ||||||||||||
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions | 10.00% | |||||||||||||
Liabilities Assumed | $ 204,457 | $ 204,457 | ||||||||||||
Repayments of Notes Payable | $ 2,500,000 | |||||||||||||
Debt Instrument, Increase (Decrease), Other, Net | $ (138,784) | |||||||||||||
Business Acquisition, Equity Interest Issued or Issuable, Description | The number of Purchase Price Shares was equal to 80% of the offering price of the Company’s common stock in its last equity offering, which price was $0.34 per share. | |||||||||||||
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High | $ 1,000,000 | |||||||||||||
Average Revenue, Maintained | 20,000 | |||||||||||||
Business Combination, Contingent Consideration, Liability | 1,000,000 | $ 678,111 | ||||||||||||
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | 321,889 | |||||||||||||
Payment for Contingent Consideration Liability, Operating Activities | $ 850,000 | |||||||||||||
Escrow Deposit | $ 150,000 | |||||||||||||
Business Combination, Consideration Transferred | 27,975,650 | |||||||||||||
Goodwill, Impairment Loss | 25,185,003 | |||||||||||||
Goodwill | 25,742,899 | $ 557,896 | 25,742,899 | |||||||||||
Share Price (in Dollars per share) | $ / shares | $ 0.06 | |||||||||||||
Revenues | $ 11,917,629 | $ 8,459,048 | ||||||||||||
Oasis Acquisition [Member] | Oasis LLCs [Member] | ||||||||||||||
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) [Line Items] | ||||||||||||||
Payments to Acquire Businesses, Gross | $ 5,995,543 | |||||||||||||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 90.00% | |||||||||||||
Debt Instrument, Face Amount | $ 4,000,000 | 4,000,000 | ||||||||||||
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares) | shares | 22,058,823 | |||||||||||||
Oasis Acquisition [Member] | Deposit [Member] | ||||||||||||||
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) [Line Items] | ||||||||||||||
Payments to Acquire Businesses, Gross | $ 250,000 | |||||||||||||
Oasis Acquisition [Member] | Additional Payments [Member] | ||||||||||||||
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) [Line Items] | ||||||||||||||
Payments to Acquire Businesses, Gross | $ 1,800,000 | $ 1,800,000 | ||||||||||||
Original Contemplated Transaction Payment [Member] | Oasis Acquisition [Member] | Oasis LLCs [Member] | ||||||||||||||
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) [Line Items] | ||||||||||||||
Payments to Acquire Businesses, Gross | $ 6,200,000 |
ACQUISITION OF ALTERNATIVE SO_4
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) - Schedule of Business Acquisitions, by Acquisition - Oasis Acquisition [Member] - USD ($) | Jun. 27, 2018 | Feb. 28, 2018 | May 31, 2020 | May 31, 2019 |
Business Acquisition [Line Items] | ||||
Initial purchase price | $ 2,050,000 | $ 6,200,000 | ||
Cash paid in connection with transaction | 5,995,543 | |||
Note payable | 3,810,820 | |||
Contingent consideration | 678,111 | |||
Common stock | 15,441,176 | |||
Total purchase price | 27,975,650 | |||
Net tangible assets | 595,151 | |||
Goodwill | 25,742,899 | $ 557,896 | $ 25,742,899 | |
Total purchase price | 27,975,650 | |||
Intellectual Property [Member] | ||||
Business Acquisition [Line Items] | ||||
Intangible assets | 319,600 | |||
Licensing Agreements [Member] | ||||
Business Acquisition [Line Items] | ||||
Intangible assets | 990,000 | |||
Trade Names [Member] | ||||
Business Acquisition [Line Items] | ||||
Intangible assets | 301,000 | |||
Noncompete Agreements [Member] | ||||
Business Acquisition [Line Items] | ||||
Intangible assets | $ 27,000 |
ACQUISITION OF ALTERNATIVE SO_5
ACQUISITION OF ALTERNATIVE SOLUTIONS (Details) - Business Acquisition, Pro Forma Information | 12 Months Ended |
May 31, 2020USD ($)$ / sharesshares | |
Business Acquisition, Pro Forma Information [Abstract] | |
Revenues | $ | $ 9,759,956 |
Net loss | $ | $ (26,671,841) |
Basic net income per share | $ / shares | $ (0.26) |
Diluted net income per share | $ / shares | $ (0.26) |
Weighted average shares - basic | shares | 102,869,612 |
Weighted average shares - diluted | shares | 102,869,612 |
JOINT VENTURE AND OPTIONS TRA_2
JOINT VENTURE AND OPTIONS TRANSACTION (Details) - USD ($) | Mar. 01, 2020 | Dec. 23, 2019 | Jun. 24, 2019 | Feb. 04, 2019 | Jan. 29, 2019 | Oct. 31, 2018 | Jun. 27, 2018 | Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 |
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items] | |||||||||||||
Payments to Acquire Businesses, Gross | $ 2,050,000 | ||||||||||||
Business Combination, Consideration Transferred, Liabilities Incurred | $ 3,810,820 | ||||||||||||
Financing Receivable, after Allowance for Credit Loss, Current | $ 5,000,000 | ||||||||||||
Note Receivable, Interest Rate, Stated Percentage | 6.00% | ||||||||||||
Interest Costs Capitalized | $ 212,601 | $ 753,977 | $ 1,553,082 | $ 491,230 | |||||||||
Proceeds from Collection of Notes Receivable | 1,385,951 | 1,682,278 | 0 | ||||||||||
Debt Instrument, Face Amount | 4,000,000 | ||||||||||||
Payments to Acquire Notes Receivable | 175,000 | 175,000 | 5,150,000 | ||||||||||
Interest Receivable, Current | $ 0 | 0 | 3,322 | 0 | |||||||||
Joint Venture with CannAssist [Member] | |||||||||||||
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items] | |||||||||||||
Interest Income, Related Party | 0 | $ 6,482 | 0 | 13,035 | 14,673 | 4,011 | |||||||
Proceeds from Collection of Notes Receivable | $ 342,567 | ||||||||||||
Financing Receivable, after Allowance for Credit Loss | $ 325,000 | ||||||||||||
Debt Instrument, Face Amount | $ 500,000 | ||||||||||||
Line of Credit Facility, Description | Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company | ||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||||||||||
Payments to Acquire Notes Receivable | $ 175,000 | $ 150,000 | |||||||||||
Principal [Member] | Joint Venture with CannAssist [Member] | |||||||||||||
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items] | |||||||||||||
Proceeds from Collection of Notes Receivable | 325,000 | ||||||||||||
Accrued Interest [Member] | Joint Venture with CannAssist [Member] | |||||||||||||
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items] | |||||||||||||
Proceeds from Collection of Notes Receivable | $ 17,567 | ||||||||||||
In Good Health [Member] | |||||||||||||
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items] | |||||||||||||
Business Combination, Consideration Transferred | $ 47,500,000 | ||||||||||||
Payments to Acquire Businesses, Gross | 35,000,000 | ||||||||||||
Business Combination, Consideration Transferred, Liabilities Incurred | 7,500,000 | ||||||||||||
Interest Income, Related Party | 50,162 | $ 75,616 | 110,727 | $ 150,411 | 296,250 | $ 174,247 | |||||||
Interest Costs Capitalized | $ 399,453 | ||||||||||||
Proceeds from Collection of Notes Receivable | 750,000 | 1,500,000 | 1,425,000 | ||||||||||
Financing Receivable, after Allowance for Credit Loss | 2,656,224 | 2,656,224 | 4,042,175 | ||||||||||
Interest Receivable | 3,322 | ||||||||||||
Option Agreement, Brake-Up Fee | $ 2,500,000 | ||||||||||||
Interest Rate, Default | 15.00% | ||||||||||||
Interest Receivable, Current | 0 | 0 | |||||||||||
In Good Health [Member] | Principal [Member] | |||||||||||||
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items] | |||||||||||||
Proceeds from Collection of Notes Receivable | 688,869 | 697,082 | 1,357,278 | ||||||||||
In Good Health [Member] | Accrued Interest [Member] | |||||||||||||
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items] | |||||||||||||
Proceeds from Collection of Notes Receivable | $ 61,131 | $ 52,918 | $ 67,722 | ||||||||||
Option Agreement [Member] | In Good Health [Member] | |||||||||||||
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items] | |||||||||||||
Business Combination, Consideration Transferred | $ 47,500,000 | ||||||||||||
Payments to Acquire Businesses, Gross | 35,000,000 | ||||||||||||
Business Combination, Consideration Transferred, Liabilities Incurred | 7,500,000 | ||||||||||||
Business Combination, Consideration Transferred, Other | $ 2,500,000 | ||||||||||||
Debt Instrument, Term | 5 years | ||||||||||||
Option Agreement [Member] | Restricted Stock [Member] | In Good Health [Member] | |||||||||||||
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items] | |||||||||||||
Equity Issued in Business Combination, Fair Value Disclosure | $ 5,000,000 |
ACCOUNTS RECEIVABLE (Details)
ACCOUNTS RECEIVABLE (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | |
Receivables [Abstract] | ||||||
Accounts Receivable, after Allowance for Credit Loss, Current | $ 281,827 | $ 281,827 | $ 161,409 | $ 163,571 | ||
Accounts Receivable, Credit Loss Expense (Reversal) | $ 0 | $ 0 | 5,992 | $ 0 | 108,392 | $ 0 |
Accounts Receivable, Allowance for Credit Loss, Writeoff | 7,668 | $ 101,512 | ||||
Proceeds, Accounts Receivable, Previously Written Off, Recovery | $ 1,746 |
PREPAID EXPENSES AND OTHER CU_3
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($) | 6 Months Ended | 12 Months Ended | ||
Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | |
Disclosure Text Block Supplement [Abstract] | ||||
Escrow Deposit Disbursements Related to Property Acquisition | $ 0 | $ 136,190 | $ 281,966 | $ 0 |
PREPAID EXPENSES AND OTHER CU_4
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - Deferred Costs, Capitalized, Prepaid, and Other Assets - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Deferred Costs, Capitalized, Prepaid, and Other Assets [Abstract] | |||
Deposits | $ 2,262 | $ 2,315 | $ 211,493 |
Prepaid expenses | 231,777 | 178,920 | |
Total | $ 297,320 | $ 234,092 | $ 390,413 |
INVENTORY (Details) - Schedule
INVENTORY (Details) - Schedule of Inventory, Current - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Schedule of Inventory, Current [Abstract] | |||
Raw materials | $ 527,984 | $ 134,697 | $ 323,635 |
Finished goods | 860,416 | 440,545 | 423,198 |
Total | $ 1,388,400 | $ 575,242 | $ 746,833 |
NOTES RECEIVABLE (Details)
NOTES RECEIVABLE (Details) - USD ($) | Feb. 26, 2020 | Dec. 23, 2019 | Oct. 31, 2018 | Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | May 31, 2018 | May 31, 2015 | Jan. 29, 2019 |
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Note Receivable, Interest Rate, Stated Percentage | 6.00% | |||||||||||
Proceeds from Collection of Notes Receivable | $ 1,385,951 | $ 1,682,278 | $ 0 | |||||||||
Financing Receivable, after Allowance for Credit Loss, Current | $ 5,000,000 | |||||||||||
Interest Costs Capitalized | 212,601 | $ 753,977 | 1,553,082 | 491,230 | ||||||||
Interest Receivable, Current | $ 0 | 0 | 3,322 | 0 | ||||||||
CannAssist LLC [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | $ 342,567 | |||||||||||
Interest Income, Other | 0 | $ 6,553 | 0 | $ 13,035 | ||||||||
Notes Receivable [Member] | Principal [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | 2,743,229 | |||||||||||
Notes Receivable [Member] | Accrued Interest [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | 181,771 | |||||||||||
Notes Receivable [Member] | Affiliated Entity [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Financing Receivable, before Allowance for Credit Loss | $ 500,000 | |||||||||||
Note Receivable, Interest Rate, Stated Percentage | 12.00% | |||||||||||
Asset Impairment Charges | $ 500,000 | |||||||||||
Proceeds from Collection of Notes Receivable | $ 50,000 | |||||||||||
Financing Receivable, after Allowance for Credit Loss | 0 | 0 | 0 | |||||||||
Allowance for Doubtful Other Receivables, Current | 450,000 | 450,000 | 450,000 | |||||||||
Notes Receivable [Member] | CannAssist LLC [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Interest Income, Other | 14,673 | 4,011 | ||||||||||
Notes Receivable [Member] | CannAssist LLC [Member] | Line of Credit [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Financing Receivable, before Allowance for Credit Loss | $ 500,000 | |||||||||||
Note Receivable, Interest Rate, Stated Percentage | 8.00% | |||||||||||
Financing Receivable, after Allowance for Credit Loss, Current | 0 | |||||||||||
Interest Receivable, Current | 0 | |||||||||||
IGH Note [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | 750,000 | 1,500,000 | 1,425,000 | |||||||||
Financing Receivable, after Allowance for Credit Loss, Current | $ 5,000,000 | 2,656,224 | 2,656,224 | 4,042,175 | ||||||||
Note Receviable, Interest Rate | 6.00% | |||||||||||
Note Receivbale, Number of Installments | 8 | |||||||||||
Interest Income, Other | 50,162 | 110,727 | 296,250 | 174,247 | ||||||||
Interest Costs Capitalized | 399,453 | $ 0 | ||||||||||
Interest Rate, Default | 15.00% | |||||||||||
Interest Receivable, Current | $ 0 | 0 | 3,322 | |||||||||
IGH Note [Member] | Principal [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | 1,385,951 | |||||||||||
IGH Note [Member] | Accrued Interest [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | $ 114,049 | |||||||||||
Principal [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | 1,357,278 | |||||||||||
Principal [Member] | CannAssist LLC [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | 325,000 | |||||||||||
Accrued Interest [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | $ 67,722 | |||||||||||
Accrued Interest [Member] | CannAssist LLC [Member] | ||||||||||||
NOTES RECEIVABLE (Details) [Line Items] | ||||||||||||
Proceeds from Collection of Notes Receivable | $ 17,567 |
PROPERTY, PLANT AND EQUIPMENT_2
PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | |
PROPERTY, PLANT AND EQUIPMENT (Details) [Line Items] | ||||||
Payments to Acquire Property, Plant, and Equipment | $ 163,019 | $ 1,566,882 | $ 1,923,338 | $ 1,037,262 | ||
Escrow Deposit Disbursements Related to Property Acquisition | 0 | 136,190 | 281,966 | 0 | ||
Property, Plant and Equipment, Disposals | 16,817 | |||||
Gain (Loss) on Disposition of Property Plant Equipment | $ 0 | $ 0 | 0 | 0 | (16,817) | 0 |
Depreciation | $ 142,856 | $ 57,644 | $ 283,748 | $ 113,180 | 323,279 | $ 173,277 |
Alternative Solutions, LLC [Member] | ||||||
PROPERTY, PLANT AND EQUIPMENT (Details) [Line Items] | ||||||
Gain (Loss) on Disposition of Property Plant Equipment | $ 933,142 |
PROPERTY, PLANT AND EQUIPMENT_3
PROPERTY, PLANT AND EQUIPMENT (Details) - Property, Plant and Equipment - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, gross | $ 1,741,830 | $ 969,196 | |
Less: accumulated depreciation | $ (1,151,948) | (868,200) | (546,408) |
Property, plant, and equipment, net | 3,654,780 | 3,775,509 | 1,910,301 |
Computer Equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, gross | 116,090 | 94,887 | 53,152 |
Furniture and Fixtures [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, gross | 145,103 | 144,025 | 140,701 |
Leasehold Improvements [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, gross | $ 2,769,219 | $ 2,662,967 | $ 1,293,660 |
RIGHT TO USE ASSETS AND LIABI_3
RIGHT TO USE ASSETS AND LIABILITIES - OPERATING LEASES (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||
Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | Jun. 01, 2019 | |
RIGHT TO USE ASSETS AND LIABILITIES - OPERATING LEASES (Details) [Line Items] | |||||||
Operating Lease, Expense | $ 104,793 | $ 270,410 | $ 420,953 | $ 361,404 | |||
Operating Lease, Right-of-Use Asset | 1,227,702 | 1,227,702 | 1,403,429 | 0 | $ 2,703,821 | ||
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | $ 1,781,446 | 2,675,310 | 0 | ||||
Gain (Loss) on Disposition of Other Assets | 0 | $ 0 | 0 | 0 | 28,511 | 0 | |
Amortization of Leased Asset | $ 88,897 | $ 175,727 | $ 1,124,112 | $ 1,300,392 | $ 0 | ||
Minimum [Member] | |||||||
RIGHT TO USE ASSETS AND LIABILITIES - OPERATING LEASES (Details) [Line Items] | |||||||
Lessee, Operating Lease, Term of Contract | 1 year | 1 year | 1 year | ||||
Maximum [Member] | |||||||
RIGHT TO USE ASSETS AND LIABILITIES - OPERATING LEASES (Details) [Line Items] | |||||||
Lessee, Operating Lease, Term of Contract | 4 years | 4 years | 4 years |
RIGHT TO USE ASSETS AND LIABI_4
RIGHT TO USE ASSETS AND LIABILITIES - OPERATING LEASES (Details) - Lessee, Operating Lease, Disclosure - USD ($) | Nov. 30, 2020 | May 31, 2020 | Jun. 01, 2019 | May 31, 2019 |
Lessee, Operating Lease, Disclosure [Abstract] | ||||
Right to use assets | $ 1,227,702 | $ 1,403,429 | $ 2,703,821 | $ 0 |
Amount amortized | $ (1,476,119) | $ (1,300,392) |
RIGHT TO USE ASSETS AND LIABI_5
RIGHT TO USE ASSETS AND LIABILITIES - OPERATING LEASES (Details) - Lease, Cost - USD ($) | 6 Months Ended | 12 Months Ended | 18 Months Ended | ||
Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | Nov. 30, 2020 | |
Lease, Cost [Abstract] | |||||
Lease liability | $ 1,473,051 | $ 2,675,310 | $ 2,675,310 | $ 2,675,310 | |
Amount amortized | (207,409) | $ (992,296) | (1,202,259) | $ 0 | (1,409,668) |
Lease liability | 1,265,642 | 1,473,051 | 2,675,310 | 1,265,642 | |
Less: current portion | (176,275) | (336,900) | 0 | (176,275) | |
Lease liability, non-current | $ 1,089,367 | $ 1,136,151 | $ 0 | $ 1,089,367 |
RIGHT TO USE ASSETS AND LIABI_6
RIGHT TO USE ASSETS AND LIABILITIES - OPERATING LEASES (Details) - Lessee, Operating Lease, Liability, Maturity - USD ($) | Nov. 30, 2020 | May 31, 2020 | Jun. 01, 2019 | May 31, 2019 |
Lessee, Operating Lease, Liability, Maturity [Abstract] | ||||
Twelve months ended May 31, 2021 | $ 268,577 | $ 440,022 | ||
Twelve months ended May 31, 2022 | 178,570 | 184,172 | ||
Twelve months ended May 31, 2023 | 167,234 | 168,886 | ||
Twelve months ended May 31, 2024 | 172,035 | 169,617 | ||
Twelve months ended May 31, 2025 | 176,980 | 174,489 | ||
Thereafter | 810,327 | 899,441 | ||
Total | 1,773,723 | 2,036,627 | ||
Less: Present value discount | (508,081) | (563,576) | ||
Lease liability | $ 1,265,642 | $ 1,473,051 | $ 2,675,310 | $ 2,675,310 |
INTANGIBLE ASSETS (Details)
INTANGIBLE ASSETS (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||
Amortization of Intangible Assets | $ 28,715 | $ 28,030 | $ 58,583 | $ 58,304 | $ 125,913 | $ 115,074 |
INTANGIBLE ASSETS (Details) - S
INTANGIBLE ASSETS (Details) - Schedule of Finite-Lived Intangible Assets - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Finite-Lived Intangible Assets [Line Items] | |||
Intangible Assets, Gross | $ 1,664,112 | $ 1,663,593 | $ 1,641,563 |
Intangible Assets, Accumulated Amortization | (301,491) | (242,389) | (116,476) |
Intangible Assets, Net | 1,362,621 | 1,421,204 | 1,525,087 |
Goodwill [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible Assets, Gross | 301,000 | ||
Intangible Assets, Accumulated Amortization | (57,692) | ||
Intangible Assets, Net | 243,308 | ||
Intellectual Property [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible Assets, Gross | 319,600 | 319,600 | 319,600 |
Intangible Assets, Accumulated Amortization | (77,237) | (61,257) | (29,297) |
Intangible Assets, Net | 242.363 | 258,343 | 290,303 |
Customer Relationships [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible Assets, Gross | 990,000 | 990,000 | 990,000 |
Intangible Assets, Accumulated Amortization | (119,625) | (94,875) | (45,375) |
Intangible Assets, Net | 870,375 | 895,125 | 944,625 |
Noncompete Agreements [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible Assets, Gross | 27,000 | 27,000 | 27,000 |
Intangible Assets, Accumulated Amortization | (27,000) | (25,882) | (12,378) |
Intangible Assets, Net | 0 | 1,118 | 14,622 |
Internet Domain Names [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible Assets, Gross | 26,512 | 25,993 | 3,963 |
Intangible Assets, Accumulated Amortization | (4,887) | (2,683) | (1,834) |
Intangible Assets, Net | $ 21,625 | $ 23,310 | 2,129 |
Trademarks and Trade Names [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible Assets, Gross | 301,000 | ||
Intangible Assets, Accumulated Amortization | (27,592) | ||
Intangible Assets, Net | $ 273,408 |
INTANGIBLE ASSETS (Details) -_2
INTANGIBLE ASSETS (Details) - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense - USD ($) | Nov. 30, 2020 | May 31, 2020 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | ||
2021 | $ 111,989 | $ 113,080 |
2022 | 111,989 | 111,962 |
2023 | 111,989 | 111,962 |
2024 | 111,989 | 111,962 |
2025 | 111,989 | 111,962 |
Thereafter | 802,676 | 860,276 |
$ 1,362,621 | $ 1,421,204 |
GOODWILL (Details)
GOODWILL (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||
Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | Sep. 11, 2018 | Jul. 24, 2018 | Jun. 27, 2018 | |
Disclosure Text Block Supplement [Abstract] | |||||||||
Goodwill | $ 557,896 | $ 557,896 | $ 557,896 | $ 25,742,899 | $ 25,742,899 | ||||
Goodwill, Impairment Loss | $ 0 | $ 0 | $ 0 | $ 0 | $ 25,185,003 | $ 0 | |||
Share Price (in Dollars per share) | $ 0.06 | $ 0.81 | $ 0.70 |
OTHER ASSETS (Details) - Schedu
OTHER ASSETS (Details) - Schedule of Other Assets - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Schedule of Other Assets [Abstract] | |||
Security deposits | $ 167,455 | $ 167,455 | |
$ 167,455 | $ 167,455 | $ 167,455 |
ACCOUNTS PAYABLE AND ACCRUED _3
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - Schedule of Accounts Payable and Accrued Liabilities - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Schedule of Accounts Payable and Accrued Liabilities [Abstract] | |||
Trade accounts payable | $ 723,573 | $ 591,060 | $ 510,210 |
Accrued payroll and payroll taxes | 226,272 | 212,361 | 230,119 |
Accrued liabilities | 369,462 | 625,399 | |
Deferred rent liability | 0 | 151,399 | |
Total | $ 1,430,765 | $ 1,172,883 | $ 1,517,127 |
NOTES PAYABLE AND CONVERTIBLE_3
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) | Jun. 01, 2018USD ($) |
Debt Disclosure [Abstract] | |
Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity | $ 1,265,751 |
NOTES PAYABLE AND CONVERTIBLE_4
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 | Jun. 01, 2018 |
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt [Line Items] | ||||
Notes payable | $ 0 | $ 4,000,000 | ||
Less: Discount | 0 | (67,384) | $ (750,000) | |
Notes Payable, Net of Discounts | 0 | 3,932,616 | ||
Current portion | $ 5,147,073 | 0 | 3,932,616 | |
Long term portion | 0 | 0 | ||
Oasis Note [Member] | Loans Payable [Member] | ||||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt [Line Items] | ||||
Notes payable | $ 0 | $ 4,000,000 |
NOTES PAYABLE AND CONVERTIBLE_5
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) - USD ($) | Jun. 01, 2018 | Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 |
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items] | |||||||
Note amount | $ 4,000,000 | ||||||
Discount charged to operations | $ 35,833 | $ 395,070 | $ 259,070 | $ 790,140 | $ 853,983 | 1,580,280 | $ 921,827 |
Repaid | $ 2,638,784 | $ 3,999,168 | 1,060,000 | ||||
Oasis Note [Member] | |||||||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items] | |||||||
Original Issue Discount | 189,180 | ||||||
Oasis Note [Member] | Loans Payable [Member] | |||||||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items] | |||||||
Note interest rate | 6.00% | ||||||
Note due | Dec. 4, 2019 | ||||||
Secured | secured by all of the membership interests in Alternative Solutions and the Oasis LLCs and by the assets of the Oasis LLCs | ||||||
Original Issue Discount | $ 189,180 | ||||||
Discount charged to operations | 67,384 | 121,796 | |||||
Interest Accrued | 82,037 | $ 225,333 | |||||
Repaid | 1,671,296 | ||||||
Note reduced for legal fees | 133,389 | ||||||
Note reduced for other costs | 5,395 | ||||||
Principal [Member] | Oasis Note [Member] | Loans Payable [Member] | |||||||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items] | |||||||
Repaid | 1,363,925 | ||||||
Accrued Interest [Member] | Oasis Note [Member] | Loans Payable [Member] | |||||||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items] | |||||||
Repaid | 370,370 | ||||||
August 14, 2019 [Member] | Principal [Member] | Oasis Note [Member] | Loans Payable [Member] | |||||||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items] | |||||||
Repaid | $ 2,500,000 |
NOTES PAYABLE AND CONVERTIBLE_6
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, Gross | $ 20,095,813 | $ 19,883,212 | $ 18,360,230 |
Less: Discount | (1,448,590) | (2,238,730) | (3,819,010) |
Convertible Notes Payable, | 18,647,223 | 17,644,482 | 14,541,220 |
Total - Convertible Notes Payable, Net of Discounts, Current Portion | 5,147,073 | 0 | |
Total - Convertible Notes Payable, Net of Discounts, Long-term Portion | 13,500,150 | 17,644,482 | 14,541,220 |
Navy Capital Debenture 1 [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, Gross | 4,504,457 | 4,504,457 | 4,134,400 |
Navy Capital Debenture 2 [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, Gross | 1,126,114 | 1,126,114 | 1,033,600 |
Murray FA Debenture [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, Gross | 112,613 | 112,613 | 103,496 |
Darling Capital Debenture [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, Gross | 599,101 | 599,101 | 550,478 |
Sabharwal Debenture [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, Gross | 168,919 | 168,919 | 155,176 |
Srinivasan Debenture 6 [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, Gross | 84,459 | 84,459 | 77,588 |
US Convertible Debenture 7 [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, Gross | $ 13,500,150 | $ 13,287,549 | $ 12,305,492 |
NOTES PAYABLE AND CONVERTIBLE_7
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt (Parentheticals) - USD ($) | 6 Months Ended | 12 Months Ended | |
Nov. 30, 2020 | May 31, 2020 | May 31, 2019 | |
Navy Capital Debenture 1 [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt (Parentheticals) [Line Items] | |||
Amount | $ 4,000,000 | $ 4,000,000 | |
Interest rate | 8.00% | 8.00% | |
Dated | Oct. 31, 2018 | Oct. 31, 2018 | |
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | |
Discount recorded | $ 3,254,896 | $ 3,254,896 | |
Discount | 542,483 | 1,084,965 | $ 632,896 |
Accrued interest | $ 180,179 | $ 344,962 | 191,363 |
Convertible | The U.S. Convertible Debenture 1 is convertible into units (the "Convertible Debenture Units") at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 1 is convertible into units (the "Convertible Debenture Units") at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | |
matures | 3 years | 3 years | |
Transferred | $ 82,688 | $ 370,057 | 134,400 |
Navy Capital Debenture 2 [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt (Parentheticals) [Line Items] | |||
Amount | $ 1,000,000 | $ 1,000,000 | |
Interest rate | 8.00% | 8.00% | |
Dated | Oct. 31, 2018 | Oct. 31, 2018 | |
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | |
Discount recorded | $ 813,724 | $ 813,724 | |
Discount | 135,621 | 271,241 | 158,224 |
Accrued interest | $ 45,045 | $ 86,240 | 47,841 |
Convertible | The U.S. Convertible Debenture 2 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 2 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | |
matures | 3 years | 3 years | |
Transferred | $ 20,672 | $ 92,514 | 33,600 |
Murray FA Debenture [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt (Parentheticals) [Line Items] | |||
Amount | $ 100,000 | $ 100,000 | |
Interest rate | 8.00% | 8.00% | |
Dated | Oct. 24, 2018 | Oct. 24, 2018 | |
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | |
Discount recorded | $ 75,415 | $ 75,415 | |
Discount | 12,569 | 25,138 | 14,664 |
Accrued interest | $ 4,505 | $ 8,638 | 4,945 |
Convertible | The U.S. Convertible Debenture 3 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 3 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | |
matures | 3 years | 3 years | |
Transferred | $ 2,070 | $ 9,117 | 3,496 |
Darling Capital Debenture [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt (Parentheticals) [Line Items] | |||
Amount | $ 532,000 | $ 532,000 | |
Interest rate | 8.00% | 8.00% | |
Dated | Oct. 25, 2018 | Oct. 25, 2018 | |
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | |
Discount recorded | $ 416,653 | $ 416,653 | |
Discount | 69,442 | 138,884 | 81,016 |
Accrued interest | $ 23,965 | $ 45,942 | 26,185 |
Convertible | The U.S. Convertible Debenture 4 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 4 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | |
matures | 3 years | 3 years | |
Transferred | $ 11,010 | $ 48,623 | 18,478 |
Sabharwal Debenture [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt (Parentheticals) [Line Items] | |||
Amount | $ 150,000 | $ 150,000 | |
Interest rate | 8.00% | 8.00% | |
Dated | Oct. 26, 2018 | Oct. 26, 2018 | |
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | |
Discount recorded | $ 120,100 | $ 120,100 | |
Discount | 20,017 | 40,033 | 23,353 |
Accrued interest | $ 6,757 | $ 12,950 | 7,348 |
Convertible | The U.S. Convertible Debenture 5 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 5 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | |
matures | 3 years | 3 years | |
Transferred | $ 3,104 | $ 13,743 | 5,176 |
Srinivasan Debenture 6 [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt (Parentheticals) [Line Items] | |||
Amount | $ 75,000 | $ 75,000 | |
Interest rate | 8.00% | 8.00% | |
Dated | Oct. 26, 2018 | Oct. 26, 2018 | |
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | |
Discount recorded | $ 60,049 | $ 60,049 | |
Discount | 10,008 | 20,019 | 11,674 |
Accrued interest | $ 3,378 | $ 6,475 | 3,674 |
Convertible | The U.S. Convertible Debenture 6 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10 | The U.S. Convertible Debenture 6 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10 | |
matures | 3 years | 3 years | |
Transferred | $ 1,552 | $ 6,871 | 2,588 |
US Convertible Debenture 7 [Member] | |||
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Convertible Debt (Parentheticals) [Line Items] | |||
Amount | $ 12,012,000 | $ 12,012,000 | |
Interest rate | 8.00% | 8.00% | |
Dated | Dec. 12, 2018 | Dec. 12, 2018 | |
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | |
Accrued interest | $ 536,439 | $ 1,025,549 | 458,759 |
Convertible | The Canaccord Debentures are convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The Canaccord Debentures are convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | |
matures | 3 years | 3 years | |
Transferred | $ 212,601 | $ 984,300 | $ 291,249 |
Converted | $ 25,857 | $ 25,857 | |
Converted shares (in Shares) | 32,321 | 32,321 | |
Converted, warrants (in Shares) | 16,160 | 16,160 |
NOTES PAYABLE AND CONVERTIBLE_8
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Amortization of Debt Discount - USD ($) | Jun. 01, 2018 | Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 |
Schedule of Amortization of Debt Discount [Abstract] | |||||||
Discounts on notes payable amortized to interest expense | $ 35,833 | $ 395,070 | $ 259,070 | $ 790,140 | $ 853,983 | $ 1,580,280 | $ 921,827 |
NOTES PAYABLE AND CONVERTIBLE_9
NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE (Details) - Schedule of Maturities of Long-term Debt - USD ($) | Nov. 30, 2020 | May 31, 2020 |
Schedule of Maturities of Long-term Debt [Abstract] | ||
2021 | $ 6,595,663 | $ 0 |
2022 | 13,500,150 | 19,883,212 |
2023 | 0 | 0 |
2024 | 0 | 0 |
2025 | 0 | 0 |
Thereafter | 0 | 0 |
Total | $ 20,095,813 | $ 19,883,212 |
CONTINGENT LIABILITY (Details)
CONTINGENT LIABILITY (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||
Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | Jun. 27, 2018 | |
Loss Contingency [Abstract] | |||||||
Business Combination, Liabilities Arising from Contingencies, Amount Recognized | $ 1,000,000 | ||||||
Business Combination, Contingent Consideration, Liability, Current | $ 150,000 | $ 150,000 | $ 150,000 | 1,000,000 | $ 678,111 | ||
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | 0 | $ 0 | 0 | $ 0 | 0 | $ 321,889 | |
Payment for Contingent Consideration Liability, Operating Activities | 850,000 | 850,000 | |||||
Deposit Assets | $ 150,000 | $ 150,000 | $ 150,000 |
STOCKHOLDERS_ EQUITY (Details)
STOCKHOLDERS’ EQUITY (Details) | Jul. 31, 2019 | Jul. 22, 2019USD ($)shares | Jul. 19, 2019USD ($)$ / sharesshares | Jul. 08, 2019USD ($)$ / sharesshares | May 02, 2019USD ($)shares | Mar. 01, 2019USD ($)shares | Jan. 08, 2019USD ($)shares | Dec. 12, 2018$ / sharesshares | Nov. 30, 2018$ / sharesshares | Nov. 14, 2018USD ($)$ / sharesshares | Nov. 01, 2018USD ($)shares | Oct. 23, 2018USD ($)shares | Sep. 11, 2018USD ($)$ / sharesshares | Sep. 06, 2018$ / sharesshares | Aug. 23, 2018USD ($)shares | Aug. 20, 2018USD ($)shares | Aug. 14, 2018$ / sharesshares | Aug. 10, 2018USD ($)$ / sharesshares | Aug. 09, 2018USD ($)shares | Aug. 08, 2018$ / sharesshares | Aug. 06, 2018$ / sharesshares | Jul. 31, 2018USD ($)$ / sharesshares | Jul. 27, 2018 | Jul. 24, 2018USD ($)$ / sharesshares | Jul. 20, 2018$ / sharesshares | Jun. 27, 2018USD ($)$ / sharesshares | Jun. 24, 2018USD ($)$ / sharesshares | Jun. 20, 2018USD ($)$ / sharesshares | Jun. 20, 2018CAD ($)shares | Jun. 12, 2018USD ($)shares | Jun. 01, 2018USD ($) | May 31, 2018 | May 14, 2018 | Mar. 29, 2018 | Mar. 02, 2018 | Feb. 28, 2018$ / shares | Feb. 21, 2018 | Feb. 07, 2018 | Nov. 30, 2020USD ($)$ / sharesshares | Nov. 30, 2019USD ($) | Nov. 30, 2020USD ($)$ / sharesshares | Nov. 30, 2019USD ($)shares | May 31, 2019USD ($)$ / sharesshares | May 31, 2020USD ($)$ / sharesshares | May 31, 2019USD ($)$ / sharesshares | May 31, 2018USD ($) | Feb. 28, 2019$ / shares | Jun. 20, 2018$ / shares |
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Shares Authorized (in Shares) | shares | 750,000,000 | 750,000,000 | 750,000,000 | 750,000,000 | 750,000,000 | |||||||||||||||||||||||||||||||||||||||||||
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized (in Shares) | shares | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | |||||||||||||||||||||||||||||||||||||||||||
Common Stock, Shares, Issued (in Shares) | shares | 126,571,416 | 126,571,416 | 125,839,095 | 126,521,416 | 125,839,095 | |||||||||||||||||||||||||||||||||||||||||||
Common Stock, Shares, Outstanding (in Shares) | shares | 126,571,416 | 126,571,416 | 125,839,095 | 126,521,416 | 125,839,095 | |||||||||||||||||||||||||||||||||||||||||||
Imputed Interest, Debt | $ 0 | $ 807 | ||||||||||||||||||||||||||||||||||||||||||||||
Increase (Decrease) in Due to Related Parties | 0 | (17,930) | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares | 15,677 | 16,644 | ||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding, Term | 3 years | 3 years | ||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | shares | 7,838 | 8,322 | 33,463,838 | |||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.10 | $ 1.10 | $ 0.75 | $ 0.75 | $ 0.75 | |||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 12,542 | $ 13,315 | 0 | 75,000 | ||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 125,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | $ 53,876 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 25,310 | $ 490,000 | 25,750 | $ 30,000 | $ 45,000 | 490,000 | ||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares | 31,250 | 700,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Share Price (in Dollars per share) | $ / shares | $ 0.81 | $ 0.70 | $ 0.06 | |||||||||||||||||||||||||||||||||||||||||||||
Payments for Commissions | $ 250,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Acquisitions (in Shares) | shares | 22,058,823 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Acquisitions | $ 15,441,176 | $ 14,970 | $ 0 | 25,313 | ||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance or Sale of Equity | 0 | 15,535,978 | ||||||||||||||||||||||||||||||||||||||||||||||
Warrants Issued, Price Per Warrant | (per share) | $ 0.34 | $ 0.45 | ||||||||||||||||||||||||||||||||||||||||||||||
Other Noncash Income (Expense) | $ 0 | $ (403,588) | ||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares) | shares | 5,867 | 13,684 | 129,412 | |||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant Or Rights, Exercised (in Shares) | shares | 25,000 | 40,000 | 350,000 | 0 | 0 | (415,000) | ||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | shares | 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 47,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Beneficial Conversion Feature | $ 0 | $ 5,888,707 | ||||||||||||||||||||||||||||||||||||||||||||||
Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity | $ 1,265,751 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 35,833 | $ 395,070 | $ 259,070 | $ 790,140 | $ 853,983 | 1,580,280 | 921,827 | |||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 750,000 | $ 67,384 | $ 0 | 67,384 | ||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | $ 5,888,707 | |||||||||||||||||||||||||||||||||||||||||||||||
(in Dollars per share) | $ / shares | $ 33,463,838 | $ 0 | $ 1.10 | $ 0.653 | ||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares | 1,808,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 565,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 550,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Efrat Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares | 183,040 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 57,200 | |||||||||||||||||||||||||||||||||||||||||||||||
Efrat Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 55,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Efrat Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 2,200 | |||||||||||||||||||||||||||||||||||||||||||||||
Lamadrid Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares | 103,989 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 32,497 | |||||||||||||||||||||||||||||||||||||||||||||||
Lamadrid Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 31,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Lamadrid Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 1,247 | |||||||||||||||||||||||||||||||||||||||||||||||
Lasky Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares | 65,462 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 26,185 | |||||||||||||||||||||||||||||||||||||||||||||||
Lasky Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Lasky Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 1,185 | |||||||||||||||||||||||||||||||||||||||||||||||
Newcan Funding Notes [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares | 196,336 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 78,534 | |||||||||||||||||||||||||||||||||||||||||||||||
Newcan Funding Notes [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 75,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Newcan Funding Notes [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 3,534 | |||||||||||||||||||||||||||||||||||||||||||||||
YA II PN, Ltd [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares | 640,068 | 700,616 | ||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | shares | 1,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.60 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 256,027 | $ 280,247 | ||||||||||||||||||||||||||||||||||||||||||||||
YA II PN, Ltd [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 250,000 | 250,000 | ||||||||||||||||||||||||||||||||||||||||||||||
YA II PN, Ltd [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 6,027 | $ 30,247 | ||||||||||||||||||||||||||||||||||||||||||||||
YA II PN Note #2 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Beneficial Conversion Feature | $ 362,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Newcan Convertible Note 8 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Beneficial Conversion Feature | 58,594 | |||||||||||||||||||||||||||||||||||||||||||||||
Oasis Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Original Issue Discount | 189,180 | |||||||||||||||||||||||||||||||||||||||||||||||
Navy Capital Debenture 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 3,254,896 | $ 3,254,896 | $ 3,254,896 | |||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | 3,254,896 | |||||||||||||||||||||||||||||||||||||||||||||||
Navy Capital Debenture 2 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 813,724 | 813,724 | 813,724 | |||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | 813,724 | |||||||||||||||||||||||||||||||||||||||||||||||
Navy Capital Debenture 3 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | 75,415 | |||||||||||||||||||||||||||||||||||||||||||||||
Navy Capital Debenture 4 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | 416,653 | |||||||||||||||||||||||||||||||||||||||||||||||
Navy Capital Debenture 5 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | 120,100 | |||||||||||||||||||||||||||||||||||||||||||||||
Navy Capital Debenture 6 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | 60,049 | |||||||||||||||||||||||||||||||||||||||||||||||
WestPark Capital Inc [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Unit, Description | Each warrant entitles the holder to purchase one unit, which consists of one share of common stock and a warrant to purchase one share of common stock, for C$0.65 per share | |||||||||||||||||||||||||||||||||||||||||||||||
Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 10 | $ 73 | ||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares | 731,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares) | shares | 32,319 | 32,321 | 3,697,511 | |||||||||||||||||||||||||||||||||||||||||||||
Unit Issued (in Shares) | shares | 559,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Additional Paid-in Capital [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 22,490 | $ 515,240 | ||||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | 5,888,707 | |||||||||||||||||||||||||||||||||||||||||||||||
Service Provider [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 22,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Cancellation of Contract | $ 22,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Repurchased and Retired During Period, Shares (in Shares) | shares | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Service [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Cancellation of Contract | $ 3,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Repurchased and Retired During Period, Shares (in Shares) | shares | 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Chief Executive Officer [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | $ 355,000 | |||||||||||||||||||||||||||||||||||||||||||||||
APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $ 29,583 | 325,417 | ||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement, Expense | 29,583 | 325,417 | ||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | |||||||||||||||||||||||||||||||||||||||||||||||
Chief Executive Officer [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | 50 | |||||||||||||||||||||||||||||||||||||||||||||||
Chief Executive Officer [Member] | Additional Paid-in Capital [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | $ 354,950 | |||||||||||||||||||||||||||||||||||||||||||||||
Chief Operating Officer [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | $ 35,495 | $ 215,500 | ||||||||||||||||||||||||||||||||||||||||||||||
APIC, Share-based Payment Arrangement, Increase for Cost Recognition | 2,958 | 32,542 | ||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement, Expense | 2,958 | 32,542 | ||||||||||||||||||||||||||||||||||||||||||||||
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings (in Shares) | shares | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | 2 years | ||||||||||||||||||||||||||||||||||||||||||||||
Chief Operating Officer [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | 5 | |||||||||||||||||||||||||||||||||||||||||||||||
Chief Operating Officer [Member] | Additional Paid-in Capital [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | $ 35,495 | |||||||||||||||||||||||||||||||||||||||||||||||
David Lamadrid [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 264,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares | 600,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Share Price (in Dollars per share) | $ / shares | $ 0.44 | |||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement, Expense | 50,680 | $ 213,320 | ||||||||||||||||||||||||||||||||||||||||||||||
Chief Financial Officer [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings (in Shares) | shares | 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 4 months | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | $ 17,995 | |||||||||||||||||||||||||||||||||||||||||||||||
Chief Financial Officer [Member] | Darling Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
APIC, Share-based Payment Arrangement, Increase for Cost Recognition | 1,428 | |||||||||||||||||||||||||||||||||||||||||||||||
Private Placement, Westpark Offering [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.50 | $ 0.75 | ||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | shares | 1,368,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Private Placement, Westpark Offering [Member] | Lamadrid Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Warrant, Term of Warrants | 3 years | 3 years | 3 years | 3 years | ||||||||||||||||||||||||||||||||||||||||||||
To Be Issued to Officers [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 154,014 | |||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | $ 791,668 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock To Be Issued [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 45,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares | 133,332 | 200,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Special Warrants [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | shares | 3,042,167 | 28,973,020 | 28,973,020 | |||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | (per share) | $ 0.65 | $ 0.65 | $ 0.45 | |||||||||||||||||||||||||||||||||||||||||||||
Payments for Commissions | $ 799,053 | $ 1,043,028 | ||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance or Sale of Equity | $ 9,785,978 | $ 13,037,859 | ||||||||||||||||||||||||||||||||||||||||||||||
Warrant Description | Each special warrant was automatically exercisable, for no additional consideration, into units of the Company on the earlier of: (i) the date that was five business days following the date on which the Company obtained a receipt from the applicable securities regulatory authorities in each of the jurisdictions in Canada in which the special warrants were sold for a final prospectus qualifying the distribution of the units, which was intended to be no later than November 30, 2018, and (ii) the date that was four months and one day after the completion of the Company's acquisition of all of the membership interests in Alternative Solutions, known as Oasis Cannabis | Each special warrant was automatically exercisable, for no additional consideration, into units of the Company on the earlier of: (i) the date that was five business days following the date on which the Company obtained a receipt from the applicable securities regulatory authorities in each of the jurisdictions in Canada in which the special warrants were sold for a final prospectus qualifying the distribution of the units, which was intended to be no later than November 30, 2018, and (ii) the date that was four months and one day after the completion of the Company's acquisition of all of the membership interests in Alternative Solutions, known as Oasis Cannabis | ||||||||||||||||||||||||||||||||||||||||||||||
Other Noncash Income (Expense) | $ 403,588 | |||||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Warrant Issued | $ 1,495,373 | |||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 36 months | 36 months | ||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrants or Rights, Value | $ 1,413,300 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrant, Term of Warrants | 3 years | 3 years | ||||||||||||||||||||||||||||||||||||||||||||||
Other Noncash Expense | $ 7,142,550 | |||||||||||||||||||||||||||||||||||||||||||||||
Unit, Description | the unexercised special warrants were adjusted to entitle the holders to receive 1.1 units instead of one unit of the Company | |||||||||||||||||||||||||||||||||||||||||||||||
Special Warrants [Member] | Underlying Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance or Sale of Equity | $ 4,226,394 | |||||||||||||||||||||||||||||||||||||||||||||||
Special Warrants [Member] | Underlying Warrants [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance or Sale of Equity | $ 5,559,584 | |||||||||||||||||||||||||||||||||||||||||||||||
Special Warrants [Member] | Finance Fee [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | shares | 1,448,651 | 1,448,651 | ||||||||||||||||||||||||||||||||||||||||||||||
Special Warrants [Member] | Compensation Warrants [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | shares | 2,317,842 | 2,317,842 | ||||||||||||||||||||||||||||||||||||||||||||||
Navy Green Capital Offering [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | shares | 6,875,000 | 7,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.60 | $ 0.60 | $ 0.60 | |||||||||||||||||||||||||||||||||||||||||||||
Warrant, Term of Warrants | 3 years | |||||||||||||||||||||||||||||||||||||||||||||||
Number of Units Issued (in Shares) | shares | 7,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Unit, Price Per Unit (in Dollars per share) | $ / shares | $ 0.40 | |||||||||||||||||||||||||||||||||||||||||||||||
Units, Value, Subscriptions | $ 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Unit, Description | The units collectively represent (i) 7,500,000 shares of common stock, and (ii) three-year warrants to purchase an aggregate of 7,500,000 shares of common stock at an exercise price of $0.60 per share of common stock | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | shares | 7,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Navy Capital [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.60 | |||||||||||||||||||||||||||||||||||||||||||||||
Number of Units Issued (in Shares) | shares | 6,875,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Unit, Price Per Unit (in Dollars per share) | $ / shares | $ 0.40 | |||||||||||||||||||||||||||||||||||||||||||||||
Units, Value, Subscriptions | $ 2,750,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Unit, Description | The units collectively represent (i) 6,875,000 shares of common stock, and (ii) three-year warrants to purchase an aggregate of 6,875,000 shares of common stock at an exercise price of $0.60 per share of common stock. | |||||||||||||||||||||||||||||||||||||||||||||||
Number of Subscription Agreements | 5 | |||||||||||||||||||||||||||||||||||||||||||||||
Debenture Offering, Advisory and Agent Fees [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
APIC, Share-based Payment Arrangement, Increase for Cost Recognition | 557,335 | |||||||||||||||||||||||||||||||||||||||||||||||
Unit Issued (in Shares) | shares | 559,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Unit Exercise Price (in Dollars per share) | $ / shares | $ 1.10 | |||||||||||||||||||||||||||||||||||||||||||||||
In Connection with Sale of Convertible Debt [Member] | YA II PN, Ltd [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Warrant, Term of Warrants | 5 years | |||||||||||||||||||||||||||||||||||||||||||||||
Issued to Consultants [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Warrant, Term of Warrants | 3 years | |||||||||||||||||||||||||||||||||||||||||||||||
Debenture Offering [Member] | Compensation Warrants [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | shares | 268,680 | |||||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Warrant Issued | $ 874,457 | |||||||||||||||||||||||||||||||||||||||||||||||
Debenture Offering [Member] | Debenture Offering, Advisory and Agent Fees [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Warrant, Term of Warrants | 3 years | |||||||||||||||||||||||||||||||||||||||||||||||
Unit, Description | Each warrant entitles the holder to purchase a unit for $0.80, which unit consists of one share of common stock and a warrant to purchase one-half share of common stock at an exercise price of $1.10 per share | |||||||||||||||||||||||||||||||||||||||||||||||
Issued to Officers [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | $ 93,901 |
STOCKHOLDERS_ EQUITY (Details)
STOCKHOLDERS’ EQUITY (Details) - Fair Value Measurement Inputs and Valuation Techniques | May 31, 2020 | May 31, 2019 |
Measurement Input, Expected Dividend Rate [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement Input | 0 | |
Measurement Input, Expected Term [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement Input | 3 | |
Minimum [Member] | Measurement Input, Price Volatility [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement Input | 0 | 79.02 |
Minimum [Member] | Measurement Input, Expected Dividend Rate [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement Input | 0 | |
Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement Input | 0 | 0.0268 |
Minimum [Member] | Measurement Input, Expected Term [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement Input | 0 | |
Maximum [Member] | Measurement Input, Price Volatility [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement Input | 4.003 | |
Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement Input | 0.0277 |
STOCKHOLDERS_ EQUITY (Details_2
STOCKHOLDERS’ EQUITY (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range - $ / shares | May 31, 2019 | May 31, 2018 | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 | Jul. 19, 2019 | Jul. 08, 2019 | May 30, 2019 | Nov. 14, 2018 | Sep. 06, 2018 | Aug. 14, 2018 | May 30, 2018 |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 1.10 | $ 1.10 | $ 0.75 | $ 0.75 | $ 0.75 | |||||||
Number of warrants outstanding (in Shares) | 54,818,985 | 54,835,145 | 54,835,145 | 54,818,985 | 54,818,985 | 4,495,750 | ||||||
Weighted average remaining contractual life | 1 year | 1 year 6 months | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.53 | $ 0.61 | $ 0.53 | $ 0.53 | $ 0.53 | |||||||
Number of warrants exercisable (in Shares) | 54,835,145 | 54,835,145 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.53 | $ 0.53 | ||||||||||
Warrant Exercisable at $0.49 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 0.49 | $ 0.49 | ||||||||||
Number of warrants outstanding (in Shares) | 33,465,110 | 33,465,110 | ||||||||||
Weighted average remaining contractual life | 1 year | 1 year 6 months | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.49 | $ 0.49 | ||||||||||
Number of warrants exercisable (in Shares) | 33,465,110 | 33,465,110 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.49 | $ 0.49 | ||||||||||
Warrants Exercisable at $0.50 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 0.50 | $ 0.50 | ||||||||||
Number of warrants outstanding (in Shares) | 2,736,500 | 2,736,500 | ||||||||||
Weighted average remaining contractual life | 1 year 83 days | 1 year 266 days | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.50 | $ 0.50 | ||||||||||
Number of warrants exercisable (in Shares) | 2,736,500 | 2,736,500 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.50 | $ 0.50 | ||||||||||
Warrant Exercisable at $0.60 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 0.60 | $ 0.60 | ||||||||||
Number of warrants outstanding (in Shares) | 17,500,000 | 17,500,000 | ||||||||||
Weighted average remaining contractual life | 1 year | 1 year 6 months | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.60 | $ 0.60 | ||||||||||
Number of warrants exercisable (in Shares) | 17,500,000 | 17,500,000 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.60 | $ 0.60 | ||||||||||
Warrant Exercisable at $0.75 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 0.75 | $ 0.75 | ||||||||||
Number of warrants outstanding (in Shares) | 837,500 | 837,500 | ||||||||||
Weighted average remaining contractual life | 80 days | 262 days | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.75 | $ 0.75 | ||||||||||
Number of warrants exercisable (in Shares) | 837,500 | 837,500 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.75 | $ 0.75 | ||||||||||
Warrant Exercisable at $1.10 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 1.10 | $ 1.10 | ||||||||||
Number of warrants outstanding (in Shares) | 296,035 | 296,035 | ||||||||||
Weighted average remaining contractual life | 1 year 21 days | 1 year 204 days | ||||||||||
Weighted average exercise price of outstanding warrants | $ 1.10 | $ 1.10 | ||||||||||
Number of warrants exercisable (in Shares) | 296,035 | 296,035 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 1.10 | $ 1.10 |
STOCKHOLDERS_ EQUITY (Details_3
STOCKHOLDERS’ EQUITY (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - $ / shares | May 31, 2019 | Nov. 30, 2018 | Nov. 14, 2018 | Sep. 06, 2018 | Aug. 14, 2018 | May 31, 2018 | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract] | |||||||||
Warrants outstanding, Number of Shares | 54,818,985 | 4,495,750 | 54,835,145 | 54,818,985 | |||||
Warrants outstanding, Weighted Average Exercise Price | $ 0.53 | $ 0.61 | $ 0.53 | $ 0.53 | $ 0.53 | ||||
Granted, Number of Shares | 0 | 16,160 | 50,738,235 | ||||||
Granted, Weighted Average Exercise Price | $ 33,463,838 | $ 0 | $ 1.10 | $ 0.653 | |||||
Exercised, Number of Shares | 25,000 | 40,000 | 350,000 | 0 | 0 | (415,000) | |||
Exercised, Weighted Average Exercise Price | $ 0 | $ 0 | $ 0.75 | ||||||
Cancelled / Expired, Number of Shares | 0 | 0 | 0 | ||||||
Cancelled / Expired, Weighted Average Exercise Price | $ 0 | $ 0 | $ 0 | ||||||
Warrants outstanding, Number of Shares | 54,818,985 | 54,835,145 | 54,835,145 | 54,818,985 |
GAIN ON SETTLEMENT OF LIABILI_2
GAIN ON SETTLEMENT OF LIABILITIES (Details) | Aug. 14, 2019USD ($) |
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract] | |
Gain (Loss) on Extinguishment of Debt | $ 275,000 |
FAIR VALUE OF FINANCIAL INSTR_3
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | |||
Derivative liabilities | $ 0 | $ 0 | $ 0 |
Fair Value, Inputs, Level 1 [Member] | |||
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | |||
Derivative liabilities | 0 | 0 | 0 |
Fair Value, Inputs, Level 2 [Member] | |||
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | |||
Derivative liabilities | 0 | 0 | 0 |
Fair Value, Inputs, Level 3 [Member] | |||
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | |||
Derivative liabilities | $ 0 | $ 0 | $ 0 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details) - USD ($) | Jul. 31, 2019 | Mar. 01, 2019 | Jul. 31, 2018 | Jul. 27, 2018 | Jul. 24, 2018 | May 31, 2020 | May 31, 2019 | Nov. 30, 2020 |
Former Officer [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Employee-related Liabilities, Current | $ 16,250 | $ 16,250 | $ 16,250 | |||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 103,989 | |||||||
Former Officer [Member] | Principal [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Debt Conversion, Original Debt, Amount | $ 31,250 | |||||||
Former Officer [Member] | Accrued Interest [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Debt Conversion, Original Debt, Amount | $ 1,247 | |||||||
Chief Financial Officer [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | 25,000 | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 4 months | |||||||
Stock Issued During Period, Value, Restricted Stock Award, Gross | $ 17,500 | |||||||
Chief Executive Officer [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | 500,000 | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | |||||||
Stock Issued During Period, Value, Restricted Stock Award, Gross | $ 355,000 | |||||||
Share-based Payment Arrangement, Expense | 29,583 | 325,417 | ||||||
Chief Operating Officer [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Employee-related Liabilities, Current | 16,250 | |||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | 50,000 | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | 2 years | ||||||
Stock Issued During Period, Value, Restricted Stock Award, Gross | $ 35,000 | |||||||
Share-based Payment Arrangement, Expense | $ 2,958 | $ 32,542 | ||||||
Director [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | 700,000 | |||||||
Stock Issued During Period, Value, Restricted Stock Award, Gross | $ 490,000 | |||||||
Payments for Commissions | 250,000 | |||||||
Board of Directors Chairman [Member] | Principal [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Repayments of Related Party Debt | 37,500 | |||||||
Board of Directors Chairman [Member] | Accrued Interest [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Repayments of Related Party Debt | $ 3,903 | |||||||
Affiliated Entity [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 196,336 | |||||||
Affiliated Entity [Member] | Principal [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Debt Conversion, Original Debt, Amount | $ 75,000 | |||||||
Affiliated Entity [Member] | Accrued Interest [Member] | ||||||||
RELATED PARTY TRANSACTIONS (Details) [Line Items] | ||||||||
Debt Conversion, Original Debt, Amount | $ 3,534 |
INCOME TAXES (Details)
INCOME TAXES (Details) | 12 Months Ended | ||
May 31, 2020USD ($) | May 31, 2018 | May 31, 2019USD ($) | |
Income Tax Disclosure [Abstract] | |||
Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent | 0.21 | 0.34 | |
Operating Loss Carryforwards | $ 12,087,758 | $ 14,294,045 |
INCOME TAXES (Details) - Schedu
INCOME TAXES (Details) - Schedule of Deferred Tax Assets and Liabilities - USD ($) | 12 Months Ended | |
May 31, 2020 | May 31, 2019 | |
Schedule of Deferred Tax Assets and Liabilities [Abstract] | ||
Federal and state statutory rate | 21.00% | 21.00% |
Net operating loss carry forwards | $ 2,538,429 | $ 3,001,749 |
Valuation allowance for deferred tax assets | (2,538,429) | (3,001,749) |
Net deferred tax assets | $ 0 | $ 0 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details) | Oct. 14, 2019 | Oct. 01, 2019USD ($) | Jul. 31, 2019 | Jul. 22, 2019shares | Jul. 19, 2019USD ($) | Jul. 08, 2019USD ($) | Apr. 08, 2019USD ($)shares | Mar. 01, 2019USD ($)shares | Jul. 31, 2018shares | Jul. 27, 2018 | Jul. 01, 2018USD ($)shares | Apr. 06, 2018USD ($) | Jan. 05, 2018USD ($) | Nov. 30, 2017USD ($)shares | Oct. 09, 2017USD ($) | Aug. 23, 2017USD ($) | Jul. 20, 2016USD ($) | Mar. 31, 2016USD ($) | Oct. 01, 2014 | Feb. 29, 2020USD ($) | Feb. 28, 2019USD ($)ft² | Jan. 31, 2018USD ($)ft² | Jan. 31, 2016USD ($)ft² | Aug. 31, 2018shares | Nov. 30, 2020USD ($)shares | Feb. 28, 2019USD ($)ft² | May 31, 2020USD ($) | May 31, 2019USD ($) | Apr. 17, 2017ft² |
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Loss Contingency Accrual, Provision | $ 10,000 | ||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 12,542 | $ 13,315 | $ 0 | $ 75,000 | |||||||||||||||||||||||||
Employment Agreement, Amendment | the amendment provides for certain change of control provisions, including a payment of up to three years base salary and bonuses up to a maximum of $1,000,000, if Mr. Binder resigns or is terminated in connection with a change in control of the Company | ||||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 125,000 | ||||||||||||||||||||||||||||
Employee-related Liabilities, Current | $ 226,272 | $ 212,361 | 230,119 | ||||||||||||||||||||||||||
Minimum [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Lessee, Operating Lease, Term of Contract | 1 year | 1 year | |||||||||||||||||||||||||||
Maximum [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Lessee, Operating Lease, Term of Contract | 4 years | 4 years | |||||||||||||||||||||||||||
Deposit [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Loss Contingency Accrual, Provision | 50,000 | ||||||||||||||||||||||||||||
Rent Expense [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Loss Contingency Accrual, Provision | 15,699 | ||||||||||||||||||||||||||||
Remaining Amounts Due Under Lease [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Loss Contingency Accrual, Provision | $ 30,000 | ||||||||||||||||||||||||||||
Chief Executive Officer [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Employment Agreement, Term | 5 years | ||||||||||||||||||||||||||||
Salary and Wage, Officer, Excluding Cost of Good and Service Sold | $ 150,000 | 150,000 | |||||||||||||||||||||||||||
Deferred Compensation Arrangement with Individual, Description | performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of the annual EBITDA | performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million | |||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Description | annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million | ||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | ||||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 500,000 | ||||||||||||||||||||||||||||
Chief Executive Officer [Member] | Convertible Debt [Member] | Unpaid Accrued Salary Converted to Convertible Note [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 37,500 | $ 37,500 | $ 39,521 | $ 62,500 | $ 250,000 | $ 112,500 | |||||||||||||||||||||||
Chief Executive Officer [Member] | One Time Signing Bonus [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares | 500,000 | ||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | ||||||||||||||||||||||||||||
President and Chief Financial Officer [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Salary and Wage, Officer, Excluding Cost of Good and Service Sold | $ 175,000 | ||||||||||||||||||||||||||||
Deferred Compensation Arrangement with Individual, Description | performance bonus equal to 2% of the Company’s annual EBITDA, and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA | ||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Description | annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA | ||||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 600,000 | ||||||||||||||||||||||||||||
President and Chief Financial Officer [Member] | One Time Signing Bonus [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares | 500,000 | ||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | ||||||||||||||||||||||||||||
Chief Operating Officer [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Employment Agreement, Term | 2 years | ||||||||||||||||||||||||||||
Salary and Wage, Officer, Excluding Cost of Good and Service Sold | $ 150,000 | ||||||||||||||||||||||||||||
Deferred Compensation Arrangement with Individual, Description | performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’ common stock in an amount equal to 3% of the annual EBITDA | ||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | 2 years | |||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 50,000 | ||||||||||||||||||||||||||||
Employee-related Liabilities, Current | $ 16,250 | ||||||||||||||||||||||||||||
Chief Operating Officer [Member] | One Time Signing Bonus [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares | 50,000 | ||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | ||||||||||||||||||||||||||||
President [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Salary and Wage, Officer, Excluding Cost of Good and Service Sold | $ 200,000 | $ 175,000 | |||||||||||||||||||||||||||
Deferred Compensation Arrangement with Individual, Description | performance-based bonus equal to two percent (2%) of the Company’s annual EBITDA up to a maximum annual cash compensation of $1 million including base salary, and annual stock options, exercisable at the fair market value of the Company’s common stock on the effective date of grant, in an amount equal to 2% of the Company’s EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million | performance bonus equal to 1% of the Company’s annual EBITDA, and annual restricted stock awards in an amount equal to 1% of the Company’s annual EBITDA | |||||||||||||||||||||||||||
Employment Agreement, Amendment | the amendment provides for certain change of control provisions, including a payment of up to three years base salary and bonuses up to a maximum of $1,000,000, if Mr. Glashow resigns or is terminated in connection with a change in control of the Company | ||||||||||||||||||||||||||||
President [Member] | One Time Signing Bonus [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares | 500,000 | ||||||||||||||||||||||||||||
Chief Financial Officer [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Salary and Wage, Officer, Excluding Cost of Good and Service Sold | $ 110,000 | ||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 4 months | ||||||||||||||||||||||||||||
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares | 50,000 | ||||||||||||||||||||||||||||
Chief Financial Officer [Member] | One Time Signing Bonus [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares | 50,000 | ||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year | ||||||||||||||||||||||||||||
Former Officer [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Employee-related Liabilities, Current | $ 16,250 | $ 16,250 | $ 16,250 | ||||||||||||||||||||||||||
Building [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Area of Real Estate Property (in Square Feet) | ft² | 14,392 | ||||||||||||||||||||||||||||
Lessee, Operating Lease, Term of Contract | 72 months | ||||||||||||||||||||||||||||
Lessee, Operating Lease, Renewal Term | 10 years | ||||||||||||||||||||||||||||
Building [Member] | Las Vegas, NV #1 [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Area of Real Estate Property (in Square Feet) | ft² | 1,400 | 1,400 | |||||||||||||||||||||||||||
Lessee, Operating Lease, Term of Contract | 18 months | 18 months | |||||||||||||||||||||||||||
Operating Leases, Rent Expense, Minimum Rentals | $ 1,866.70 | ||||||||||||||||||||||||||||
Operating Lease, Annual Increase | 3.00% | ||||||||||||||||||||||||||||
Building [Member] | Las Vegas, NV #1 [Member] | Minimum [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Operating Leases, Rent Expense, Minimum Rentals | $ 1,785 | ||||||||||||||||||||||||||||
Building [Member] | Las Vegas, NV #2 [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Area of Real Estate Property (in Square Feet) | ft² | 1,000 | ||||||||||||||||||||||||||||
Building [Member] | Las Vegas, NV #3 [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Area of Real Estate Property (in Square Feet) | ft² | 2,504 | 2,504 | |||||||||||||||||||||||||||
Operating Lease, Annual Increase | 3.00% | ||||||||||||||||||||||||||||
Building [Member] | Las Vegas, NV #3 [Member] | Minimum [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Operating Leases, Rent Expense, Minimum Rentals | $ 3,210 | ||||||||||||||||||||||||||||
Building and Building Improvements [Member] | Las Vegas, NV #2 [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Operating Lease, Monthly Amount Increase | $ 600 | ||||||||||||||||||||||||||||
Building and Building Improvements [Member] | Las Vegas, NV #2 [Member] | Minimum [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Operating Leases, Rent Expense, Minimum Rentals | $ 7,500 | ||||||||||||||||||||||||||||
Building and Building Improvements [Member] | Las Vegas, NV #4 [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Area of Real Estate Property (in Square Feet) | ft² | 22,000 | ||||||||||||||||||||||||||||
Building and Building Improvements [Member] | Las Vegas, NV #4 [Member] | Minimum [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Operating Leases, Rent Expense, Minimum Rentals | $ 11,000 | ||||||||||||||||||||||||||||
Building and Building Improvements [Member] | Las Vegas, NV #4 [Member] | Maximum [Member] | |||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Details) [Line Items] | |||||||||||||||||||||||||||||
Operating Leases, Rent Expense, Minimum Rentals | $ 29,000 |
Nature of Business and Signif_3
Nature of Business and Significant Accounting Policies (Details) - USD ($) | Dec. 23, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | Nov. 30, 2020 | Jun. 01, 2019 | Jun. 27, 2018 | May 31, 2018 |
Nature of Business and Significant Accounting Policies (Details) [Line Items] | |||||||||||
Proceeds from Collection of Notes Receivable | $ 1,385,951 | $ 1,682,278 | $ 0 | ||||||||
Cash and Cash Equivalents, at Carrying Value | $ 2,805,516 | $ 4,937,013 | 2,805,516 | $ 4,937,013 | 2,925,568 | 10,525,791 | $ 2,805,516 | $ 52,964 | |||
Accounts Receivable, Credit Loss Expense (Reversal) | 0 | 0 | 5,992 | 0 | 108,392 | 0 | |||||
Goodwill, Impairment Loss | 0 | 0 | 0 | 0 | 25,185,003 | 0 | |||||
Goodwill | 557,896 | 557,896 | 557,896 | 25,742,899 | 557,896 | $ 25,742,899 | |||||
Advertising Expense | 311,707 | 218,041 | $ 443,739 | 424,019 | $ 836,000 | 1,655,374 | |||||
Research and Development Expense | 5,385 | $ 0 | $ 0 | $ 0 | 12,392 | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | 88,474,321 | 86,932,861 | 88,130,526 | 86,439,117 | |||||||
Operating Lease, Right-of-Use Asset | 1,227,702 | $ 1,227,702 | $ 1,403,429 | $ 0 | 1,227,702 | $ 2,703,821 | |||||
Operating Lease, Liability | 1,265,642 | 1,265,642 | 1,473,051 | $ 2,675,310 | 1,265,642 | $ 2,675,310 | |||||
CannAssist LLC [Member] | |||||||||||
Nature of Business and Significant Accounting Policies (Details) [Line Items] | |||||||||||
Proceeds from Collection of Notes Receivable | $ 342,567 | ||||||||||
Financing Receivable, after Allowance for Credit Loss | $ 0 | $ 0 | $ 0 | $ 0 | |||||||
Warrant [Member] | |||||||||||
Nature of Business and Significant Accounting Policies (Details) [Line Items] | |||||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | 54,835,145 | 54,835,145 | 54,835,145 | 54,818,985 | |||||||
Equity Unit Purchase Agreements [Member] | |||||||||||
Nature of Business and Significant Accounting Policies (Details) [Line Items] | |||||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | 7,676,974 | 7,676,974 | 7,676,974 | 7,676,974 | |||||||
Convertible Debt Securities [Member] | |||||||||||
Nature of Business and Significant Accounting Policies (Details) [Line Items] | |||||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | 25,454,696 | 24,184,074 | 25,131,739 | 23,261,393 | |||||||
Stock Payable [Member] | |||||||||||
Nature of Business and Significant Accounting Policies (Details) [Line Items] | |||||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | 507,506 | 236,668 | 486,668 | 681,764 | |||||||
Notes Receivable [Member] | Principal [Member] | |||||||||||
Nature of Business and Significant Accounting Policies (Details) [Line Items] | |||||||||||
Proceeds from Collection of Notes Receivable | $ 2,743,229 | ||||||||||
Notes Receivable [Member] | Accrued Interest [Member] | |||||||||||
Nature of Business and Significant Accounting Policies (Details) [Line Items] | |||||||||||
Proceeds from Collection of Notes Receivable | $ 181,771 |
Nature of Business and Signif_4
Nature of Business and Significant Accounting Policies (Details) - Property, Plant and Equipment | 12 Months Ended | |
May 31, 2020 | May 31, 2019 | |
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | Term of lease | |
Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 3 years | |
Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 7 years | |
Office Equipment [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 3 years | 3 years |
Office Equipment [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 5 years | 5 years |
Machinery and Equipment [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 3 years | 3 years |
Machinery and Equipment [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | 10 years | 10 years |
Leasehold Improvements [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life | Term of lease |
Nature of Business and Signif_5
Nature of Business and Significant Accounting Policies (Details) - Disaggregation of Revenue - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | |
Disaggregation of Revenue [Line Items] | ||||||
Revenue | $ 4,907,889 | $ 3,056,431 | $ 8,688,758 | $ 5,915,446 | $ 11,917,629 | $ 8,459,048 |
Cannabis Dispensary [Member] | ||||||
Disaggregation of Revenue [Line Items] | ||||||
Revenue | 3,732,974 | 2,312,362 | 6,818,499 | 4,398,262 | 9,365,105 | 5,492,312 |
Cannabis Production [Member] | ||||||
Disaggregation of Revenue [Line Items] | ||||||
Revenue | $ 1,174,915 | $ 744,069 | $ 1,870,259 | $ 1,517,184 | $ 2,552,524 | $ 2,966,736 |
Acquisition of Alternative So_6
Acquisition of Alternative Solutions (Details) - Schedule of Business Acquisitions, by Acquisition - USD ($) | Jun. 27, 2018 | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Schedule of Business Acquisitions, by Acquisition [Abstract] | ||||
Initial purchase price | $ 2,050,000 | |||
Cash paid in connection with transaction | 5,995,543 | |||
Note payable | 3,810,820 | |||
Contingent consideration | 678,111 | |||
Common stock | 15,441,176 | |||
Total purchase price | 27,975,650 | |||
Net tangible assets | 595,151 | |||
Intangible assets | 1,637,600 | |||
Goodwill | $ 25,742,899 | $ 557,896 | $ 557,896 | $ 25,742,899 |
Prepaid Expenses and Other Cu_5
Prepaid Expenses and Other Current Assets (Details) - Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |||
Deposits | $ 2,262 | $ 2,315 | $ 211,493 |
Prepaid expenses | 295,058 | 231,777 | |
Total | $ 297,320 | $ 234,092 | $ 390,413 |
Inventory (Details) - Schedul_2
Inventory (Details) - Schedule of Inventory, Current - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Schedule of Inventory, Current [Abstract] | |||
Raw materials | $ 527,984 | $ 134,697 | $ 323,635 |
Finished goods | 860,416 | 440,545 | 423,198 |
Total | $ 1,388,400 | $ 575,242 | $ 746,833 |
Property, Plant and Equipment_4
Property, Plant and Equipment (Details) - Property, Plant and Equipment - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, gross | $ 1,741,830 | $ 969,196 | |
Less: accumulated depreciation | $ (1,151,948) | (868,200) | (546,408) |
Property, plant, and equipment, net | 3,654,780 | 3,775,509 | 1,910,301 |
Computer Equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, gross | 116,090 | 94,887 | 53,152 |
Furniture and Fixtures [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, gross | 145,103 | 144,025 | 140,701 |
Machinery and Equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, gross | 1,776,316 | 1,741,830 | |
Leasehold Improvements [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant, and equipment, gross | $ 2,769,219 | $ 2,662,967 | $ 1,293,660 |
Right to Use Assets and Liabi_7
Right to Use Assets and Liabilities - Operating Leases (Details) - Lessee, Operating Lease, Disclosure - USD ($) | Nov. 30, 2020 | May 31, 2020 | Jun. 01, 2019 | May 31, 2019 |
Lessee, Operating Lease, Disclosure [Abstract] | ||||
Right to use assets | $ 1,227,702 | $ 1,403,429 | $ 2,703,821 | $ 0 |
Amount amortized | $ (1,476,119) | $ (1,300,392) |
Right to Use Assets and Liabi_8
Right to Use Assets and Liabilities - Operating Leases (Details) - Lease, Cost - USD ($) | 6 Months Ended | 12 Months Ended | 18 Months Ended | |||
Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | Nov. 30, 2020 | Jun. 01, 2019 | |
Lease, Cost [Abstract] | ||||||
Lease liability | $ 1,265,642 | $ 1,473,051 | $ 2,675,310 | $ 1,265,642 | $ 2,675,310 | |
Less: current portion | (176,275) | (336,900) | 0 | (176,275) | ||
Lease liability, non-current | 1,089,367 | 1,136,151 | 0 | 1,089,367 | ||
Amount amortized | $ (207,409) | $ (992,296) | $ (1,202,259) | $ 0 | $ (1,409,668) |
Right to Use Assets and Liabi_9
Right to Use Assets and Liabilities - Operating Leases (Details) - Lessee, Operating Lease, Liability, Maturity - USD ($) | Nov. 30, 2020 | May 31, 2020 | Jun. 01, 2019 | May 31, 2019 |
Lessee, Operating Lease, Liability, Maturity [Abstract] | ||||
Twelve months ended November 30, 2021 | $ 268,577 | $ 440,022 | ||
Twelve months ended November 30, 2022 | 178,570 | 184,172 | ||
Twelve months ended November 30, 2023 | 167,234 | 168,886 | ||
Twelve months ended November 30, 2024 | 172,035 | 169,617 | ||
Twelve months ended November 30, 2025 | 176,980 | 174,489 | ||
Thereafter | 810,327 | 899,441 | ||
Total | 1,773,723 | 2,036,627 | ||
Less: Present value discount | (508,081) | (563,576) | ||
Lease liability | $ 1,265,642 | $ 1,473,051 | $ 2,675,310 | $ 2,675,310 |
Intangible Assets (Details) -_3
Intangible Assets (Details) - Schedule of Finite-Lived Intangible Assets - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets, gross | $ 1,664,112 | $ 1,663,593 | $ 1,641,563 |
Intangible assets, Accumulated Amortization | (301,491) | (242,389) | (116,476) |
Intangible assets, Net | 1,362,621 | 1,421,204 | 1,525,087 |
Intellectual Property [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets, gross | 319,600 | 319,600 | 319,600 |
Intangible assets, Accumulated Amortization | (77,237) | (61,257) | (29,297) |
Intangible assets, Net | 242.363 | 258,343 | 290,303 |
Customer Relationships [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets, gross | 990,000 | 990,000 | 990,000 |
Intangible assets, Accumulated Amortization | (119,625) | (94,875) | (45,375) |
Intangible assets, Net | 870,375 | 895,125 | 944,625 |
Trademarks [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets, gross | 301,000 | 301,000 | |
Intangible assets, Accumulated Amortization | (72,742) | (57,692) | |
Intangible assets, Net | 228,258 | 243,308 | |
Noncompete Agreements [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets, gross | 27,000 | 27,000 | 27,000 |
Intangible assets, Accumulated Amortization | (27,000) | (25,882) | (12,378) |
Intangible assets, Net | 0 | 1,118 | 14,622 |
Internet Domain Names [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets, gross | 26,512 | 25,993 | 3,963 |
Intangible assets, Accumulated Amortization | (4,887) | (2,683) | (1,834) |
Intangible assets, Net | $ 21,625 | $ 23,310 | $ 2,129 |
Intangible Assets (Details) -_4
Intangible Assets (Details) - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense - USD ($) | Nov. 30, 2020 | May 31, 2020 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | ||
2021 | $ 111,989 | $ 113,080 |
2022 | 111,989 | 111,962 |
2023 | 111,989 | 111,962 |
2024 | 111,989 | 111,962 |
2025 | 111,989 | 111,962 |
Thereafter | 802,676 | 860,276 |
$ 1,362,621 | $ 1,421,204 |
Other Assets (Details) - Sched
Other Assets (Details) - Schedule of Other Assets - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Schedule of Other Assets [Abstract] | |||
Security deposits | $ 167,455 | $ 167,455 | |
$ 167,455 | $ 167,455 | $ 167,455 |
Accounts Payable and Accrued _4
Accounts Payable and Accrued Liabilities (Details) - Schedule of Accounts Payable and Accrued Liabilities - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Schedule of Accounts Payable and Accrued Liabilities [Abstract] | |||
Trade accounts payable | $ 723,573 | $ 591,060 | $ 510,210 |
Accrued payroll and payroll taxes | 226,272 | 212,361 | 230,119 |
Accrued liabilities | 480,920 | 369,462 | |
Total | $ 1,430,765 | $ 1,172,883 | $ 1,517,127 |
Convertible Notes Payable (Deta
Convertible Notes Payable (Details) - Convertible Debt - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Convertible Notes Payable (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, gross | $ 20,095,813 | $ 19,883,212 | $ 18,360,230 |
Less: Discount | (1,448,590) | (2,238,730) | (3,819,010) |
Convertible Notes Payable, Net of Discounts | 18,647,223 | 17,644,482 | 14,541,220 |
Total - Convertible Notes Payable, Net of Discounts, Current Portion, net of discount of $1,448,590 and $0 | 5,147,073 | 0 | |
Total - Convertible Notes Payable, Net of Discounts, Long-term Portion, net of discount of $0 and $2,238,730 | 13,500,150 | 17,644,482 | 14,541,220 |
Navy Capital Debenture 1 [Member] | |||
Convertible Notes Payable (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, gross | 4,504,457 | 4,504,457 | 4,134,400 |
Navy Capital Debenture 2 [Member] | |||
Convertible Notes Payable (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, gross | 1,126,114 | 1,126,114 | 1,033,600 |
Murray FA Debenture [Member] | |||
Convertible Notes Payable (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, gross | 112,613 | 112,613 | 103,496 |
Darling Capital Debenture [Member] | |||
Convertible Notes Payable (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, gross | 599,101 | 599,101 | 550,478 |
Sabharwal Debenture [Member] | |||
Convertible Notes Payable (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, gross | 168,919 | 168,919 | 155,176 |
Srinivasan Debenture 6 [Member] | |||
Convertible Notes Payable (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, gross | 84,459 | 84,459 | 77,588 |
US Convertible Debenture 7 [Member] | |||
Convertible Notes Payable (Details) - Convertible Debt [Line Items] | |||
Convertible Notes Payable, gross | $ 13,500,150 | $ 13,287,549 | $ 12,305,492 |
Convertible Notes Payable (De_2
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) - USD ($) | Jul. 19, 2019 | Jul. 08, 2019 | Nov. 30, 2018 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 | Jun. 01, 2018 |
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Amount | $ 4,000,000 | |||||||
Discount recorded | 0 | $ 67,384 | $ 750,000 | |||||
Discount | $ 790,140 | $ 853,983 | 1,647,664 | 3,576,161 | ||||
Transferred | 212,601 | $ 753,977 | 1,553,082 | 491,230 | ||||
Converted | $ 12,542 | $ 13,315 | 0 | 75,000 | ||||
converted shares (in Shares) | 15,677 | 16,644 | ||||||
converted warrants (in Shares) | 7,838 | 8,322 | 33,463,838 | |||||
Total - Convertible Notes Payable Discount Current Portion | 1,448,590 | 0 | ||||||
Total - Convertible Notes Payable, Discount | 0 | 2,238,730 | 3,819,010 | |||||
Navy Capital Debenture 1 [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Amount | $ 4,000,000 | $ 4,000,000 | ||||||
Interest rate | 8.00% | 8.00% | ||||||
Dated | Oct. 31, 2018 | Oct. 31, 2018 | ||||||
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | ||||||
Discount recorded | $ 3,254,896 | $ 3,254,896 | ||||||
Discount | 542,483 | 1,084,965 | 632,896 | |||||
Accrued interest | $ 180,179 | $ 344,962 | 191,363 | |||||
Convertible | The U.S. Convertible Debenture 1 is convertible into units (the "Convertible Debenture Units") at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 1 is convertible into units (the "Convertible Debenture Units") at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | ||||||
Matures | 3 years | 3 years | ||||||
Transferred | $ 82,688 | $ 370,057 | 134,400 | |||||
Navy Capital Debenture 2 [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Amount | $ 1,000,000 | $ 1,000,000 | ||||||
Interest rate | 8.00% | 8.00% | ||||||
Dated | Oct. 31, 2018 | Oct. 31, 2018 | ||||||
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | ||||||
Discount recorded | $ 813,724 | $ 813,724 | ||||||
Discount | 135,621 | 271,241 | 158,224 | |||||
Accrued interest | $ 45,045 | $ 86,240 | 47,841 | |||||
Convertible | The U.S. Convertible Debenture 2 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 2 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | ||||||
Matures | 3 years | 3 years | ||||||
Transferred | $ 20,672 | $ 92,514 | 33,600 | |||||
Murray FA Debenture [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Amount | $ 100,000 | $ 100,000 | ||||||
Interest rate | 8.00% | 8.00% | ||||||
Dated | Oct. 24, 2018 | Oct. 24, 2018 | ||||||
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | ||||||
Discount recorded | $ 75,415 | $ 75,415 | ||||||
Discount | 12,569 | 25,138 | 14,664 | |||||
Accrued interest | $ 4,505 | $ 8,638 | 4,945 | |||||
Convertible | The U.S. Convertible Debenture 3 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 3 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | ||||||
Matures | 3 years | 3 years | ||||||
Transferred | $ 2,070 | $ 9,117 | 3,496 | |||||
Darling Capital Debenture [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Amount | $ 532,000 | $ 532,000 | ||||||
Interest rate | 8.00% | 8.00% | ||||||
Dated | Oct. 25, 2018 | Oct. 25, 2018 | ||||||
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | ||||||
Discount recorded | $ 416,653 | $ 416,653 | ||||||
Discount | 69,442 | 138,884 | 81,016 | |||||
Accrued interest | $ 23,965 | $ 45,942 | 26,185 | |||||
Convertible | The U.S. Convertible Debenture 4 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 4 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | ||||||
Matures | 3 years | 3 years | ||||||
Transferred | $ 11,010 | $ 48,623 | 18,478 | |||||
Sabharwal Debenture [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Amount | $ 150,000 | $ 150,000 | ||||||
Interest rate | 8.00% | 8.00% | ||||||
Dated | Oct. 26, 2018 | Oct. 26, 2018 | ||||||
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | ||||||
Discount recorded | $ 120,100 | $ 120,100 | ||||||
Discount | 20,017 | 40,033 | 23,353 | |||||
Accrued interest | $ 6,757 | $ 12,950 | 7,348 | |||||
Convertible | The U.S. Convertible Debenture 5 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The U.S. Convertible Debenture 5 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | ||||||
Matures | 3 years | 3 years | ||||||
Transferred | $ 3,104 | $ 13,743 | 5,176 | |||||
Srinivasan Debenture 6 [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Amount | $ 75,000 | $ 75,000 | ||||||
Interest rate | 8.00% | 8.00% | ||||||
Dated | Oct. 26, 2018 | Oct. 26, 2018 | ||||||
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | ||||||
Discount recorded | $ 60,049 | $ 60,049 | ||||||
Discount | 10,008 | 20,019 | 11,674 | |||||
Accrued interest | $ 3,378 | $ 6,475 | 3,674 | |||||
Convertible | The U.S. Convertible Debenture 6 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10 | The U.S. Convertible Debenture 6 is convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10 | ||||||
Matures | 3 years | 3 years | ||||||
Transferred | $ 1,552 | $ 6,871 | 2,588 | |||||
US Convertible Debenture 7 [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Amount | $ 12,012,000 | $ 12,012,000 | ||||||
Interest rate | 8.00% | 8.00% | ||||||
Dated | Dec. 12, 2018 | Dec. 12, 2018 | ||||||
Conversion rate (in Dollars per share) | $ 0.80 | $ 0.80 | ||||||
Accrued interest | $ 536,439 | $ 1,025,549 | 458,759 | |||||
Convertible | The Canaccord Debentures are convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | The Canaccord Debentures are convertible into Convertible Debenture Units at a conversion price of $0.80 per Convertible Debenture Unit. Each Convertible Debenture Unit consists of (i) one share of the Company's common stock, and (ii) one-half of one warrant, with each warrant exercisable for three years to purchase a share of common stock at a price of $1.10. | ||||||
Matures | 3 years | 3 years | ||||||
Transferred | $ 212,601 | $ 984,300 | $ 291,249 | |||||
Converted | $ 25,857 | $ 25,857 | ||||||
converted shares (in Shares) | 32,321 | 32,321 | ||||||
converted warrants (in Shares) | 16,160 | 16,160 | ||||||
Three Months Ended November 30, 2020 [Member] | Navy Capital Debenture 1 [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Accrued interest | $ 90,089 | |||||||
Transferred | 0 | |||||||
Three Months Ended November 30, 2020 [Member] | Navy Capital Debenture 2 [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Accrued interest | 22,523 | |||||||
Transferred | 0 | |||||||
Three Months Ended November 30, 2020 [Member] | Murray FA Debenture [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Accrued interest | 2,252 | |||||||
Transferred | 0 | |||||||
Three Months Ended November 30, 2020 [Member] | Darling Capital Debenture [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Accrued interest | 11,983 | |||||||
Transferred | 0 | |||||||
Three Months Ended November 30, 2020 [Member] | Sabharwal Debenture [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Accrued interest | 3,378 | |||||||
Transferred | 0 | |||||||
Three Months Ended November 30, 2020 [Member] | Srinivasan Debenture 6 [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Accrued interest | 1,689 | |||||||
Transferred | 0 | |||||||
Three Months Ended November 30, 2020 [Member] | US Convertible Debenture 7 [Member] | ||||||||
Convertible Notes Payable (Details) - Convertible Debt (Parentheticals) [Line Items] | ||||||||
Accrued interest | 270,003 | |||||||
Transferred | $ 212,601 |
Convertible Notes Payable (De_3
Convertible Notes Payable (Details) - Schedule of Amortization of Debt Discount - USD ($) | Jun. 01, 2018 | Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2020 | Nov. 30, 2019 | May 31, 2020 | May 31, 2019 |
Schedule of Amortization of Debt Discount [Abstract] | |||||||
Discounts on notes payable amortized to interest expense | $ 35,833 | $ 395,070 | $ 259,070 | $ 790,140 | $ 853,983 | $ 1,580,280 | $ 921,827 |
Convertible Notes Payable (De_4
Convertible Notes Payable (Details) - Schedule of Maturities of Long-term Debt - USD ($) | Nov. 30, 2020 | May 31, 2020 |
Schedule of Maturities of Long-term Debt [Abstract] | ||
2021 | $ 6,595,663 | $ 0 |
2022 | 13,500,150 | 19,883,212 |
2023 | 0 | 0 |
2024 | 0 | 0 |
2025 | 0 | 0 |
Thereafter | 0 | 0 |
Total | $ 20,095,813 | $ 19,883,212 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - Share-based Payment Arrangement, Option, Exercise Price Range - $ / shares | May 31, 2019 | May 31, 2018 | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 | Jul. 19, 2019 | Jul. 08, 2019 | May 30, 2019 | Nov. 14, 2018 | Sep. 06, 2018 | Aug. 14, 2018 | May 30, 2018 |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 1.10 | $ 1.10 | $ 0.75 | $ 0.75 | $ 0.75 | |||||||
Number of warrants outstanding (in Shares) | 54,818,985 | 54,835,145 | 54,835,145 | 54,818,985 | 54,818,985 | 4,495,750 | ||||||
Weighted average remaining contractual life | 1 year | 1 year 6 months | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.53 | $ 0.61 | $ 0.53 | $ 0.53 | $ 0.53 | |||||||
Number of warrants exercisable (in Shares) | 54,835,145 | 54,835,145 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.53 | $ 0.53 | ||||||||||
Warrant Exercisable at $0.49 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 0.49 | $ 0.49 | ||||||||||
Number of warrants outstanding (in Shares) | 33,465,110 | 33,465,110 | ||||||||||
Weighted average remaining contractual life | 1 year | 1 year 6 months | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.49 | $ 0.49 | ||||||||||
Number of warrants exercisable (in Shares) | 33,465,110 | 33,465,110 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.49 | $ 0.49 | ||||||||||
Warrants Exercisable at $0.50 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 0.50 | $ 0.50 | ||||||||||
Number of warrants outstanding (in Shares) | 2,736,500 | 2,736,500 | ||||||||||
Weighted average remaining contractual life | 1 year 83 days | 1 year 266 days | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.50 | $ 0.50 | ||||||||||
Number of warrants exercisable (in Shares) | 2,736,500 | 2,736,500 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.50 | $ 0.50 | ||||||||||
Warrant Exercisable at $0.60 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 0.60 | $ 0.60 | ||||||||||
Number of warrants outstanding (in Shares) | 17,500,000 | 17,500,000 | ||||||||||
Weighted average remaining contractual life | 1 year | 1 year 6 months | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.60 | $ 0.60 | ||||||||||
Number of warrants exercisable (in Shares) | 17,500,000 | 17,500,000 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.60 | $ 0.60 | ||||||||||
Warrant Exercisable at $0.75 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 0.75 | $ 0.75 | ||||||||||
Number of warrants outstanding (in Shares) | 837,500 | 837,500 | ||||||||||
Weighted average remaining contractual life | 80 days | 262 days | ||||||||||
Weighted average exercise price of outstanding warrants | $ 0.75 | $ 0.75 | ||||||||||
Number of warrants exercisable (in Shares) | 837,500 | 837,500 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 0.75 | $ 0.75 | ||||||||||
Warrant Exercisable at $1.10 [Member] | ||||||||||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||||||||||
Exercise Price | $ 1.10 | $ 1.10 | ||||||||||
Number of warrants outstanding (in Shares) | 296,035 | 296,035 | ||||||||||
Weighted average remaining contractual life | 1 year 21 days | 1 year 204 days | ||||||||||
Weighted average exercise price of outstanding warrants | $ 1.10 | $ 1.10 | ||||||||||
Number of warrants exercisable (in Shares) | 296,035 | 296,035 | ||||||||||
Weighted average exercise price of exercisable warrants | $ 1.10 | $ 1.10 |
Stockholders' Equity (Details_2
Stockholders' Equity (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - $ / shares | May 31, 2019 | Nov. 30, 2018 | Nov. 14, 2018 | Sep. 06, 2018 | Aug. 14, 2018 | May 31, 2018 | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract] | |||||||||
Warrants outstanding, Number of Shares | 54,818,985 | 4,495,750 | 54,835,145 | 54,818,985 | |||||
Warrants outstanding, Weighted Average Exercise Price | $ 0.53 | $ 0.61 | $ 0.53 | $ 0.53 | $ 0.53 | ||||
Granted, Number of Shares | 0 | 16,160 | 50,738,235 | ||||||
Granted, Weighted Average Exercise Price | $ 33,463,838 | $ 0 | $ 1.10 | $ 0.653 | |||||
Exercised, Number of Shares | 25,000 | 40,000 | 350,000 | 0 | 0 | (415,000) | |||
Exercised, Weighted Average Exercise Price | $ 0 | $ 0 | $ 0.75 | ||||||
Cancelled / Expired, Number of Shares | 0 | 0 | 0 | ||||||
Cancelled / Expired, Weighted Average Exercise Price | $ 0 | $ 0 | $ 0 | ||||||
Warrants outstanding, Number of Shares | 54,818,985 | 54,835,145 | 54,835,145 | 54,818,985 |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis - USD ($) | Nov. 30, 2020 | May 31, 2020 | May 31, 2019 |
Fair Value of Financial Instruments (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | |||
Derivative liabilities | $ 0 | $ 0 | $ 0 |
Fair Value, Inputs, Level 1 [Member] | |||
Fair Value of Financial Instruments (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | |||
Derivative liabilities | 0 | 0 | 0 |
Fair Value, Inputs, Level 2 [Member] | |||
Fair Value of Financial Instruments (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | |||
Derivative liabilities | 0 | 0 | 0 |
Fair Value, Inputs, Level 3 [Member] | |||
Fair Value of Financial Instruments (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | |||
Derivative liabilities | $ 0 | $ 0 | $ 0 |